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Abstract	Current	control	strategies	are	failing	to	contain	the	tuberculosis	(TB)	epidemic	and	 are	 limited	 by	 our	 lack	 of	 understanding	 of	Mycobacterium	 tuberculosis	
(M.tb)	 transmission	dynamics,	especially	 in	high	HIV	prevalence	settings.	M.tb	infection	 in	 children	aged	under	5	years	of	 age	 indicates	 recent	 transmission,	acting	 as	 a	 sentinel	 for	 infectious	 (typically	 adult)	 TB	 and	 highlights	 recent	failures	in	community	control	measures.	The	overall	aim	of	this	research,	which	was	based	in	a	high	HIV	prevalence	rural	community	in	northern	Malawi,	was	to	delineate	 M.tb	 transmission	 events	 occurring	 within	 the	 context	 of	 a	 well-implemented	 TB	 control	 programme,	 and	 thereby	 elucidate	 factors	 driving	transmission	 that	are	not	being	addressed	by	current	control	 strategies.	 	This	thesis	presents	findings	from	a	series	of	linked	studies,	including	a	longitudinal	tuberculin	 skin-test	 (TST)	 study	 of	 pre-school	 children	 in	 an	 area	 under	demographic	surveillance,	and	a	household	contact	study	of	smear-positive	TB	cases.				Estimates	of	the	average	annual	risk	of	M.tb	infection	(ARTI)	in	this	population	of	young	BCG-vaccinated	children	varied	widely	depending	on	the	method	used	to	estimate	infection	prevalence.		A	previously	overlooked	method	of	estimating	
M.tb	 infection	 prevalence,	 initially	 published	 by	 Rust	 and	 Thomas	 in	 1975,	appeared	to	be	only	method	to	appropriately	adjust	for	the	marked	effect	of	BCG-attributable	 induration	 in	 the	 youngest	 children	 (aged	 <2	 years).	 Marked	differences	 in	 the	 estimates	 of	 the	 risk	 of	M.tb	 infection	 when	 using	 cross-sectional	data	compared	to	using	longitudinal	data	are	also	highlighted.		
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Age,	known	contact	with	a	smear-positive	TB	case	and	community	M.tb	exposure	(defined	 as	 the	 average	 notification	 rate	 of	 smear-positive	 TB	 per	 100,000	population)	 were	 risk	 factors	 for	 prevalent	 and	 incident	 M.tb	 infection	 in	children.		Being	HIV-exposed	in	utero	was	the	strongest	risk	factor	for	prevalent	infection,	 whilst	 having	 an	 HIV-positive	 father	 was	 strongly	 associated	 with	incident	infection.		Additional	risk	factors	for	incident	infection	included	church	attendance	and	travel	on	mini-buses.		No	evidence	was	found	in	the	household	contact	 study	 that	 smear-positive	 tuberculosis	 patients	 on	 antiretroviral	treatment	(ART)	were	more	likely	to	transmit	M.tb	infection	to	household	child	contacts	 (as	 inferred	 from	 TST	 positivity)	 compared	 to	 smear-positive	tuberculosis	 patients	 not	 on	 ART.	 	 However,	 child	 contacts	 of	 HIV-negative	individuals	had	nearly	three	times	the	odds	of	having	a	positive	TST	compared	to	 child	 contacts	 of	 HIV-positive	 TB	 patients	 not	 on	 ART;	 this	 was	 partly	explained	by	differences	in	the	degree	of	smear	positivity.		HIV-related	risk	factors	for	prevalent	and	incident	M.tb	 infection	in	pre-school	children	 highlight	 that	 interventions,	 such	 as	 screening	 for	 HIV	 and	 TB	 with	implementation	 of	 isoniazid	 preventive	 therapy	 where	 indicated	 within	 the	household	of	HIV-positive	individuals	may	further	reduce	the	burden	of	TB	at	a	community	level	in	the	longer	term.	Findings	from	this	research	also	highlight	the	 need	 for	 better	 infection	 control	 practices	 (improved	 ventilation)	 in	congregate	settings	such	as	churches	and	mini-buses.	There	is	an	urgent	need	for	improved	ongoing	surveillance	to	guide	the	implementation	of	context-specific	TB	control	strategies.		 	
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1. Introduction				 	
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1.1	 Tuberculosis	control,	elimination	and	eradication	
Tuberculosis	 (TB),	 caused	predominantly	by	 the	 airborne	 transmission	of	 the	bacillus	 Mycobacterium	 tuberculosis	 (M.tb),1	 has	 afflicted	 humans	 from	prehistoric	times,2	reaching	epidemic	proportions	in	Europe	and	North	America	during	the	18th	and	19th	centuries.3	Dramatic	declines	in	TB	mortality	and	disease	were	 evident	 by	 the	 early	 20th	 century,	 predating	 the	 availability	 of	 effective	treatment.4,5	Improvements	in	living	and	social	conditions	which	occurred	in	the	early	1900s	are	thought	to	have	led	to	a	decrease	in	transmission	by	reducing	the	average	number	infected	by	each	infectious	TB	case,4	although	a	comprehensive	explanation	for	this	decline	remains	elusive.3,6		By	the	mid-1930s,	in	the	pre-chemotherapy	era,	the	sustained	decline	prompted	Wade	 Hampton	 Frost,	 the	 ‘father	 of	 modern	 epidemiology’,7	 to	 make	 the	statement:				 “…the	eventual	eradication	of	tuberculosis	only	requires	that	the	present	balance	against	it	be	maintained”.				This	statement	was	tempered	by	the	additional	assertion	that:		 “[There	are]…	only	two	forces,	which	singly	or	together,	would	check	or	reverse	the	striking	downward	trend	of	TB.	These	are:	(1)	a	decrease	in	human	resistance	to	the	disease,	or	(2)	some	fundamental	change	in	the	adaptation	of	the	tubercle	bacillus	to	its	host,	tending	to	favor	survival	of	the	parasite.”8				
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Regrettably	 the	 ‘two	 forces’	 foretold	 by	 Frost	 that	 could	 potentially	 halt	 the	eventual	eradication	of	TB	may	well	have	materialised	in	the	form	of	the	epidemic	spread	of	 the	retrovirus,	Human	Immunodeficiency	Virus	(HIV)	 in	 the	1980s,9	and	 the	evolution	and	global	dissemination	of	drug-resistant	strains	of	M.tb.10		However,	these	are	not	the	only	two	factors	limiting	our	ability	to	eradicate	M.tb	today.	 Failure	 of	 case	 finding	 and	 poor	 treatment	 adherence	 hinder	 the	effectiveness	of	early	case	detection	and	effective	TB	treatment,	which	are	the	cornerstone	of	global	TB	control	strategies.		Despite	 significant	 progress	 through	 the	Directly	 Observed	 Treatment,	 Short-course	(DOTS)	strategy	in	the	1990s	and	the	Stop	TB	strategy	since	2006,11	we	have	been	unable	to	mitigate	the	disastrous	impact	of	the	HIV	pandemic	on	global	TB	control	predicted	decades	earlier,9,12,13	which	continues	to	overwhelm	health	systems	 today,	 especially	 in	 sub-Saharan	 Africa.14,15	 Case	 detection	 and	treatment	 completion	 have	 been	 the	 cornerstone	 of	 global	 TB	 control,	 yet	evidence	 points	 to	 continued	 person-to-person	 M.tb	 transmission,	 even	 in	settings	with	well-implemented	national	TB	control	programmes.16-18	The	year	2015	marked	a	transition	in	global	TB	control	with	a	step-up	from	the	Stop	TB	strategy	 to	 the	 ambitious	 End	 TB	 strategy,	 affirming	 the	 ultimate	 goal	 of	eliminating	 TBi	 by	 2050.19	 It	 is	 worth	 noting	 that	 in	 order	 to	 achieve	 this	formidable	task,	reductions	in	global	TB	incidence	in	the	order	of	ten	times	the	current	rate	of	decline	are	required.20																																																											i	Elimination	 is	defined	as	achieving	an	 incidence	of	<	1	case	of	all	 forms	of	TB	per	1,000,000	population	per	year	
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This	 has	 led	 to	 a	 renewed	 focus	 on	 additional	 control	 interventions,21	 which	include	 active	 case	 finding	 (ACF)	 as	 a	 means	 to	 interrupt	 transmission,22	improved	 diagnosis	 and	 treatment	 of	 established	 M.tb	 infection	 thereby	‘controlling	the	seedbeds’	of	future	cases,23	and	a	greater	emphasis	on	a	biosocial	approach	and	sustainable	development	to	put	an	end	to	the	TB	epidemic.24	Some	of	 these	 strategies	 have	 a	 robust	 evidence-base	whereas	 others	 have	weaker	grounds	for	advocating	wider	implementation.25		To	inform	which	components	should	be	part	of	a	maximally	effective	complement	of	interventions	we	need	a	better	 understanding	 of	 M.tb	 transmission	 dynamics,	 especially	 in	 high	 HIV	burden	settings.			
1.2	 Knowledge	gaps	in	M.tb	transmission	research	
Significant	 knowledge	 gaps	 in	 M.tb	 transmission	 research	 remain	 despite	decades	of	 scientific	 investigation.	 	Unfortunately,	 improved	understanding	of	
M.tb	 transmission	dynamics	as	 a	 research	priority	has	been	underfunded	and	was	excluded	from	the	research	and	development	component	of	the	2011-2015	Global	Plan	to	Stop	TB.26				The	lack	of	recognition	of	M.tb	transmission	research	as	a	research	priority	area	by	funders,	was	one	of	the	reasons	that	I	and	a	fellow	PhD	student	at	University	College	of	London	(UCL),	Tom	Yates,	organised	an	M.tb	Transmission	meeting,	which	was	held	in	London	in	November	2014.		The	event	was	co-funded	by	the	TB	Modelling	and	Analysis	Consortium,	UCL	Population	Health	Domain,	and	the	TB	Centre	at	the	London	School	of	Hygiene	&	Tropical	Medicine.	This	meeting	led	
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to	a	publication	of	a	Review	article	on	M.tb	transmission	in	high	burden	settings,	which	 is	 presented	 in	 Chapter	 2.	 	 The	 agenda	 for	 the	meeting	 and	 the	 list	 of	attendees	are	included	in	Appendix	I.			Knowledge	 gaps	 in	 M.tb	 transmission	 research	 will	 be	 covered	 in	 detail	 in	Chapter	2	as	part	of	 the	review.	The	research	priorities	which	are	specifically	addressed	by	the	work	presented	in	this	thesis	include:			 i. measuring	M.tb	transmission	at	a	population-level	ii. identifying	drivers	of	recent	M.tb	transmission	iii. providing	insight	into	where	M.tb	transmission	occurs	in	the	community	iv. improving	 our	 understanding	 of	 the	 effect	 of	 HIV	 and	 antiretroviral	therapy	on	M.tb	transmission	dynamics		
1.3	 Research	setting	
The	Karonga	Prevention	Study,	a	research	group	collaborating	with	the	Malawi	National	 Tuberculosis	 Programme	 (NTP),	 has	 been	 supporting	 core	 TB	programme	 activities	 and	 conducting	 population-level	 TB	 epidemiological	studies	in	Karonga	district,	northern	Malawi,	since	1986.27				Significant	findings	from	previous	TB	epidemiological	studies	conducted	by	the	research	group	include:	
• failure	of	BCG	vaccination	to	protect	against	adult	pulmonary	TB,	despite	protecting	against	leprosy28	
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• estimation	 that	 about	 two	 thirds	 of	 active	 TB	 arises	 from	 recent	infection29	
• HIV-associated	 TB	mostly	 follows	 recent	M.tb	 infection,	 irrespective	 of	pre-existing	latent	infection30		
• recognisable	recent	contact	is	responsible	for	about	10%	of	disease31-33	
• proportion	 of	 TB	 cases	 due	 to	 recent	 transmission	has	 decreased	 over	time,	as	has	the	proportion	of	TB	cases	transmitting	and	giving	rise	to	new	cases34	
• drug	 resistance	 has	 remained	 constant	 (<10%)	 over	 more	 than	 20	years,35	an	 indicator	of	 the	existence	of	a	well-implemented	TB	control	programme	in	the	district.		Adult	HIV	prevalence	was	4%	in	1988-90,	reaching	a	peak	of	around	13%	in	early	2000,27	and	has	currently	plateaued	around	9%.35		Figure	1	is	an	extension	of	the	original	TB	incidence	analysis	of	all	new	episodes	of	smear-positive	pulmonary	TB	in	adults	in	Karonga	District	from	1988	to	2011	published	in	2013.35	For	the	purposes	of	 this	 thesis,	 the	 candidate	has	updated	 the	analysis	with	 the	most	recently	 available	 data.	 	 Adult	 population	 denominators	 for	 Karonga	 District	were	acquired	from	KPS	whole	population	survey	data	for	the	1980s	and	from	national	censuses	from	1998	to	2008.35		An	assumption	of	exponential	growth	of	3%	per	annum	from	2008	to	2017	was	used	based	on	the	observed	population	growth	between	censuses	in	1998	and	2008.	The	figure	illustrates	the	peak	in	the	incidence	of	new	smear-positive	pulmonary	tuberculosis	in	the	late	1990s	at	around	 140	 per	 100,000	 population	 per	 year	 and	 then	 the	 continued	 steady	
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decline	 to	 levels	below	 those	 seen	 in	 the	earlier	years	of	 the	HIV	epidemic	 to	around	60	per	100,000	population	per	year	in	2016.	
	
Figure	 1.	 Incidence	 of	 new	 smear-positive	 pulmonary	 TB	 in	 adults	 (per	
100,000	population/year)	in	Karonga	district	from	1988-90	to	2015-17		The	greater	part	of	the	fieldwork	for	this	research	was	undertaken	in	the	Karonga	demographic	 surveillance	 site	 (DSS:	 population	 39,000).	 See	 Figure	 2.	 The	demographic	 surveillance	 site	was	 set	up	 in	 the	 south	of	 the	district	 in	2002,	primarily	 to	 provide	 a	 platform	 for	 epidemiological	 studies	 of	 HIV	 and	 HIV-associated	infectious	disease	and	to	monitor	the	impact	of	interventions	such	as	antiretroviral	therapy	(ART).36				
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		HDSS	health	demographic	surveillance	site	
Figure	2.	Map	of	the	DSS	within	Malawi	in	relation	to	Tanzania,	Zambia	and	
Mozambique	(Source:	MEIRU/KPS)	
	BCG	 vaccination	was	 introduced	 into	 the	 district	 initially	 among	 all	 ages	 in	 a	vaccine	 trial	 in	 the	 mid	 1980s.	 	 It	 has	 been	 part	 of	 the	 routine	 Expanded	Programme	on	 Immunisation	 since	 1990,	 and	 is	 given	 at	 first	 health	 systems	contact.27			Conducting	M.tb	transmission	research	within	the	context	of	a	well-implemented	TB	control	programme	in	a	high	HIV	prevalence	setting,	such	as	Malawi,	is	ideal.		It	has	enabled	 the	elucidation	of	 factors	driving	community	M.tb	 transmission	that	 are	 not	 being	 addressed	 by	 current	 prevention	 strategies.	 An	 in-depth	understanding	of	 local	TB	epidemiology	made	possible	by	preceding	 research	has	also	greatly	facilitated	detailed	interpretation	of	research	findings.			
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1.4	 Study	rationale:	children	as	‘sentinels’	
The	potentially	long	latent	period	of	M.tb	infection	and	the	inability	to	distinguish	between	 recent	 and	 historic	 infection	 complicates	 studies	 examining	 M.tb	transmission	dynamics.37	 It	was	 therefore	decided	 to	undertake	 this	 research	primarily	using	pre-school	children	(aged	under	5	years)	based	on	the	logic	that	
M.tb	 infection	 in	 the	very	young	necessarily	 results	 from	recent	 transmission.		
M.tb	 infection	 in	 pre-school	 children	 acts	 as	 a	 sentinel	 of	 the	 presence	 of	infectious	adult	tuberculosis,1,38	thus	having	the	potential	to	highlight	failure	of	contemporary	TB	control	measures.	1,39	Identifying	recent	M.tb	infection	in	this	subset	of	the	population	also	increases	the	chance	of	being	able	to	pinpoint	the	source	of	new	infections	in	space,	as	young	children	spend	more	time	near	their	home	and	close	family	than	do	adults.		The	concept	of	using	young	children	as	‘sentinels’	to	identify	potential	sources	of	community	M.tb	 transmission	 is	 not	 new.	 	 A	 case-finding	 study	 published	 by	Griffiths	et	al.	in	1963	used	serial	annual	tuberculin-testing	of	school	children	in	Cardiff	to	detect	children	who	were	recent	‘tuberculin	convertors’	and	went	on	to	trace	the	source	of	their	infection	by	radiographically	screening	all	household	contacts	 of	 1000	 child	 convertors,	 identifying	 183	 contacts	 with	 previously	undiagnosed	tuberculosis.40		Even	as	early	as	1930,	Kielland	suggested,	in	a	letter	to	 the	 Journal	of	 the	Norwegian	Tuberculosis	Association,	 the	systematic	use	of	repeated	tuberculin	tests	for	early	diagnosis	and	case	finding,	using	tuberculin-positive	school	children	as	the	starting	point	for	case	finding.41		
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1.5	 Conceptual	framework	and	definitions	of	terms	used	in	
thesis	
Our	understanding	of	the	natural	history	following	M.tb	exposure	to	established	
M.tb	 infection	 through	 to	 disease	 remains	 open	 to	 question.42-44	 However	 a	number	 of	 risk	 factors	 resulting	 in	 established	 M.tb	 infection	 and	 disease	following	M.tb	exposure	have	been	identified.	Figure	3	(based	on	a	conceptual	hierarchical	 framework	as	 suggested	by	Victora	et	al.)45	provides	 a	 simplified	schematic	 of	 the	 risk	 factors	 at	 the	 individual,	 household,	 societal	 and	environmental	 level	 which	 affect	 progression	 at	 different	 points	 along	 the	continuum	 from	M.tb	 exposure	 through	 to	 established	 infection,	 disease	 and	ultimately	to	cure	or	death	from	TB	disease.		Those	risk	factors	relevant	to	this	research,	 namely	 those	 resulting	 in	 established	 M.tb	 infection,	 have	 been	highlighted	in	the	box	with	a	dashed	blue	line.	 	 	Risk	factors	for	prevalent	and	incident	M.tb	infection	which	were	examined	as	part	of	this	work	are	featured	in	blue	font	in	the	figure.		
	
Definition	of	terms	used	in	this	thesis	are	presented	in	the	Table	1.	
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Figure	 3.	 Conceptual	 framework	 illustrating	 risk	 factors	 associated	with	 transition	 from	 each	 state	 from	 exposure	 to	M.tb	
exposure	through	to	infection	and	disease	46,47	
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Term	 Definition	 Comment	
Infectiousness	 Propensity	to	transmit	M.tb		 This	relates	to	source	case	characteristics,	e.g.	active	disease	vs	subclinical,	presence	of	lung	cavitation	vs	none,	bacillary	load,	HIV	status,	health-seeking	behaviour,	and	whether	on	effective	treatment	or	not	(and	not	to	contact	characteristics,	e.g.	susceptability	to	infection	following	exposure)	48	
Recent	transmission	 M.tb	transmission	which	has	occurred	within	the	last	5	years	 For	the	purposes	of	this	thesis,	all	M.tb	transmission	which	has	occurred	within	the	last	5	years	is	defined	as	recent,	using	children	aged	under	5	years	as	sentinels	of	M.tb	transmission	
Exposure	 Exposure	to	M.tb	bacilli		
For	the	purposes	of	this	thesis,	exposure	is	defined	as	contact	with	diagnosed	smear-positive	pulmonary	TB.	49,	50	In	the	community,	this	is	quantified	as	an	average	notification	rate	of	smear-positive	pulmonary	TB	per	year	per	residential	area	and	within	the	household	as	proximity	to	index	case,	e.g.		resident	within	the	same	household,	slept	in	the	same	room,	slept	in	the	same	bed	etc.)		
Close	contact	 Household	contact	with	diagnosed	TB	case	 For	the	purposes	of	this	thesis,	close	contact	is	defined	as	any	form	of	household	contact	(including	non-residential	household	contact)	with	a	diagnosed	TB	case,	e.g.	a	child	staying	with	a	grandparent	for	a	2-week	period	50	
Congregate	setting/gathering	place	 Places	where	>10	persons	within	a	community	come	together,	e.g.	at	a	funeral,	in	a	church,	in	a	mini-bus		 Congregate	setting/gathering	places	examined	in	this	research	do	not	include	long-term	institutionalised	congregate	settings	such	as	correctional	facilities,	schools,	care	homes	or	refugee	camps.			
Table	1.	Definitions	of	terms	used	in	thesis		
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1.6	 Research	aim	and	objectives	
The	overall	aim	of	the	research	was	to	investigate	M.tb	transmission	in	a	rural,	high	HIV	prevalence	setting	using	classical	field	epidemiological	techniques.		The	specific	objectives	were	to:	1. Estimate	 the	prevalence	and	annual	risk	of	M.tb	 infection	 in	pre-school	children	as	a	measure	of	recent	M.tb	transmission	2. Identify	risk	factors	for	prevalent	and	incident	M.tb	infection	in	pre-school	children	3. Identify	potential	locations	of	recent	M.tb	transmission	in	the	community	4. Assess	the	effect	of	ART	on	the	‘infectiousness’	of	HIV–positive	adults	with	smear-positive	pulmonary	TB			
1.7	 Thesis	outline	
The	format	of	this	thesis	is	that	of	a	‘research	paper	style’	dissertation.		The	thesis	is	composed	of	manuscripts	that	have	been	published,	accepted	for	publication,	or	 are	 ready	 for	 submission,	 and	 are	 bookended	 by	 an	 introduction	 and	discussion	section.	All	papers	are	formatted	according	to	journal	requirements.		The	chapters	are	as	follows:		
Chapter	1	(this	chapter)	introduces	the	area	of	research,	the	starting	point	that	led	 up	 to	 the	 project,	 the	 study	 rationale	 including	 the	 research	 aim	 and	objectives	and	the	outline	of	the	‘research-style’	thesis.		
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Chapter	2	presents	the	literature	review	undertaken	for	this	thesis	which	is	a	published	 review	 paper	 (joint	 first	 author)	 “The	 transmission	 of	
Mycobacterium	 tuberculosis	 in	 high	 burden	 settings”	 published	 in	 Lancet	Infectious	Diseases.	Reference:	Yates	TA,	Khan	PY,	Knight	GM,	Taylor	JG,	McHugh	TD,	Lipman	M,	White	RG,	Cohen	T,	Cobelens	FG,	Wood	R,	Moore	DA,	Abubakar	I.	Lancet	Infect	Dis.	2016	Feb;	16(2):227-38.		
Chapter	3	consists	of	the	manuscript	titled	“Challenges	in	the	estimation	of	
the	annual	 risk	of	Mycobacterium	 tuberculosis	 infection	 in	 children	aged	
under	5	years”	published	in	the	American	Journal	of	Epidemiology.	Reference:		Khan	PY,	Glynn	 JR,	Mzembe	T,	Mulawa	D,	Chiumya	R,	Crampin	AC,	Kranzer	K,	Fielding	 KL.	 Am	 J	 Epidemiol.	 2017	May	 19.	 doi:	 10.1093/aje/kwx153.	 [Epub	ahead	of	print].		
Chapter	 4	 is	 the	 published	 paper	 “Risk	 factors	 for	 Mycobacterium	
tuberculosis	 infection	 in	 2-4	 year	 olds	 in	 a	 rural	 HIV-prevalent	 setting”	published	 in	 the	 International	 Journal	 of	 Tuberculosis	 and	 Lung	 Disease.		
Reference:	Khan	PY,	Glynn	JR,	Fielding	KL,	Mzembe	T,	Mulawa	D,	Chiumya	R,	Fine	PE,	Koole	O,	Kranzer	K,	Crampin	AC.	Int	J	Tuberc	Lung	Dis.	2016	Mar;	20(3):	342-9.			
Chapter	 5	 presents	 a	 draft	 paper	 “Incident	 Mycobacterium	 tuberculosis	
infection	 in	 young	 children	 identifies	 risk	 factors	 for	 recent	 community	
transmission	in	rural	Malawi.”		This	paper	is	comprised	of	a	risk	factor	analysis	including	potential	locations	of	recent	community	M.tb	transmission.	
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Chapter	6	is	comprised	of	the	manuscript	(in	press)	titled	“Does	antiretroviral	
treatment	 increase	 the	 infectiousness	 of	 smear-positive	 pulmonary	
tuberculosis?”	 which	 examines	 the	 prevalence	 of	 M.tb	 infection	 in	 child	household	contacts	of	adult	smear-positive	pulmonary	TB	cases	by	 index	case	HIV/ART	 status.	 Accepted	 for	 publication	 in	 the	 International	 Journal	 of	Tuberculosis	 and	 Lung	 Disease	 on	 the	 28th	 July	 2017.	 Reference:	 Khan	 PY,	Crampin	AC,	Mzembe	T,	Koole	O,	Fielding	KL,	Kranzer	K,	Glynn	JR.	Int	J	Tuberc	Lung	Disease.	2017	(in	press).		The	 discussion,	main	 conclusions,	 recommendations	 for	 further	 research	 and	potential	interventions	strategies	are	presented	in	Chapter	7.			
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2	 Mycobacterium	tuberculosis	transmission	in	high	
burden	settings:	literature	review			 	
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2.1	 Introduction	
This	chapter	 is	a	published	review	on	the	transmission	of	M.tb	 in	high	burden	settings,	which	was	jointly	co-first-authored	by	me	and	Tom	Yates,	a	PhD	student	at	UCL.		The	main	purpose	of	the	review	was	to	highlight	the	research	gaps	in	the	field	 of	M.tb	 transmission	 research.	 	 In	 summary,	 we	 identified	 a	 number	 of	research	priorities	including	the	need	for	the	identification	of	effective	strategies	for	 tuberculosis	 infection	 control,	 a	 call	 for	 improved	 understanding	 of	 the	transmissibility	 of	 drug-resistant	 strains	 and	 of	 where	 transmission	 is	 taking	place,	 and	 better	 estimates	 of	 the	 effect	 of	 HIV	 and	 antiretroviral	 therapy	 on	transmission	dynamics.		We	also	highlight	the	different	methods	of	quantifying	
M.tb	transmission	and	their	limitations,	including	measuring	transmission	at	the	population-level.		The	 copyright	 agreement	 is	 with	 Science	 Direct	 and	 available	 to	 view	 in	 the	Appendix	II.		
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3	 Measuring	the	annual	risk	of	Mycobacterium	
tuberculosis	infection	in	young	children			 	
	 36	
3.1	 Introduction	
The	annual	risk	of	M.tb	infection	(ARTI)	is	a	calculated	average	from	an	observed	prevalence	 of	M.tb	 infection	 in	 a	 specified	 population.	 By	 approximating	 the	incidence	of	M.tb	infection,	it	has	the	potential	to	provide	information	about	the	extent	of	community	M.tb	transmission.		However,	accuracy	of	the	estimation	of	this	metric	is	a	function	of,	and	therefore,	dependent	on	the	measure	of	observed	
M.tb	infection	prevalence	in	the	chosen	population.		This	 next	 chapter	 is	 a	 methodological	 research	 paper	 which	 highlights	 the	difficulties	in	estimating	the	ARTI	in	children,	especially	in	a	setting	where	the	vast	 majority	 of	 children	 have	 been	 BCG-vaccinated	 and	 the	 prevalence	 of	infections	due	to	non-tuberculous	mycobacteria	are	non-negligible.				In	the	paper,	a	method	first	described	more	than	40	years	ago	in	the	American	
Journal	of	Epidemiology	was	used.	 	I	came	across	this	paper	whilst	reading	the	paper	by	Rieder14	on	the	methodological	issues	in	the	estimation	of	the	burden	of	 tuberculosis	 (TB)	 from	 tuberculin	 surveys.	 Rieder	mentions	 that	 Rust	 and	Thomas	developed	a	model	based	on	tuberculin	skin	test	(TST)	data	in	United	States	Navy	recruits	by	asking	about	known	history	of	exposure	to	a	TB	case	and	separated	 people	 into	 contacts	 and	 non-contacts,	 which	 then	 allowed	 a	separation	 of	 the	 influences	 of	 TST	 reactions	 caused	 by	 environmental	mycobacteria	from	those	resulting	from	infection	with	M.tb.			As	part	of	my	PhD	research,	I	had	TST	data	from	children	aged	under	5	from	the	demographic	surveillance	site	in	Karonga	and	contemporaneous	TST	data	from	
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children	aged	under	5	with	known	household	exposure	to	a	smear-positive	TB	case,	so	decided	to	analyse	my	data	using	the	Rust	and	Thomas	method.				I	 think	 that	 method	 has	 been	 under-utilised	 and	 not	 taken	 up	 by	 other	researchers	because	 it	requires	TST	data	 to	be	available	on	those	with	known	household	exposure	to	a	TB	case	and	those	who	have	not	been	exposed	in	the	same	population,	which	is	not	widely	available.		I	do	think	that	it	is	regrettable	that	in	some	countries	where	large	tuberculin	surveys	were	being	undertaken	in	school	 children	 in	 the	 late	 1970s	 that	 a	 concurrent	 tuberculin	 study	 in	 child	household	 contacts	 of	 TB	 was	 not	 undertaken.	 	 It	 may	 have	 not	 even	 been	considered.	 	 However,	 there	 are	 also	major	 cost	 and	 resource	 implications	 of	conducting	such	an	additional	study	on	a	large	scale.		
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ABSTRACT	Accurate	 estimates	 of	 Mycobacterium	 tuberculosis	 (M.tb)	 infection	 in	 young	children	provide	a	critical	 indicator	of	on-going	community	M.tb	transmission.	Cross	reactions	due	to	infection	with	environmental	mycobacteria	and/or	bacille	Calmette-Guérin	 (BCG)	 vaccination	 compromise	 the	 estimates	 derived	 from	population-level	tuberculin	skin	test	surveys	using	traditional	cut-off	methods.		Newer	 statistical	 approaches	 are	 prone	 to	 failure	 of	 model	 convergence,	especially	 in	 settings	 where	 the	 prevalence	 of	 M.tb	 infection	 is	 low	 and	environmental	sensitisation	is	high.	We	conducted	a	tuberculin	skin	test	survey	in	 5119	 pre-school	 children	 in	 the	 general	 population	 and	 among	 household	contacts	 of	 tuberculosis	 cases	 in	 2012-2014	 in	 the	 same	 district	 in	 northern	Malawi,	 where	 sensitisation	 to	 environmental	 mycobacteria	 is	 common	 and	almost	 all	 children	 are	 BCG-vaccinated.	 	 We	 compared	 different	 proposed	methods	of	estimating	M.tb	prevalence,	 including	a	method	described	by	Rust	and	 Thomas	more	 than	 40	 years	 ago.	With	 the	 different	 methods,	 estimated	prevalence	in	the	general	population	was	0.7%-11.9%	at	age	<2	years	and	0.8-3.3%	at	age	2-4	years.	The	Rust	and	Thomas	method	was	the	only	method	to	give	a	lower	estimate	in	the	younger	age	group	(0.7%	vs	0.8%),	suggesting	it	was	the	only	 method	 which	 adjusted	 appropriately	 for	 the	 marked	 effect	 of	 BCG-attributable	induration	in	the	very	young.			 Word	count:	200	
	
Keywords:	Mycobacterium	 tuberculosis;	 infection	 prevalence;	 tuberculin	 skin	test;	annual	risk	of	tuberculous	infection	(ARTI);	children;	BCG;	Malawi	
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Abbreviations:	
M.tb	 Mycobacterium	tuberculosis	TST	 tuberculin	skin	test	ARTI	 annual	risk	of	M.tb	infection	BCG	 bacille	Calmette-Guérin	KHDSS	 Karonga	Health	and	Demographic	Surveillance	Site	IGRA	 interferon-gamma	release	assay	HIV	 human	immunodeficiency	virus	
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Introduction	Childhood	 tuberculosis	 has	 not	 been	 considered	 a	 priority	 in	 high	 burden	settings	 until	 recent	 years.1	 Children	 have	 pauci-bacillary	 disease	 and	 are	unlikely	 to	 contribute	 to	 onward	 transmission	 of	Mycobacterium	 tuberculosis	(M.tb).2	This	has	 led	 to	significant	under-reporting	of	paediatric	 tuberculosis.1	However	childhood	tuberculosis	and	M.tb	infection	in	the	very	young	necessarily	result	 from	recent	 transmission,	so	accurate	estimates	could	provide	a	critical	indicator	 of	 the	 effectiveness	 of	 prevention	 programmes	 to	 curtail	 on-going	community	M.tb	transmission.3,4		Historically,	measurements	of	 the	global	burden	of	 tuberculosis,	 including	 the	incidence	of	tuberculosis	disease	have	been,	in	part,	inferred	from	estimates	of	the	annual	risk	of	M.tb	infection	(ARTI)	as	derived	from	M.tb	infection	prevalence	data	obtained	from	tuberculin	skin	test	(TST)	surveys	in	school-age	children.5-7	Direct	estimates	of	 tuberculosis	disease	 incidence	would	require	prohibitively	large	 longitudinal	cohorts,	even	 in	areas	where	the	burden	of	disease	 is	high.8		Hence	 the	 comparatively	 cheaper	 and	 logistically	 simpler	 TST	 surveys	 were	undertaken	 on	 a	 global	 programmatic	 scale.	 	 The	 inference	 of	 tuberculosis	disease	incidence	from	ARTI	was	based	on	Styblo’s	rule,	where	a	1%	ARTI	risk	corresponds	to	50	incident	tuberculosis	cases	per	100,000	population	per	year.5	It	 is	now	recognised	that	accurate	estimates	of	 incidence	of	tuberculosis	cases	using	the	‘Styblo’	method	are	not	valid,9	though	trend	estimates	of	ARTI	based	on	tuberculin	surveys	can	be	useful.10-13	
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The	 TST	 measures	 the	 immunological	 response	 to	 a	 previously	 acquired	infection	with	a	mycobacterium	 that	shares	antigens	with	 those	 in	 tuberculin.		The	challenge	is	to	disentangle	reactions	due	to	M.tb	infection	from	reactions	due	to	exposure	to	environmental	mycobacteria	and	bacille	Calmette-Guérin	(BCG)	vaccination.12	Despite	the	lack	of	specificity		of	the	TST,14	and	because	of	the	cost	and	 logistical	 issues	 (need	 for	venepuncture,	 skilled	personnel	and	 laboratory	equipment)15	 and	 the	 lack	 of	 clarity	 around	 the	 conversion	 and	 reversion	phenomena	associated	with	serial	testing	of	the	more	specific	interferon-gamma	release	assays	(IGRAs),16	serial	population-wide	tuberculin	surveys	undertaken	in	young	 children	 in	high	burden	 countries	 remain	as	one	of	 the	 few	ways	 to	assess	 the	 impact	 of	 tuberculosis	 control	 strategies	 over	 time.	 However,	 this	assessment	 relies	 on	 the	 need	 for	 a	 consistent	 estimate	 of	 M.tb	 infection	prevalence	which	 is	 not	 always	 possible	with	 the	 traditional	 cut-off	methods,	especially	 in	settings	where	cross-reactivity	with	environmental	mycobacteria	and	BCG-attributable	reactions	are	common.11,17			
	Despite	the	advent	of	sophisticated	statistical	techniques,	such	as	latent	variable	modelling,18	ascertainment	of	the	prevalence	of	M.tb	infection	using	tuberculin	data	 is	 not	 always	 possible;	 failures	 of	 the	 model	 to	 converge	 are	 frequent,	especially	 in	 areas	 where	 there	 is	 a	 moderate	 to	 strong	 influence	 of	 cross-reactions	 and	 low	 prevalence	 of	 M.tb	 infection.12	 An	 alternative	 method	 to	estimate	 the	 prevalence	 of	M.tb	 infection	was	 published	 by	Rust	 and	Thomas	forty	years	ago,19	using	tuberculin	data	from	US	Navy	recruits.	The	authors	stated	that	their	proposed	approach	should	“become	even	more	preferable	in	the	years	to	 come”	 as	 the	prevalence	of	M.tb	 infection	 continued	 to	decrease	 compared	
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with	 the	 prevalence	 of	 infection	 with	 environmental	 mycobacteria,	 which	 is	likely	to	remain	constant.			We	aim	to	determine	the	prevalence	of	M.tb	infection	and	the	ARTI	in	recently	BCG-vaccinated	pre-school	children	in	rural	Malawi	using	the	model	proposed	by	Rust	and	Thomas.		We	compare	these	estimates	with	those	derived	using	the	classical	TST	cut-off	methods	(≥10mm	and	≥15mm),	fixed	mirror,6,20	and	mixture	analysis.21-24		
Methods	
Study	setting	Karonga	district,	northern	Malawi	is	predominantly	rural	with	an	adult	human	immunodeficiency	 virus	 (HIV)	 prevalence	 around	 9%,	 and	 incidence	 of	 new	smear-positive	tuberculosis	of	87/100,000	adults	per	year.25	BCG	vaccination	is	administered	to	children	on	first	health	system	contact	(usually	birth)	as	part	of	the	 Expanded	 Programme	 on	 Immunisation.	 The	 whole	 population	 (~39,000	people)	in	an	area	in	the	south	of	the	district	is	under	demographic	surveillance	in	the	Karonga	Health	and	Demographic	Surveillance	Site	(KHDSS).26		
Study	participants	
Population	at	low	risk	of	M.tb	infection	We	 conducted	 a	 population-wide	 TST	 survey	 in	 pre-school	 children	 in	 2012,	nested	in	the	KHDSS.		All	children	aged	3	months	to	4	years	old	resident	in	the	KHDSS	area	at	the	time	of	household	recruitment	were	eligible	to	take	part	in	the	study.			
		 45	
Population	at	high	risk	of	M.tb	infection	We	also	conducted	a	district-wide	cross-sectional	tuberculosis	household	case-contact	 study	 from	 January	 2013	 to	 December	 2014.	 	 Household	 contacts,	including	 children	 <	 5	 years,	 of	 an	 adult	 with	 smear-positive	 pulmonary	tuberculosis	were	tuberculin	tested.				
Study	procedures	Field	staff	were	trained	in	the	placement	and	reading	of	skin	tests	according	to	standard	 international	 guidelines.27	 Two	 international	 units	 of	 tuberculin	purified	protein	derivative	RT23	(Statens	Serum	Institut,	Copenhagen,	Denmark)	were	injected	into	the	volar	surface	of	the	forearm,	and	induration	was	measured	48-72	hours	 later.	The	 transverse	and	 longitudinal	diameter	of	 the	 induration	was	recorded	to	the	nearest	millimetre,	and	an	average	calculated.20		Children	with	TST≥10mm	were	assessed	for	tuberculosis-related	symptoms	by	field	staff,	and	the	results	were	recorded	in	the	child’s	health	passport.		Any	child	with	symptoms	suggestive	of	tuberculosis	(fever,	weight	 loss,	 failure	to	thrive,	night	sweats	or	cough)	was	reviewed	by	a	clinician	and	referred	to	the	district	hospital.		All	children	with	TST≥15mm	were	commenced	on	6-month	isoniazid	preventive	 treatment	 (10mg/kg	 once	 daily)	 after	 active	 disease	 had	 been	excluded.		Demographic	 data	 on	 sex,	 household	 size,	 household	 socioeconomic	 status	(using	a	composite	score	based	on	quality	of	dwelling	place,	number	of	assets,	employment	of	head	of	household,	 food	 security	 and	availability	of	 soap)	and	
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maternal	HIV	status	were	collected	for	all	study	participants.	HIV	status	of	the	child	was	not	ascertained	unless	clinically	indicated.	Written	informed	consent	was	obtained	from	a	parent	or	guardian	of	each	participating	child.		
Ethics	approval	Both	studies	were	approved	by	the	Malawi	National	Health	Sciences	Research	Committee	(study	protocols	#944	and	#1049)	and	the	London	School	of	Hygiene	and	Tropical	Medicine	Ethics	committee	(study	protocols	#6065	and	#6285).				
Statistical	analyses	The	frequency	distributions	of	induration	for	(i)	population	at	higher	risk	of	M.tb	
infection:	 children	 aged	 <5	 years	 resident	 in	 the	 household	 of	 an	 adult	 with	smear-positive	pulmonary	tuberculosis,	and	(ii)	population	at	lower	risk	of	M.tb	
infection:	children	aged	<5	years	resident	 in	the	KHDSS,	excluding	20	children	who	 had	 known	 direct	 household	 contact	 with	 tuberculosis,	 were	 tabulated	using	2mm	categories	to	minimise	the	number	of	categories	with	no	data.				We	 then	 used	 four	 methods	 to	 estimate	 M.tb	 infection	 prevalence	 in	 both	populations:		
1. Rust	and	Thomas	method	This	method	is	based	on	the	distribution	of	induration	size	(mm)	rather	than	a	classification	system	of	defining	individuals	as	positive,	negative	or	doubtful.	The	technique	was	originally	applied	to	a	well-defined	population	of	white	male	US	Navy	 recruits	 aged	17-21	years	old,	who	had	been	 lifetime	US	 residents.	This	
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population	 was	 then	 divided	 into	 two	 groups,	 those	 with	 known	 household	exposure	to	a	tuberculosis	case	based	on	self-report,	defined	as	‘high	risk’	and	those	without	such	exposure,	defined	as	‘low	risk’.				The	Rust	 and	 Thomas	method	 is	 built	 on	 a	 simple	mathematical	model.	 	 The	underlying	assumptions	are	that:		
• the	population	can	be	divided	into	two	groups	which	differ	only	in	the	prevalence	of	the	infection	
• there	is	an	identifiable	category	in	which	no	individual	has	M.tb	infection	(TST	=	0mm)	
• there	is	an	identifiable	category	in	which	all	individuals	have	M.tb	infection	(TST	≥	n	mm)		The	 rationale	 of	 the	 Rust	 and	 Thomas	model	 is	 as	 follows:	 in	 a	 hypothetical	population	 without	 any	M.tb	 infection,	 the	 majority	 will	 have	 a	 TST	 of	 zero	induration.	 	 If	sensitisation	to	environmental	mycobacteria	and/or	recent	BCG	vaccination	 is	 prevalent,	 reactions	 of	 moderate	 size	 will	 also	 occur.	 	 The	distribution	of	this	population	is	called	the	“non-infected”	distribution,	referring	to	the	absence	of	infection	with	M.tb.	Comparably,	in	a	hypothetical	population	in	which	everyone	has	been	infected	with	M.tb,	all	but	a	few	individuals	will	have	a	 fairly	 large	 reaction	 size,	 and	 a	 bell-shaped	 “infected”	 distribution	 will	 be	observed.	 	 In	 an	 existent	 population,	 the	 observed	 distribution	 will	 be	 a	combination	of	“infected”	and	“non-infected”	distributions.	Thus,	 the	observed	‘higher	 risk’	 and	 ‘lower	 risk’	 groups	 are	 each	 a	 mixture	 of	 overlapping	
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distributions	of	“infected”	and	“non-infected”.		If	one	observed	the	"non-infected”	population	alone,	there	would	be	a	very	large	proportion	with	zero	induration,	and	 the	 proportion	 of	 “non-infected”	 with	 small-	 to	 medium-sized	 reactions	would	 depend	 on	 the	 prevalence	 of	 nontuberculous	 mycobacterial	 infection	and/or	BCG-attributable	induration,	i.e.	the	distribution	of	reaction	size	depends	upon	sensitisation	to	environmental	mycobacteria	or	recent	BCG	vaccination,	but	not	upon	contact	status.		Expressed	in	a	different	way,	the	ratio	of	the	proportion	with	zero	induration	to	the	proportion	“non-infected”	is	constant	(Equation	1).19			Similarly,	the	distribution	of	reaction	sizes	among	those	who	are	truly	infected	is	independent	of	contact	status.	Assuming	that	there	is	a	reaction	size	(n)	above	which	all	individuals	are	infected,	the	ratio	of	the	proportion	in	category	n	to	the	proportion	“infected”	is	constant	(Equation	2).			
Equation	1	for	“non-infected”	population	!"1 − % = 	 !′"1 − %′			
Equation	2	for	“infected”	population	!)% = 	!′)%′ 		where	!" 		=	proportion	of	‘higher	risk’	population	with	zero	induration	!′"	=	proportion	of	‘lower	risk’	population	with	zero	induration	!) 	=	proportion	of	‘higher	risk’	population	in	induration	category	n	!′) 	=	proportion	of	‘lower	risk’	population	in	induration	category	n	
P	=	prevalence	of	M.tb	infection	in	the	‘higher	risk’	population	
P’	=	prevalence	of	M.tb	infection	in	the	‘lower	risk’	population		
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Equations	1	and	2	can	then	be	solved	for	P	and	P’;	the	prevalence	of	M.tb	infection	in	the	‘higher	risk’	and	‘lower	risk’	respectively.		 P	=	 *)	(*’"	–	*")*)*/"0*/)*"		P’	=	*1)	(*’"	–	*")*)*/"0*/)*"		A	 TST	 reaction	 size	 of	 ≥	 20mm	 was	 chosen	 as	 the	 category	 n	 in	 which	 all	individuals	 were	 assumed	 to	 have	M.tb	 infection.	 	 This	 category	 was	 chosen	following	 examination	 of	 the	 prevalence	 of	 infection	 calculated	 for	 different	values	of	n.	 	The	optimal	 choice	being	 that	 category	n	 in	which	 the	computed	prevalence	is	approximately	the	same	as	that	for	higher	values	of	n.19		(Web	table	1	and	Web	appendix	1	to	see	why	a	reaction	size	of	20mm	was	chosen).				Bias-corrected	95%	confidence	intervals	were	calculated	using	a	bootstrapping	approach	in	Stata	version	14.1	(Stata	Corporation,	College	Station,	TX,	USA).		
2. Fixed	cut-off	points	at	10mm	or	15mm	
M.tb	 infection	 prevalence	was	 calculated	 as	 the	 proportion	 of	 children	with	 a	“positive”	TST	defined	by	these	cut-offs,	divided	by	the	total	number	of	children	with	a	TST	result		
3. Fixed	mirror	method	(17mm)	The	 fixed	mirror	method	 assumes	 that	 in	 individuals	 with	M.tb	 infection	 the	distribution	of	induration	size	is	symmetric	around	a	fixed	mode	of	17mm,	and	
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that	 no	 non-specific	 reactions,	 such	 as	 BCG-attributable	 induration,	 reach	17mm.6,20	Therefore	all	reactions	of	17mm	were	counted	once	and	indurations	of	>17mm	were	counted	twice	and	summed	to	obtain	the	estimated	number	of	
M.tb	infections.	Prevalence	was	calculated	as	the	count	of	‘M.tb	infections’	divided	by	the	total	number	of	children	with	TST	results.24				
4. Mixture	analysis	Mixture	analysis	of	the	tuberculin	survey	data,	which	is	a	form	of	latent	variable	modelling,18	was	based	on	implementation	of	the	Bayesian	Markov	Chain	Monte	Carlo	approach	 in	R	(R	Foundation	 for	Statistical	Computing,	Vienna).28	Three	parametric	models	(Weibull,	lognormal	and	gamma	distributions)	were	tested	to	determine	 the	 best	 fit	model	 using	 the	maximum	 log	 likelihood	 function	 as	 a	guide.		The	quality	of	the	fit	was	assessed	by	comparing	predicted	and	observed	frequencies	via	posterior	predictive	model	checks.24,28		
Sensitivity	analyses	The	 effect	 of	 neonatal	 BCG	 vaccination	 on	 TST	 induration,	 which	 is	 most	pronounced	 in	 the	 first	 few	 months	 after	 vaccination,	 is	 thought	 to	 wane	rapidly.29,30	The	analysis	was	repeated,	 stratifying	children	 into	under	2	years	and	≥	2	years	to	assess	the	effect	of	BCG-attributable	induration	on	estimates	of	
M.tb	prevalence.	
	
Annual	risk	of	M.tb	infection	(ARTI)	The	ARTI,	the	probability	of	being	infected	in	any	one	year,	was	calculated	using	the	formula:31	
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ARTI	 ≈ 1 −	(1 − P)8 9	
	where	P=	prevalence	of	M.tb	infection,	a=	the	mean	age	of	children.	The	ARTI	was	only	calculated	for	the	children	resident	in	the	KHDSS,	which	was	assumed	to	be	representative	of	the	ARTI	in	children	aged	<5	years	in	the	district.		
Results	The	frequency	distribution	of	tuberculin	data	from	the	‘lower	risk’	and	‘higher	risk’	study	populations	are	shown	in	Table	1	and	the	Web	figures	1-4.		Among	all	children	 <5	 years,	 85%	 of	 the	 ‘lower	 risk’	 population	 had	 zero	 induration	compared	to	56%	of	the	‘higher	risk’	population	(p<0.001).		When	stratifying	by	age,	 the	proportion	with	zero	 induration	 in	the	 ‘lower	risk’	group	was	92%	in	those	aged	≥2	years	compared	to	73%	in	those	aged	<2	years.		In	the	‘higher	risk’	group	the	proportion	with	zero	induration	was	54%	in	those	aged	≥2	years	and	60%	in	those	<2	years.	There	was	no	evidence	that	distribution	of	induration	size	was	affected	by	HIV	exposure	status	of	the	child	(chi-squared	test:	 ‘lower’	risk	group	p=0.9;	‘higher’	risk	group	p=0.8).		Web	figure	4	illustrates	the	percentage	distribution	of	induration	category	stratified	by	HIV	exposure	status	and	contact	status.		
Prevalence	of	M.tb	infection		Table	 2	 shows	 the	 estimated	 prevalence	 of	M.tb	 infection	 using	 the	 different	methods.	 In	 the	 ‘lower	 risk’	 group	 the	 estimates	 of	 infection	prevalence	were	consistently	 higher	 in	 the	 under-2s	 compared	 to	 those	 aged	 ≥2	 years	 in	 all	methods	except	for	the	Rust	and	Thomas	model.		For	the	under-2s	the	estimates	
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ranged	 from	 0.7%	 to	 11.9%;	 the	mixture	model	 and	 the	 cut-off	 TST	 ≥10mm	method	estimated	 the	highest	 infection	prevalence	 (11	–	12%).	 	Although	 the	fixed	mirror	method	estimated	a	similar	infection	prevalence	for	≥	2years	to	the	Rust	and	Thomas	method,	in	the	under-2s	the	infection	prevalence	was	nearly	3	times	that	of	the	Rust	and	Thomas	method.		In	the	‘higher	risk’	group	the	estimates	were	higher	in	the	children	aged	≥	2	years	compared	to	the	youngest	age	group	for	all	methods.		The	estimates	for	the	older	age	group	in	the	‘higher	risk’	group	were	similar	for	all	methods,	ranging	from	39.9	%	to	42.0%,	except	for	the	TST	cut-off	≥15mm	method,	which	estimated	a	prevalence	 of	 M.tb	 infection	 of	 31.9%.	 	 The	 bias-corrected	 95%	 confidence	interval	of	Rust	and	Thomas	model	for	the	‘higher	risk’	children	aged	<	2	years	includes	0.	 	This	 is	 likely	 to	be	a	 result	of	 the	 small	 sample	 size,	n=52,	 in	 this	group.		
ARTI	The	estimates	of	the	ARTI	ranged	from	0.3%	(95%	CI:	0.1	–	0.9%)	to	2.6%	(95%	CI:	1.8	–	2.7)	depending	on	the	method	used	to	estimate	the	prevalence	of	M.tb	infection.	 	The	Rust	and	Thomas	model	estimate	was	the	most	conservative	at	0.3%	(95%	CI:	0.1	–	0.9%).		It	was	also	the	method	which	demonstrated	the	least	difference	in	ARTI	estimates	when	stratified	by	age	(see	Table	3).	
	
Discussion	Our	findings	highlight	the	challenges	of	using	tuberculin	surveys	to	estimate	the	risk	of	M.tb	infection	in	young	BCG-vaccinated	children.	ARTI	estimates	varied	5-
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fold	depending	on	the	method	used	to	estimate	M.tb	 infection	prevalence.	The	Rust	 and	 Thomas	 method	 generated	 a	 consistent	 estimate	 of	M.tb	 infection	prevalence	 and	 ARTI,	 irrespective	 of	 age,	 in	 a	 setting	 where	 sensitisation	 to	environmental	mycobacteria	is	known	to	be	high	22,	and	over	90%	of	children	are	BCG-vaccinated	within	3	months	of	birth.		It	was	the	only	method	which	appeared	to	appropriately	adjust	for	the	marked	effect	of	BCG-attributable	induration	in	the	very	young	(aged	<	2	years).			The	Rust	and	Thomas	method	protects	against	changes	in	prevalence	estimates	caused	 by	 differences	 in	 strength	 of	 tuberculin	 used	 or	 the	 use	 of	 different	equipment	and/or	techniques,	thus	making	it	possible	to	compare	M.tb	infection	prevalence	found	by	different	investigators	at	varying	times	and	place.19	Because	the	Rust	and	Thomas	method	relies	on	 the	distribution	of	 induration	 in	 those	known	to	have	been	exposed	to	M.tb	and	the	distribution	of	induration	in	those	at	 ‘lower’	 risk	 at	 the	 same	 point	 in	 time,	 as	 long	 as	 the	 same	 tuberculin	 and	technique	 is	used	 in	both	populations,	 the	prevalence	estimates	over	 time	are	much	more	likely	to	be	comparable,	despite	differences	in	geographical	settings,	climate	 zones,	 changing	 BCG	 vaccination	 policies	 and	 introduction	 of	 new	vaccines.		In	addition,	the	Rust	and	Thomas	model	can	be	used	to	generate	the	probability	of	M.tb	infection	at	each	induration	size,	therefore	making	it	possible	to	 calculate	 sensitivity	 and	 specificity,	 area	 under	 Receiver	 Operating	Characteristic	 curve	 and	 the	 positive	 predictive	 value	 of	 the	 TST	 in	 a	 given	population.14		Another	advantage	compared	to	traditional	cut-off	methods	is	that	prevalence	estimates	are	less	sensitive	to	alterations	in	the	chosen	critical	point.		For	the	Rust	and	Thomas	method	this	is	the	reaction	size	category	in	which	all	
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individuals	 are	 assumed	 to	 have	M.tb	 infection.	As	 long	 as	 this	 reaction	 size	exceeds	 the	 maximum	 reaction	 size	 occurring	 among	 the	 ‘non-infected’,	 the	calculated	prevalence	will	only	be	subject	to	random	fluctuations.	 	However,	if	the	 reaction	 size	 is	 too	 small,	 the	 basic	 assumption	 that	 all	 individuals	 with	reactions	of	that	size	or	larger	have	been	infected	with	M.tb	will	not	be	fulfilled	and	 the	 estimated	 infection	 prevalence	 will	 therefore	 overestimate	 the	 true	prevalence.19				One	of	the	reasons	that	the	method	has	been	apparently	forgotten	may	be	the	requirement	 of	 tuberculin	 data	 from	 ‘low	 risk’	 and	 ‘high	 risk’	 groups.	 The	US	Navy	recruits	 study,	used	 in	 the	original	 study,	used	 	 self-report	of	household	contact	with	a	 tuberculosis	 case.32	 In	our	 study,	we	combined	 tuberculin	data	from	a	TST	survey	conducted	in	a	demographic	surveillance	area	and	data	from	a	 concurrent	 tuberculosis	 case-contact	 household	 study	 in	 the	whole	 district.		The	 demographic	 surveillance	 area	 may	 not	 be	 representative	 of	 the	 whole	district:		research	has	been	conducted	in	KHDSS	for	the	last	12	years,	which	may	have	 influenced	 health-seeking	 behaviour	 which	 in	 turn	 may	 affect	 M.tb	transmission	dynamics	in	the	area.	One	of	the	major	assumptions	of	the	Rust	and	Thomas	model	is	that	the	‘high	risk’	and	‘low	risk’	populations	only	differ	with	respect	to	contact	status	and	therefore	prevalence	of	infection.		Reassuringly	in	our	 study	 the	 two	groups	did	not	differ	 significantly	with	 regards	 to	 age,	 sex,	household	size,	household	socioeconomic	status	and	maternal	HIV	status	 (see	Web	appendix	2	and	Web	table	2).				
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In	 the	 ‘lower	 risk’	 group	 the	 proportion	 of	 children	 with	 a	 TST≥20mm	 (our	chosen	 nth	 category)	 was	 larger	 in	 the	 under-2s	 (0.3%)	 than	 in	 the	 over-2s	(0.2%)	in	our	study.	 	If	these	are	not	due	to	M.tb	infection	it	would	violate	the	assumption	that	only	those	truly	infected	are	included	in	the	nth	category	and	would	therefore	over-estimate	the	infection	prevalence.		Similarly	for	the	fixed	mirror	method,	any	induration	size	≥	17mm	due	to	BCG-attributable	induration	rather	 than	 true	 M.tb	 infection	 prevalence	 would	 over-estimate	 infection	prevalence.	Very	large	induration	secondary	to	BCG	vaccination	is	more	likely	to	occur	in	the	under-2s	who	have	been	more	recently	vaccinated.		Interestingly,	a	Taiwanese	study	which	proposed	age-specific	cut-offs	to	detect	M.tb	infection	in	children,	suggested	a	cut-off	of	21mm	for	infants	aged	less	than	2	years.33	Data	in	the	larger	induration	(>20mm)	categories	were	sparse	and	misclassification	of	a	small	number	has	a	large	effect	on	the	resultant	proportion	in	the	nth	category,	which	is	a	limitation	of	the	data.		The	95%	confidence	interval	of	the	prevalence	of	M.tb	infection	in	the	‘high	risk’	children	aged	less	than	2	years	using	the	Rust	and	 Thomas	 method	 included	 0,	 also	 underscoring	 the	 importance	 of	 an	adequate	 sample	 size.	 A	 similar	 study	 among	 older	 children,	 adolescents	 and	young	adults,	who	are	likely	to	be	at	greater	risk	for	M.tb	infection	compared	to	young	children,20,34,35	would	be	useful	to	assess	the	robustness	of	the	Rust	and	Thomas	method.	 It	would	require	a	household	contact	study	as	well	as	a	“low	risk”	population	survey	which	would	have	cost	implications.				Our	 findings	 present	 evidence	 that	 the	 Rust	 and	 Thomas	method	 appears	 to	address	the	effect	of	recent	BCG	vaccination	in	the	under-2s.		In	the	over-2s,	the	results	of	 the	different	methods	vary	 less	and	are	all	 likely	to	be	plausible	but	
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because	the	Rust	and	Thomas	method	performed	more	appropriately	in	dealing	with	 the	 cross-reactions	 due	 to	 BCG	 in	 the	 younger	 age	 group,	 we	 can	 have	confidence	that	it	is	dealing	appropriately	with	cross-reactivity	in	the	older	age	group	as	well.			One	 may	 ask	 the	 question,	 why	 should	 we	 continue	 to	 advocate	 the	 use	 of	tuberculin	in	an	era	of	more	specific	diagnostics	such	as	IGRAs	and	newer	skin	tests,	such	as	the	C-Tb	skin	test,	a	novel	skin	test	containing	ESAT-6	and	CFP-10,	antigens	which	 are	 specific	 to	M.tb?36	The	 latest	 skin	 tests,	 for	which	 there	 is	currently	limited	data,	do	appear	to	offer	higher	specificity	than	tuberculin,	but	this	 might	 come	 at	 the	 cost	 of	 reduced	 sensitivity.37	 The	 cost,	 technical	complexity	 and	 the	 requirement	 of	 a	 laboratory	 infrastructure	 in	 order	 to	undertake	 large	 IGRA	 surveys	 usually	 precludes	 population-level	 studies.	However,	IGRA	sub-studies	nested	within	tuberculin	surveys	could	potentially	be	used	 to	 refine	 estimates	of	M.tb	 infection	prevalence	 12,38,39,	 although	 it	 is	 not	clear	 how	 discrepancies	 between	 TST	 and	 IGRA	 should	 be	 interpreted.	 In	longitudinal	 studies,	 IGRA	 and	 TST	 responses	 seem	 to	 convert	 and	 revert	 at	different	 rates,	 so	 the	 two	 tests	 are	 unlikely	 to	 give	 the	 same	 assessment	 of	infection	in	any	population.40,41		We	wanted	to	estimate	the	ARTI	in	pre-school	children	based	on	the	rationale	that	 determination	 of	 the	 average	 ARTI	 in	 the	 very	 young	 provides	 a	 critical	indicator	of	the	extent	of	recent	M.tb	transmission.		It	is	important	to	bear	in	mind	that	 risk	 of	M.tb	 infection	 is	 not	 independent	 of	 age,20,34,42	 and	 is	most	 likely	related	 to	 M.tb	 exposure	 through	 age-assortative	 social	 mixing.43	 Thus	 the	
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average	ARTI	in	the	youngest	within	a	population	is	unlikely	to	be	representative	of	the	ARTI	in	those	that	are	older,	but	it	does	provide	the	most	contemporary	marker	of	recent	M.tb	transmission.	Repeated	tuberculin	surveys	in	the	youngest	generation	 could	 potentially	 be	 used	 to	 assess	 whether	 implementation	 of	tuberculosis	control	strategies	within	the	community	have	resulted	in	a	decrease	of	recent	M.tb	transmission.11		
Conclusion	There	 is	unequivocally	a	need	 for	more	accurate	epidemiological	 indicators	of	
M.tb	 transmission	 and	 M.tb	 infection	 prevalence	 estimates	 in	 order	 to	understand	the	dynamics	of	the	tuberculosis	epidemic	in	varying	settings	44.	In	our	study,	 the	Rust	and	Thomas	method	was	 the	only	method	 to	 find	a	 lower	estimate	in	the	youngest	age	group,	suggesting	that	it	accounted	appropriately	for	the	cross-reactivity	due	to	BCG	vaccination.	 Word	count:	3702	
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Table	1.	Frequency	Distribution	of	Tuberculin	Data	in	Children	Aged	Under	5	years	in	Rural	Malawi	in	2012-2014	Stratified	by	Risk	
Group	and	Age	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	 	
	 FREQUENCY	DISTRIBUTION	OF	TUBERCULIN	DATA	
INDURATION	SIZE	
(MM)	
LOWER	RISK	GROUP	 HIGHER	RISK	GROUP	
ALL	<	5	YEARS		N=4,947	 <	2	YEARS	N=1,797	 ≥2	YEARS	N=3,150	 ALL	<	5	YEARS		N=152	 <	2	YEARS	N=52	 ≥2	YEARS	N=100		 n	 %	 n	 %	 n	 %	 n	 %	 n	 %	 n	 %	0	 4,187	 84.6	 1,301	 72.5	 2,886	 91.6	 85	 55.9	 31	 59.6	 54	 54.0	2	–	3	 26	 0.5	 10	 0.6	 16	 0.5	 3	 2.0	 1	 1.9	 2	 2.0	4	–	5	 72	 1.4	 37	 2.0	 35	 1.1	 2	 1.3	 2	 3.8	 0	 0.0	6	–	7	 160	 3.2	 105	 5.8	 55	 1.8	 4	 2.6	 3	 5.8	 1	 1.0	8	–	9	 191	 3.9	 137	 7.6	 54	 1.7	 2	 1.3	 1	 1.9	 1	 1.0	10	–	11	 99	 2.0	 60	 3.3	 39	 1.2	 4	 2.6	 1	 1.9	 3	 3.0	12	–	13	 88	 1.8	 62	 3.5	 26	 0.8	 8	 5.3	 3	 5.8	 5	 5.0	14	–	15	 64	 1.3	 49	 2.7	 15	 0.5	 9	 5.9	 2	 3.8	 7	 7.0	16	–	17	 32	 0.6	 22	 1.2	 10	 0.3	 11	 7.2	 2	 3.8	 9	 9.0	18	–	19	 19	 0.4	 9	 0.5	 10	 0.3	 13	 8.6	 2	 3.8	 11	 11.0	20	–	21	 3	 0.1	 1	 0.1	 2	 0.1	 8	 5.3	 3	 5.8	 5	 5.0	22+	 6	 0.1	 4	 0.2	 2	 0.1	 3	 2.0	 1	 1.9	 2	 2.0	
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Table	2.	Mycobacterium	tuberculosis	Infection	Prevalence	Estimates	and	95%	Confidence	Intervals	Using	Different	Methods	in	Children	
Aged	Under	5	years	in	2012-2014	in	Rural	Malawi	
TST	tuberculin	skin	test;	CI	confidence	interval	Lower	risk	group	is	composed	of	children	aged	under	5	years	resident	in	the	demographic	surveillance	site	Higher	risk	group	is	composed	of	children	aged	under	5	years	who	are	resident	in	the	household	of	a	smear-positive	pulmonary	TB	index	case			 	
Method	to	estimate	
M.tb	infection	
prevalence		
LOWER	RISK	GROUP	 HIGHER	RISK	GROUP	
ALL	<5	YEARS		N=4,947	 <	2	YEARS	N=1,797	 ≥2	YEARS	N=3,150	 ALL	<	5	YEARS	N=152	 <	2	YEARS	N=52	 ≥2	YEARS	N=100	%	 95	%	CI	 %	 95	%	CI	 %	 95	%	CI	 %	 95	%	CI	 %	 95	%	CI	 %	 95	%	CI	TST	cut-off	 	 	 	 	 	 	 	 	 	 	 	 	10	mm	 6.3	 5.6,	7.0	 11.5	 10.1,	13.1	 3.3	 2.7,	4.0	 38.6	 30.3,	47.5	 26.9	 15.6,	41.0	 41.8	 31.5,	52.6	
15mm	 1.9	 1.6,	2.4	 3.4	 2.6,	4.3	 1.1	 0.8,	1.5	 28.8	 21.2,	37.3	 17.3	 8.2,	30.3	 31.9	 22.5,	42.5	
Fixed	mirror		 1.3	 1.0,	1.7	 2.0	 1.4,	2.7	 1.0	 0.7,	1.4	 36.8	 29.2,	45.0	 26.9	 15.6,	41.0	 42.0	 32.2,	53.3	
Mixture	model	 6.4	 3.4,	9.9	 12.4	 4.4,	19.3	 1.9	 0.03,	4.7	 33.4	 24.2,	43.1	 27.6	 4.4,	47.8	 39.9	 24.4,	49.9	
Rust	&	Thomas	model	 0.9	 0.3,	2.4	 0.7	 0.1,	4.6	 0.8	 0.2,	2.6	 34.5	 25.6,	43.8	 18.2	 0.0,	35.8	 41.5	 30.2,	51.8	
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Table	 3.	 	 Annual	 Risk	 of	Mycobacterium	 tuberculosis	 infection	 (ARTI)	 Estimates	 Based	 on	Mycobacterium	 tuberculosis	 Infection	
Prevalence	Estimates	in	the	Children	Under	5	years	in	2012-2014	Resident	in	the	Demographic	Surveillance	Area	in	Rural	Malawi	
Method	used	to	
estimate	prevalence	
of	M.tb	infection	
ARTI	
ALL	<5	YEARS	 <	2	YEARS	 ≥	2	YEARS	%	 95	%	CI	 %	 95	%	CI	 %	 95	%	CI	
TST	cut-off	 	 	 	 	 	 	10	mm	 2.4	 1.8,	2.7	 10.2	 6.3,	11.6	 1.0	 0.7,	1.2	15mm	 0.7	 0.5,	0.8	 3.0	 2.3,	3.8	 0.3	 0.2,	0.4	Fixed	mirror		 0.5	 0.4,	0.7	 1.8	 1.2,	2.4	 0.3	 0.2,	0.4	Mixture	model	 2.6	 1.4,	4.0	 10.5	 3.2,	17.1	 0.6	 0.1,	1.4	Rust	&	Thomas	model	 0.3	 0.1,	0.9	 0.6	 0.1,	4.1	 0.2	 0.1,	0.8	TST	tuberculin	skin	test;	ARTI	annual	risk	of	M.tb	infection;	CI	Confidence	Interval			
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Web	Material	
Web	 table	 1.	 M.tb	 Infection	 Prevalence	 (%)	 Using	 Different	 Induration	
Categories	for	n	and	stratified	by	risk	group	and	different	age	categories		 	 Induration	(mm)	considered	to	identify	M.tb	infection:		 	 22+	 20+	 18+	 16+	 14+	 12+	 10+	
‘Higher	risk’	group	(years)	
All	<	5	 35.9	 34.5	 34.8	 35.2	 36.0	 37.0	 38.3	<	2	 19.5	 18.2	 18.7	 19.8	 22.1	 24.1	 27.2	≥	2	 43.4	 41.5	 41.7	 41.8	 42.0	 42.4	 43.1	
‘Lower	risk’	group	(years)	
All	<	5	 2.9	 0.9	 1.2	 1.8	 3.1	 4.6	 6.5	<	2	 2.3	 0.7	 1.3	 2.6	 5.5	 7.9	 11.7	≥2		 3.9	 0.8	 1.0	 1.2	 1.6	 2.3	 3.4	2.0	-	2.9		 3.9	 1.6	 0.6	 0.6	 0.8	 1.3	 2.6	3.0	–	3.9	 -	 -	 1.2	 1.2	 1.4	 1.8	 3.0	4.0	–	4.9	 -	 1.2	 1.2	 1.8	 2.6	 3.9	 4.4	
	
Web	appendix	1	The	 prevalence	 of	M.tb	 infection	 for	 each	 group	 was	 calculated	 for	 different	reaction	size	categories	using	the	equations	for	P	and	P’	(see	Methods)	and	are	shown	 in	 table	 above	 (Web	 table	 1).	 Infection	 prevalence	 estimates	 start	 to	become	‘approximately	constant’,	as	deduced	from	visual	inspection,	from	16+	category	 in	all	groups	apart	 from	the	under-2s	 in	 the	 ‘lower	risk’	group.	 	This	suggests	that	the	16+	category	in	the	‘lower	risk’	under-2s	includes	individuals	who	are	not	truly	‘infected’.	In	order	to	fulfil	the	assumption	that	all	individuals	in	category	n	are	‘infected’,	one	must	choose	the	largest	induration	size	allowed	by	the	data.	 	 In	 this	dataset,	reaction	size	of	20mm	was	chosen	to	represent	n	category	as	there	was	obvious	instability	of	estimates	for	the	22+	category	seen	across	all	groups	due	to	the	small	numbers	in	this	category.		
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Web	figure	1.		Histogram	illustrating	the	distribution	of	non-zero	TST	data	
in	all	children	aged	<	5	years	stratified	by	risk	group	(‘lower	risk’	N=4947;	
‘higher	risk’	N=152)												
Web	figure	2.		Histogram	illustrating	the	distribution	of	non-zero	TST	data	
in	children	in	the	‘lower	risk’	group	stratified	by	age	(<2	years	N=1797;	≥2	
years	N=3150)									
	
n=496	72.4%	zero	induration	 n=264	91.6%	zero	induration	
n=762	(84.6%	zero	induration)	 n=67	(55.9%	zero	induration)	
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Web	figure	3.		Histogram	illustrating	the	distribution	of	non-zero	TST	data	
in	children	in	the	‘higher	risk’	group	stratified	by	age	(<2	years	N=52;	≥2	
years	N=100)		 							
n=21	59.6%	zero	induration	 n=46	54.0%	zero	induration	
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Web	figure	4.		Percentage	distribution	of	induration	category	stratified	by	
HIV	exposure	status	and	contact	status	of	children	(‘Lower’	risk	not	HIV-
exposed	n=4453;	HIV-exposed	n=272;	‘higher’	risk	not	HIV-exposed	n=98;	
HIV-exposed	n=17)		
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Web	appendix	2	The	Rust	and	Thomas	method	depends	on	the	assumption	that	the	two	groups	only	differ	with	respect	to	contact	status	and	prevalence	of	M.tb	infection.		Table	(2)	shows	 the	demographic	characteristics	of	 the	 ‘lower	risk’	and	 ‘higher	risk’	group.		
Web	table	2.	Demographic	Characteristics	of	the	‘Lower	Risk’	and	‘Higher	
Risk’	Groups	 	 ‘Lower	risk’	 ‘Higher	risk’	Age	in	years	(mean	(sd))	 2.6	(1.4)	 2.7	(1.3)	Male	(%)	 50.0	 48.5	Mother	HIV	positive	(%)	 5.5%	(95%	CI	4.9	–	6.2)	 7.9%	(95%	CI	4.1	–	13.4)	Median	no.	of	adults	in	the	HH	(IQR)	 2	(2	-	3)	 2	(1	-	2)	Proportion	in	the	lowest	SES	category	 28.4%	 23.4%	sd	standard	deviation;	HH	household;	IQR	interquartile	range;	CI	confidence	interval	SES	socioeconomic	status			 	
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At	a	Glance	Commentary	
Scientific	 knowledge	 on	 the	 Subject:	 Important	 gaps	 exist	 in	 our	 knowledge	 of	Mycobacterium	 tuberculosis	 (M.tb)	 transmission,	 especially	 in	 high	 HIV	prevalence	settings,	and	there	is	significant	uncertainty	about	where	most	M.tb	transmission	takes	place	 in	 the	community.	Young	children	with	 incident	M.tb	infection	are	sentinels	of	recent	community	transmission	and	may	highlight	new	areas	for		tuberculosis	(TB)	control	programmes	to	target.	
	
What	this	Study	Adds	to	the	Field:	In	this	population-based	longitudinal	tuberculin	skin	test	(TST)	study	in	children	in	rural	Malawi,	increasing	age,	having	an	HIV-positive	father,	 living	within	a	residential	area	with	a	higher	tuberculosis	(TB)	notification	 rate,	 attendance	 at	 church,	 and	 travel	 on	 mini-buses	 were	 all	independent	 risk	 factors	 for	 incident	 M.tb	 infection,	 as	 inferred	 from	 TST	conversion.	Identifying	risk	factors	for	incident	M.tb	infection	in	young	children	provides	 insight	 into	 drivers	 of	 community	M.tb	 transmission	 which	 are	 not	being	addressed	by	current	TB	control	strategies.		
 
This	 article	 has	 an	 online	 data	 supplement,	which	 is	 accessible	 from	 this	 issue’s	
table	of	content	online	at	www.atsjournals.org			 	
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Abstract	
Rationale:	Incident	Mycobacterium	tuberculosis	(M.tb)	infection	in	young	children	is	a	critical	indicator	of	recent	community	transmission,	highlighting	failures	in	TB	control	measures	
Objectives:	To	investigate	risk	factors	associated	with	incident	M.tb	infection	in	children	living	in	an	HIV-prevalent	setting.	
Methods:	 Children	 aged	 under	 6	 years	 of	 age	 resident	 within	 a	 demographic	surveillance	 site	 in	Malawi	were	 recruited.	 Tuberculin	 skin	 testing	 (TST)	was	performed	at	baseline	and	repeated	after	1-2	years.	Incident	M.tb	infection	was	defined	as	TST	conversion	from	<10mm	to	≥10mm	with	an	increment	of	≥13mm	(based	on	mixture	analysis).	Multivariate	analyses	used	random-effects	Poisson	regression.	
Measurements	and	Main	Results:	Among	the	3066	children	who	underwent	serial	TST,	 91	 children	 TST-converted	 (3.0%),	 giving	 an	 incidence	 of	 1.6	 per	 100	person-years	(95%	CI:	1.3	–	2.0	per	100py).		Age	(incidence	rate	ratio	(IRR)	1.4:	95%	CI	1.1	-	3.0	for	each	year	increase	in	age),	having	an	HIV-positive	father	(IRR	2.3:	95%	CI	1.2-	4.3),	 living	within	a	residential	area	with	a	smear-positive	TB	notification	rate	>	30	per	100,000	(IRR	2.5:	95%	CI	1.4	–	4.4),	church	attendance	(IRR	3.4:	95%	0.8	–	14.1)	and	travel	on	mini-buses	(IRR	1.8:	95%	CI	1.1	–	3.0)	were	all	associated	with	incident	M.tb	 infection.	Sixty-eight	percent	of	incident	infections	were	attributable	to	church	attendance.	
Conclusions:	 This	 research	 highlights	 the	 need	 for	 better	 infection	 control	practices	in	congregate	settings	such	as	churches	and	mini-buses	and	supports	the	call	for	the	implementation	of	TB-HIV	interventions	at	the	household	level	to	further	reduce	the	burden	of	TB.			 	
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Introduction	Tuberculosis	(TB)	remains	one	of	the	leading	causes	of	death	from	an	infectious	disease	globally.1	A	hugely	ambitious	target	of	 ‘ending	the	global	TB	epidemic’	within	 the	 next	 20	 years,	 defined	 as	 less	 than	 10	 new	 cases	 per	 100,000	population	per	year,	has	been	set	by	the	World		Health	Organisation	(WHO)	as	part	 of	 the	 End	 TB	 Strategy.2	 	 Achieving	 this	 overarching	 goal	would	 require	sustained	reductions	in	TB	incidence	of	up	to	5-10	fold	higher	than	the	current	average	 decrease	 of	 1.5%	 per	 annum.3	 This	 required	 acceleration	 in	 the	reduction	of	TB	incidence	will	only	be	realised	if	there	is	increased	emphasis	on	minimising	transmission.4		Unfortunately,	we	do	not	yet	know	how	best	to	break	the	M.tb	transmission	cycle,	as	significant	gaps	remain	in	our	understanding	of	the	dynamics	of	M.tb	transmission,	especially	in	high	HIV	prevalence	settings.5				Childhood	 TB	 usually	 follows	 transmission	 from	 an	 infectious	 adult;6-8	 	 and	because	 in	 young	 children	 infection	must	 be	 recent,	 TB	 incidence	 in	 children	provides	a	measure	of	the	recent	performance	of	TB	control	programmes,9	and	is	potentially	an	indicator	of	Mycobacterium	tuberculosis	(M.tb)	transmission	‘hot	spots’	in	a	community.10		The	incidence	of	M.tb	infection	in	children	should	be	a	more	precise	measure	of	contemporaneous	M.tb	 transmission	 in	a	community	than	the	 incidence	of	TB	disease,	as	 it	 is	more	timely	and	not	all	M.tb-infected	children	 progress	 to	 active	 disease.	 	 Knowledge	 of	 the	 distribution	 of	 M.tb	infection	in	children	may	assist	evaluation	of	the	level	of	ongoing	transmission	and	help	to	guide	control	strategies.11	
 
		 90	
We	 conducted	 a	 population-wide	 tuberculin	 skin	 test	 (TST)	 cohort	 study	 in	young	children	resident	in	a	demographic	surveillance	site	in	Karonga	district,	Malawi,	 to	 estimate	 the	 incidence	 of	M.tb	 infection	 and	 identify	 risk	 factors	associated	with	recent	M.tb	transmission	to	children	in	the	community.		
Methods	
Study	setting	and	study	population	The	study	setting	and	study	population	in	the	Karonga	demographic	surveillance	area	 (DSS)	 has	 been	 described	 in	 detail.12,13	 In	 brief,	 the	 Karonga	 DSS	 has	 a	population	of	about	39,000;	adult	HIV	prevalence	is	around	9%	and	incidence	of	new	smear-positive	TB	is	approximately	85	per	100,000	population	per	year.12,13				
Study	design	The	initial	baseline	survey	was	conducted	in	January	2012	to	April	2013	among	all	children	aged	from	3	months	to	4	years	old	resident	within	the	Karonga	DSS.		The	plan	was	 to	 repeat	 a	TST	one	 year	 later	 in	 all	 children	whose	 initial	 TST	induration	 was	 less	 than	 10mm	 at	 baseline.	 	 Unfortunately,	 due	 to	 a	 global	shortage	of	RT23	tuberculin	and	difficulties	in	procurement,14	there	was	a	delay	in	some	children	receiving	the	2nd	TST.	Only	those	children	aged	less	than	6	years	of	age	by	the	time	of	the	2nd	round	of	TST	(January	2013	to	August	2015)	were	eligible	for	inclusion	in	the	cohort	study.	The	median	time	between	TSTs	was	1.7	years,	with	an	interquartile	range	of	1.1	to	2.6	years.		
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Case	definition	TST	conversion	was	defined	as	any	child	with	an	 increase	in	 induration	size	≥	13mm.	An	increase	of	13mm	was	based	on	mixture	analysis	(described	below),		rather	than	the	traditional	criteria	proposed	by	the	American	Thoracic	Society	(ATS)	of	an	 increase	≥10mm.15	Children	who	had	a	TST	of	 less	 than	10mm	at	baseline	were	assumed	to	be	uninfected	at	baseline.		
Study	procedures	The	movement	 and	 contacts	 of	 each	 child	 were	 recorded	 through	 structured	guardian	interviews	prior	to	the	placing	of	the	second	TST,	to	reduce	recall	bias.		Information	on	history	of	TB	within	the	family	and	close	contacts	within	the	last	year	were	ascertained	using	a	standardised	questionnaire.		An	adaptation	to	the	questionnaire	to	record	the	number	of	times	the	child	had	attended	any	crowded	community	 gathering	 places,	 such	 as	 funerals,	 churches,	 healthcare	 facilities,	markets	and	travel	on	minibuses	within	the	last	year	was	made	part-way	through	the	2nd	round	of	TST.		Therefore,	data	on	attendance	at	gathering	places	was	only	available	on	2041	children	(66.6%	of	the	total	cohort).		All	children	identified	with	incident	M.tb	infection	were	evaluated	for	TB-related	symptoms,	examined	for	evidence	of	BCG	scar	and	scar	size,	and	height,	weight	and	 mid	 upper	 arm	 circumference	 were	 recorded.	 Any	 child	 with	 symptoms	suggestive	of	TB	(fever,	weight	loss,	failure	to	thrive,	night	sweats	or	cough)	was	reviewed	by	a	clinician	and	referred	to	the	district	hospital.	The	HIV	status	of	the	children	 was	 not	 determined	 unless	 clinically	 indicated	 at	 the	 hospital.	 All	children	 with	 incident	M.tb	 infection	 were	 commenced	 on	 6-month	 isoniazid	
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preventive	 therapy	 (IPT)	 (10	mg/kg	once	daily)	 after	active	disease	had	been	excluded.		
Demographic	data	Demographic	data	available	include	detailed	information	on	family	relationships,	household	 socio-economic	 status	 (SES),	 global	 positioning	 system	 (GPS)	 co-ordinates,	dwelling	structure,	and	vaccination	history.	Adult	HIV	status	(age	≥15	years)	 was	 collected	 in	 HIV	 sero-prevalence	 surveys	 from	 2007	 to	 2011	 and	other	studies	nested	within	the	DSS	in	2012	to	2014.				A	composite	dwelling	index	was	generated	based	on	the	building	materials	used	and	the	presence	or	absence	of	glass	windows.16	A	composite	score	for	household	socioeconomic	status	was	created	using	head	of	household	employment,	number	of	assets,	and	availability	of	soap.17	The	lowest	10–	15%	scores	were	coded	as	‘1’,	the	highest	 15%	as	 ‘4’	 and	 the	middle	 groups	were	divided	 into	 ‘2’	 and	 ‘3’	 to	create	the	respective	socio-economic	indices.		Food	insecurity	was	defined	as	a	binary	variable	based	on	whether	there	had	been	a	time	in	the	last	year	when	there	was	not	enough	food	for	the	household	to	have	its	normal	meals	(described	as	 either	 fewer	 meals	 per	 day,	 and/or	 smaller	 meals,	 and/or	 less	 variety	 of	foods).		
Diagnosed	TB	cases	in	DSS	Bacteriological	 (including	 smear	 and	 culture	 status),	 demographic	 (including	GPS	co-ordinates	of	TB	case	household/s)	and	clinical	(including	HIV	status)	data	were	 available	 from	 an	 ongoing	 prospective	 cohort	 of	 all	 patients	 starting	
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treatment	for	TB	in	the	district.18	A	total	of	38	adults	(aged	≥15	years)	resident	in	 the	 DSS	 were	 diagnosed	 with	 smear-positive	 pulmonary	 TB	 during	 2013–2015.	 	 The	 average	 annual	 smear-positive	 TB	 notification	 rate	 for	 each	predefined	residential	area	of	approximately	450	households	was	calculated	as	the	number	of	smear-positive	TB	cases	reported	per	year	per	100,000	population	for	the	period	2013–2015.	Distance	to	the	nearest	smear-positive	pulmonary	TB	case,	distance	to	the	nearest	clinic	and	distance	to	the	main	tarmac	road	were	calculated	 using	 ArcGIS	 10®	 software	 (Environmental	 Systems	 Research	Institute,	Redlands,	CA,	USA).			
Statistical	analysis	Mixture	 analysis	 of	 the	 tuberculin	 data	 was	 based	 on	 implementation	 of	 the	Expectation	 Maximisation	 (EM)	 algorithm	 in	 R	 (R	 Foundation	 for	 Statistical	Computing,	Vienna)	by	fitting	a	finite	mixture	model	to	the	observed	profiles	of	the	 non-zero	 increment	 in	 induration	 size	 in	 mm.13,19-21	 The	 density	 of	 the	bimodal	distribution	of	the	tuberculin	data	(see	results)	is	defined	as:	
ƒ	(,|., 0), 1), 02, 12) = .×5)(,|0), 1)) + (1 − .)×52(,|02, 12)	
where	D1	and	D2	are	the	distributions	accounting	for	the	first	(i.e.	lower	increment	in	 induration	 size:	 mean	 and	 standard	 deviation,	0), 1))	and	 second	 (i.e.	 the	higher	increment	in	induration	size:	mean	and	standard	deviation,	02, 12)	peaks	respectively,	and	λ	 and	(1	–	λ)	are	 the	weights	 for	 the	D1	and	D2	distributions,	respectively.22		The	fitted	finite	mixture	model	was	used	to	identify	a	cut-off	value	that	discriminated	the	two	modes	of	the	dataset.		This	was	done	by	calculating	
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the	probability,	P,	to	belong	to	the	lower	induration	size	peak	as	P	=	D1/(D1	+	D2)	to	be	less	than	0.05	(to	maximise	specificity	of	the	definition	of	TST	conversion).	This	was	then	used	to	derive	the	cut-off	value.		The	confidence	interval	of	the	cut-off	value	was	computed	using	Monte	Carlo	simulations.21,22		A	 random	 effects	 Poisson	 regression	 model,	 to	 account	 for	 clustering	 within	residential	area,	was	used	to	assess	the	relationship	between	risk	factors	and	TST	conversion.	The	likelihood	ratio	test	was	used	to	assess	the	overall	significance	of	 risk	 factors,	 tests	 for	 trend	and	departures	 from	 linearity,	unless	otherwise	specified.	Only	those	risk	factors	most	strongly	associated	with	the	outcome	were	tested	 in	 the	multivariable	 analysis	 (p<0.2).	 Sex,	 household	 SES	 and	 dwelling	structure	were	included	as	a	priori	confounders	in	the	multivariate	model.	The	baseline	category	for	each	of	the	variables	relating	to	gathering	place	attendance	was	chosen	a	priori	as	those	unexposed.	The	data	were	collected	as	categorical	variables	grouped	as	0,	1-3,	4-12,	12-23,	≥24	visits	 in	 the	 last	year.	 	Very	 few	children	 had	 not	 attended	 church	 in	 the	 last	 year	 (4%)	 so	 this	 category	was	combined	with	the	next	category	(1-3	visits).		To	prevent	over-parameterisation	of	 the	 multivariate	 model,	 risk	 factors	 were	 limited	 to	 a	 maximum	 of	 8	parameters.		There	was	no	evidence	of	a	dose	response	in	number	of	visits	and	risk	of	M.tb	infection	for	any	of	the	gathering	places	on	univariate	analysis	and	so	these	data	were	categorised	as	binary	variables.		Sensitivity	analyses	were	undertaken	using	(i)	the	standard	ATS	criteria	of	TST	conversion	 ≥10mm;	 (ii)	 a	 more	 stringent	 cut-off	 of	 ≥15mm	 to	 define	 TST	
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conversion;	and	(iii)	using	TST	conversion	≥13mm	and	excluding	children	with	a	TST	conversion	of	between	9	to	12mm	from	the	analysis.		The	population	attributable	fraction	(PAF)	was	calculated	using	the	formula:	23	
PAF	 = 	p’ RR − 1RR 	
where	 p’	 =	 proportion	 of	 cases	 exposed;	 RR	 =	 adjusted	 rate	 ratio	 of	 the	association	 of	 TST	 conversion	 in	 children	 with	 the	 risk	 factor.	 	 Analysis	 was	performed	using	Stata	13.1	for	Mac	(Stata	Corporation,	College	Station,	TX).			
Ethics	approval	The	 study	 was	 approved	 by	 the	 Malawi	 National	 Health	 Sciences	 Research	Committee,	 Lilongwe,	 Malawi	 and	 the	 London	 School	 of	 Hygiene	 &	 Tropical	Medicine	 Ethics	 Committee,	 London,	 UK.	 	 Written	 informed	 consent	 was	provided	by	a	parent	or	guardian	of	each	participating	child.	
	
Results		A	 total	of	3357	children	aged	under	6	years	were	eligible	 for	 inclusion	 in	 the	cohort,	3066	(91.3%)	of	whom	underwent	a	2nd	TST	which	was	read	within	72	hours.		The	study	flowchart	is	shown	in	Figure	1.			
Tuberculin	data	The	frequency	distribution	of	all	TST	conversions	(i.e.	increments	between	TSTs	>	0	mm,	n=350)	is	shown	in	Figure	2a.		Of	those	children,	who	had	zero	induration	
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at	baseline,	90	per	cent	(2477/2745)	did	not	exhibit	any	 induration	at	 the	2nd	TST.	 	 Of	 those	 children	 who	 had	 some	 evidence	 of	 tuberculin	 sensitivity	(induration	between	2mm	and	9mm)	at	baseline,	73	per	cent	(235/321)	had	a	decrease	in	the	size	of	induration	at	the	2nd	TST;	most	of	whom	reverted	to	zero	induration	(220/235).		Mixture	 analysis	 of	 all	 TST	 conversions	 (range	 2	 to	 26mm)	 generated	 a	 two-component	 distribution,	 as	 shown	 in	 Figure	 2b.	 The	 mean	 (and	 standard	deviation)	were	6.5	(2.3),	and	14.7	(3.1)	for	the	1st	and	2nd	peak	respectively.	The	derived	cut-off	point	using	the	finite	mixture	model	was	12.8	(95%	CI	12.6	–	13.0)	as	shown	in	Figure	2b.	A	TST	conversion	of	13mm	was	chosen	to	define	incident	
M.tb	infection	to	minimise	false	positives.		Of	 the	 2588	 children	 with	 no	 known	 HIV-exposure	 in	 utero,	 2128	 (82.2%)	exhibited	 no	 change	 in	 induration	 size	 between	 TSTs,	 compared	 to	 77.8%	(238/306)	 of	 HIV-exposed	 children	 (chi-squared,	 P=0.32).	 The	 median	 and	interquartile	range	(IQR)	of	the	increment	in	induration	size	between	TSTs	were	similar	 in	HIV-exposed	(n=42,	median	7	mm,	 IQR	6–13)	and	non-HIV-exposed	children	(n=292,	median	8	mm,	IQR	6–13).			
Incidence	of	M.tb	infection	Of	 the	 3066	 children	 who	 underwent	 serial	 skin	 testing,	 91	 TST-converted	(3.0%).	The	3066	children	contributed	5580	person-years	(py),	giving	an	M.tb	infection	incidence	of	1.6	per	100py	(95%	CI:	1.3	–	2.0	per	100py).		Using	the	ATS	criteria	of	TST	conversion	≥10mm,	M.tb	 infection	incidence	was	2.5	per	100py	
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(95%CI	 2.1	 –	 2.9	 per	 100py)	 and	 using	 the	 more	 stringent	 TST	 conversion	≥15mm,	infection	incidence	was	1.1	per	100py	(95%	CI:	0.8	–	1.4).		
Risk	factors	associated	with	incident	M.tb	infection	The	 incidence	of	TST-conversion	 (incident	M.tb	 infection)	was	higher	at	older	ages,	 among	 those	 without	 documented	 BCG	 vaccination,	 those	 with	 known	household	contact	with	an	infectious	TB	case	and	those	resident	in	areas	with	a	higher	community	M.tb	exposure.		The	incidence	was	lower	in	those	living	in	the	worst	dwellings	but	there	was	no	association	with	other	measures	of	SES.	The	incidence	was	higher	in	those	with	an	HIV	positive	father	but	with	only	a	weak	association	with	HIV-positive	mothers	or	HIV	prevalence	in	the	area	(Table	1).		Data	on	attendance	at	gathering	places	within	the	last	year	were	only	available	on	2041	children.	A	table	showing	the	characteristics	of	children	in	whom	data	on	attendance	at	gathering	places	were	collected	compared	to	children	in	whom	these	data	were	not	available	is	 included	in	the	online	supplement	(Table	E1).	Although	a	higher	percentage	of	children	had	mothers	who	were	HIV-positive	and	a	higher	percentage	of	children	 lived	 in	areas	with	 the	higher	 community	
M.tb	exposure	(based	on	average	notification	rate	of	smear-positive	pulmonary	TB),	M.tb	incidence	rate	in	these	children	was	1.5	per	100py	(95%	CI:	1.2	–	1.90),	which	was	 similar	 to	 the	 incidence	 rate	 seen	 in	 the	 total	 study	population.	 In	those	with	data	available,	there	was	weak	evidence	for	an	association	with	travel	on	a	mini-bus	and	school	attendance	(p<0.1)	and	even	weaker	evidence	(p<0.2)	for	 an	 association	with	 church	 attendance	 and	 going	 to	market	 on	 univariate	analysis	(Table	2).	
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In	the	multivariable	model,	age	at	the	time	of	the	1st	skin	test,	known	HIV-positive	father,	 higher	 community	M.tb	 exposure,	 attendance	 at	 church	 and	 travel	 on	mini-buses	were	the	only	risk	factors	which	were	associated	with	incident	M.tb	infection	(p<0.05;	Table	3).		A	one	year	increase	in	age	at	1st	TST	was	associated	with	a	1.4	increase	in	the	incidence	rate	of	M.tb	infection	(aOR	1.4,	95%	CI	1.1	–	3.0;	 p=0.01).	 	 Attendance	 at	 church	 was	 the	 strongest	 risk	 factor	 for	 M.tb	infection,	with	children	who	had	attended	church	at	least	4	times	in	the	last	year,	having	a	3.4-fold	increase	in	the	rate	of	incident	infection	compared	to	children	who	 had	 attended	 church	 0-3	 times	 in	 the	 last	 year,	 although	 the	 confidence	interval	was	wide	(aOR	3.4,	95%	CI	0.8	–	14.1;	p=0.04).	Having	an	HIV-positive	father	was	associated	with	a	2.3	times	increase	in	incident	M.tb	infection	(aOR	2.3,	95%	CI	1.2	–	4.2;	p=0.02)	and	community	M.tb	exposure	was	associated	with	a	 2.5-fold	 increase	 in	 incidence	 rate	 (aOR	 2.5,	 95%	 CI	 1.4	 –	 4.4,	 p=0.002).		Children	who	had	travelled	on	a	mini-bus	within	the	 last	year	had	a	1.8	 times	higher	 incidence	rate	than	children	who	had	not	been	on	a	mini-bus	(aOR	1.8,	95%	CI:	1.1	–	3.0,	p=0.03).			The	proportion	of	incident	M.tb	infection	attributable	to	having	an	HIV-positive	father,	being	resident	in	an	area	with	higher	community	M.tb	exposure,	church	attendance	 and	 travel	 on	 mini-bus	 was	 6.9%,	 28.7%,	 67.8%	 and	 27.7%,	respectively	 (Table	 3).	 The	 confidence	 interval	 around	 the	 population	attributable	fraction	(PAF)	for	church	attendance	includes	0,	reflecting	the	wide	confidence	interval	of	the	effect	estimate	in	the	multivariable	model.		
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In	 the	 sensitivity	 analyses,	 using	 the	 ATS	 criteria	 for	 TST	 conversion	 (TST	increase	≥10mm)	as	the	definition	of	incident	M.tb	infection	reduced	the	strength	of	the	association	for	all	risk	factors	in	the	multivariable	model,	whilst	using	the	more	 stringent	 definition	 (TST	 increase≥15mm)	 reduced	 the	 strength	 of	 the	association	with	church	attendance	(aOR	2.5:	95%	CI	0.6	–	10.4)	and	increased	the	strength	of	the	association	with	having	a	known	HIV-positive	father	(aOR	3.0:	95%	CI	1.2	–	7.6)	but	made	little	difference	to	the	other	risk	factors.		Excluding	children	with	TST	increases	between	9	and	12	mm	made	little	difference	to	the	original	multivariable	model	using	TST	increase≥13mm	(Table	3).			
	
Discussion	Despite	a	well-functioning	TB	control	programme	in	Karonga,18	the	risk	of	M.tb	infection	in	children	is	estimated	to	be	1.6%	(95%	CI	1.3	–	2.0%)	per	annum	in	our	study.	 	 	Using	children	with	 incident	M.tb	 infection	as	 ‘sentinels’	of	 recent	transmission,	 we	 have	 identified	 a	 number	 of	 factors	 which	 are	 potentially	driving	community	M.tb	transmission.		Exposure	to	crowding	in	poorly	ventilated	indoor	 congregate	 settings,	 such	 as	 churches	 and	 mini-buses,	 having	 a	 HIV-positive	father,	and	community	M.tb	exposure	as	estimated	from	TB	notification	data	are	all	associated	with	an	increased	risk	of	incident	M.tb	infection	in	young	children.			Travel	 on	minibus	was	 associated	with	 a	 nearly	 2-fold	 increase	 in	 the	 rate	 of	incident	 M.tb	 transmission	 in	 young	 children,	 and	 church	 attendance	 was	associated	with	a	3-fold	increase	in	the	rate	of	incident	infection.		Although	the	
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confidence	interval	for	church	attendance	in	the	multivariable	model	was	wide,	the	direction	of	the	effect	was	consistent	in	each	of	the	sensitivity	analyses	and	the	p	value	from	the	likelihood	ratio	test	for	inclusion	of	this	risk	factor	in	each	of	the	models	was	 consistently	 less	 than	0.05.	A	higher	 level	 of	 community	M.tb	exposure	was	associated	with	a	2-fold	increase	in	the	rate	of	incident	infection	in	children.	However,	only	10/91	(11%)	of	TST	conversions	occurred	in	children	known	to	be	resident	within	200	metres	of	a	diagnosed	smear-positive	TB	case.		This	 suggests	 that	 the	 majority	 of	 M.tb	 transmission	 to	 young	 children	 is	occurring	 as	 a	 result	 of	 casual	 contact	with	 undiagnosed	 infectious	 TB	 in	 the	community	rather	than	neighbourhood	contact	with	known	smear-positive	TB	cases.		There	has	been	an	accumulation	of	evidence	over	the	years,	that	in	high	burden	 settings,	 despite	 some	 evidence	 for	 clustering	 of	 M.tb	 infection	 and	disease	 within	 households	 at	 a	 population-level,11,24,25	 the	 majority	 of	 M.tb	transmission,	 occurs	 from	 community	 contact	 rather	 than	 from	 within	 the	household	or	close	contacts.26-29				It	is	unsurprising	that	travel	on	mini-bus	is	associated	with	an	increased	risk	of	incidence	 infection	 in	 our	 study.	 	 Public	 transport	 in	 low-	 and	middle-income	countries,	which	is	often	densely	crowded	and	poorly	ventilated,	has	been	shown	to	pose	a	significant	risk	of	M.tb	transmission	in	other	settings.30-32	Interestingly,	we	 found	 no	 evidence	 of	 an	 association	 between	 incident	M.tb	 infection	 and	attendance	 at	 healthcare	 facilities	 in	 our	 setting.	 	 Outpatient	waiting	 areas	 in	healthcare	clinics	in	rural	Malawi	tend	to	be	outdoor	spaces	with	seating	areas	and	are	therefore	well-ventilated,	reducing	the	risk	of	transmission,33	whereas	churches	are	indoors.		Social	contact	pattern	data	from	Zambia,	which	is	a	similar	
		 101	
setting	 to	 ours,	 found	 that	 the	 highest	 adult/youth	 and	 child	 contact	 hours	occurred	in	churches.34		Churches	have	been	long	identified	as	locations	of	M.tb	transmission;35-37	and	these	locales	do	provide	ideal	conditions	for	community	‘outbreaks’,38	with	effective	aerolisation	of	‘infectious’	droplet	nuclei	generated	by	 singing,39	 within	 a	 confined	 poorly-ventilated	 space	 which	 is	 filled	 with	individuals	of	all	ages	 in	close	proximity	 to	each	other.	 In	our	study,	67.8%	of	incident	 M.tb	 infections	 in	 young	 children	 were	 attributable	 to	 church	attendance,	 which	 implies	 that	 potential	 impact	 from	 better	 infection	 control	practices,	 such	 as	 opening	 windows40	 or	 installing	 roof-driven	 turbines41	 in	churches	may	be	substantial	in	reducing	M.tb	infection	risk	in	this	community.		Although	 M.tb	 incidence	 was	 not	 associated	 with	 HIV	 prevalence	 at	 the	community	level,	HIV	in	fathers	was	associated	with	M.tb	infection	in	children	in	our	setting.		A	higher	prevalence	of	M.tb	infection	in	children	born	to	HIV-positive	women	was	found	on	analysis	of	the	baseline	TST	prevalence	data;		children	who	were	 exposed	 to	 HIV	 in	 utero	had	 a	 3-fold	 increase	 in	 odds	 of	 TST-positivity	compared	to	children	born	to	HIV-negative	mothers,13	a	finding	replicated	in	a	number	of	studies	 in	sub-Saharan	Africa.42-44	However,	maternal	HIV	 infection	was	not	associated	with	incident	M.tb	 infection	in	this	analysis.	This	may	have	been	 because	 children	 who	 had	 a	 TST≥10mm	 at	 baseline	 (prevalent	 M.tb	infection)	were	not	eligible	for	a	repeat	skin	test	thereby	illustrating	one	of	the	drawbacks	of	using	a	TST	cohort	design	to	estimate	infection	risk,	which	is	the	exclusion	at	baseline	of	individuals	at	highest	risk,	i.e.	those	at	highest	risk	are	usually	already	infected	at	baseline.4			
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The	increased	risk	of	M.tb	 infection	seen	in	children	of	men	with	HIV	infection	may	be	due	to	undiagnosed	TB	in	these	fathers.		Of	note,	no	HIV-positive	fathers	had	 been	 diagnosed	with	 any	 form	 of	 TB	 during	 the	 study	 period.	 A	 recently	conducted	meta-analysis	 of	 sex	 differences	 in	 TB	 burden	 in	 low-	 and	middle-income	 countries	 found	 that	 the	 male-to-female	 prevalence	 ratio	 for	 smear-positive	TB	was	2.5	(95%	CI	2.1	–	3.0).45	Prolonged	duration	of	infectiousness	of	TB	appears	to	be	associated	with	male	sex,	even	in	countries	with	a	generalized	HIV	epidemic	where	females	are	disproportionately	more	affected	by	HIV.45	The	authors	also	highlighted	that	men	were	less	likely	to	access	and	remain	in	HIV	care,	and	would	therefore	be	less	likely	to	be	assessed	and	treated	for	TB.	It	is	assumed	that	because	women	are	usually	the	main	carers	of	young	children,	they	are	the	most	likely	source	of	M.tb	infection	to	children.	But	a	modelling	study	by	Dodd	et	al.	using	adult	TB	disease	prevalence,	M.tb	infection	incidence	in	children	and	social	contact	pattern	data	collected	in	a	high	HIV/TB	burden	setting	(South	Africa	and	Zambia)	found	that	more	than	50%	of	infections	in	men,	women	and	children	were	due	to	contact	with	adult	men.5			Another	finding	of	note	from	this	study	is	the	difference	in	estimate	of	the	risk	of	
M.tb	infection	per	annum	in	Karonga	when	using	longitudinal	data	compared	to	cross-sectional	 data.	 	 Incidence	 of	M.tb	 infection,	 estimated	 to	 be	 1.6	 per	 100	person-years	 in	 children	 under	 6	 years	 in	 this	 study	 is	much	 higher	 than	 the	average	annual	risk	of	infection	(ARTI)	of	0.3%	(95%	CI:	0.1	–	0.9%)	derived	from	
M.tb	 infection	prevalence	data	collected	during	 the	baseline	TST	round	of	 this	cohort	study.46	Even	using	the	most	stringent	cut-off	of	TST	conversion	≥15mm	to	define	M.tb	infection,	infection	incidence	is	estimated	to	be	1.1	per	100py	(95%	
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CI:	0.8	–	1.4	per	100py),	which	remains	higher	than	the	ARTI	estimate	although	the	95%	confidence	intervals	do	cross.			
Methodological	shortcomings	of	the	use	of	TST	in	longitudinal	studies	have	been	widely	cited,9	with	‘boosting’	of	pre-sensitisation	to	mycobacterial	antigens	from	repeat	skin	testing	complicating	interpretation.47,48		‘Boosting’	is	a	phenomenon	best	described	as	an	effect	of	the	initial	tuberculin	test	which,	although	it	elicits	minimal	or	no	reactivity	itself,	acts	as	an	antigenic	stimulus	able	to	recall	waned	or	reverted	pre-existing	mycobacterial	sensitivity,	i.e.	from	remote	exposure	to	
M.tb	but	also	from	remote	exposure	to	other	mycobacterial	antigens	such	as	BCG	vaccination	 and/or	 non-tuberculous	 mycobacteria	 (NTM)	 infection.47	 Thus	resulting	in	a	level	of	reactivity	observed	at	the	subsequent	test	which	may	be	indistinguishable	 from	M.tb	 infection,	 even	 if	 the	 individual	 has	 never	 been	infected	with	M.tb.48,49	From	a	mixture	analysis	of	the	tuberculin	data	a	bimodal	distribution	of	the	increment	in	induration	size	between	TSTs	was	apparent.		The	1st	peak	most	likely	representing	“boosting”	of	the	TST	response	to	previous	BCG	vaccination	and/or	NTM	sensitisation	with	a	mean	of	6.5mm,	and	the	2nd	peak	of	the	bimodal	distribution,	with	a	mean	of	14.7mm,	most	likely	representing	M.tb	infection.	 	 Using	 the	 probability	 distributions	 generated	 by	 the	 finite-mixture	model	 we	 were	 able	 to	 identify	 a	 cut-off	 of	 TST	 conversion	 ≥13mm	 which	minimised	the	inclusion	of	false	positives	(probability	<	0.05)	whilst	maintaining	adequate	power	for	the	risk	factor	analysis.			Estimates	of	risk	of	infection	derived	from	M.tb	prevalence	data	have	long	been	recognized	as	potentially	under-estimating	the	ARTI.49,50,51		Waning	of	tuberculin	
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sensitivity	was	noted	as	early	as	1948	in	the	Prophit	survey,	which	was	one	of	the	largest	studies	of	the	natural	history	of	M.tb	infection	undertaken	in	the	pre-chemotherapy	and	pre-BCG	vaccination	era.		At	the	time	the	authors	highlighted	that	TST	reversions	were	important	enough	to	considerably	modify	the	incidence	of	 tuberculin	 sensitization	 in	 a	 given	 community.50	However,	 the	 authors	 of	 a	large	 longitudinal	 study	 conducted	 in	 Bangalore,	 India	 over	 a	 decade	 later	concluded	that	the	estimates	of	infection	risk	from	longitudinal	tuberculin	data	were	a	‘gross	over-estimation’.52		The	study	design	for	this	TST	cohort	study	in	India	included	an	additional	skin	test	using	a	tuberculin	which	had	a	strength	of	PPD	RT23	20	times	stronger	than	the	tuberculin	used	in	the	initial	skin	test.		This	additional	test	was	only	undertaken	in	those	individuals	found	to	have	induration	less	than	13mm	at	the	first	skin	test.	This	second	skin	test	was	done	1	week	after	the	first	skin	test	as	part	of	the	first	round	of	skin	testing.		This	is	likely	to	have	contributed	to	an	even	greater	degree	of	 ‘boosting’	which	became	apparent	on	the	second	round	of	TST	one	year	later,	leading	to	significant	misclassification	of	
M.tb	infection	status.			More	 recently,	 controversies	 have	 arisen	 around	 how	 best	 to	 estimate	 the	incidence	of	M.tb	infection	as	a	measure	of	the	M.tb	transmission	in	population-level	 intervention	 studies;	 with	 tuberculin	 reactivity	 being	 deemed	 an	unsatisfactory	 surrogate.53	 Although	 interpretation	 of	 induration	 from	 repeat	TST	 is	 complicated,	 similar	 issues	with	 conversions	and	 reversions	have	been	observed	with	serial	interferon-gamma	release	assays	(IGRA)	testing	and	there	are	no	data	to	date	to	suggest	that	IGRAs	are	better	at	identifying	the	incidence	of	new	M.tb	infection	than	the	TST.54	Estimates	from	longitudinal	studies	using	
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IGRA	in	high	burden	settings	have	similarly	found	much	higher	estimates	of	the	risk	of	infection	compared	to	estimates	derived	from	cross-sectional	data;	with	a	study	 in	 South	 African	 adolescents	 estimating	 annual	 risk	 of	 14.0%	 using	longitudinal	data	compared	to	7.3%	from	cross-sectional	data.		The	fact	remains	that	 we	 currently	 do	 not	 fully	 understand	what	 TSTs	 and	 IGRAs	 are	 actually	measuring;55	 whether	 it	 is	 a	 measure	 of	 M.tb	 exposure	 and/or	 cleared	 or	established	M.tb	infection.		The	derived	metric	is	mostly	likely	a	composite	effect	of	the	intensity	of	M.tb	exposure	and	the	susceptibility	of	the	individual	to	M.tb	infection,56	and	is	almost	certainly	likely	to	differ	in	varying	populations.		Incidence	of	M.tb	infection	provides	the	most	robust	proxy	measure	of	the	force	of	infection	in	the	community;	if	it	can	indeed	be	estimated	accurately.	However,	the	force	of	infection	in	this	population,	estimated	to	be	around	1.6%	per	annum,	may	 not	 be	 representative	 of	 the	 adult	 population.	 The	 intensity	 of	 contact	between	‘infectious’	individuals	and	children	under	6	years	of	age	may	not	reflect	the	 intensity	 of	 contact	 between	 ‘infectious’	 adults	 and	 susceptible	adolescents/adults	 in	 the	 community.	 	 Children,	 adolescents	 and	 adults	 have	different	social	contact	patterns,5,57	and	therefore	incidence	of	M.tb	infection	in	children	most	likely	does	not	reflect	the	incidence	in	adults.9	Risk	factors	for	M.tb	infection	in	children	also	differ	from	those	in	adults,	as	shown	by	the	increased	risk	 of	 household	 TB	 contact	 in	 young	 children	 compared	 to	 adults.58,59	 The	increase	in	rate	of	M.tb	infection	seen	with	a	one	year	increase	in	age,	even	in	this	young	 population	 reflects	 increasing	M.tb	 exposure	 as	 children	 become	more	mobile	 and	 begin	 to	 mix	 with	 individuals	 outside	 of	 the	 household.	 Thus	confirming	 that	 the	 assumption	 used	 to	 derive	 the	 ARTI	 from	M.tb	 infection	
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prevalence,	that	the	risk	of	M.tb	infection	is	constant	within	age	categories,	is	not	valid.9		Findings	from	this	study	in	a	low-to-moderate	burden	setting	suggest	that	well-established	 risk	 factors	 are	driving	 community	M.tb	 transmission,	 such	as	 the	presence	 of	 undiagnosed	 ‘infectious’	 individuals	 in	 the	 community	 and	inadequate	 ventilation	 in	 congregate	 settings.60	 	 Simple	 infection	 control	practices,	 such	as	opening	windows	or	even	holding	congregations	 in	outdoor	spaces	may	go	some	way	to	mitigating	the	risk	of	transmission.	HIV	infection	in	the	family	also	appears	to	be	a	risk	factor	for	incident	and	prevalent	M.tb	infection	in	young	children	in	Malawi,	and	a	more	family-orientated	approach	in	HIV/TB	programmes	may	reduce	the	future	burden	of	TB	morbidity	and	mortality	in	HIV-prevalent	settings.		
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Tables	
Table	1.		Risk	factors	for	incident	M.tb	infection			 	
N	 TST-conversion	
(≥13mm)	
Exposure	
time	(100	py)	 M.tb	infection	incidence	per	100py	(95%	CI)	 Crude	rate	ratio*	(95%	CI)	 P	value		 	
Overall	incidence	rate		 3066	 91	 55.80	 1.63	 1.33	–	2.00	 -	 -	 -	
	 	 	 	 	 	 	 	 	 	
Risk	factors	 	 	 	 	 	 	 	 	 	
Child-related	 	 	 	 	 	 	 	 	 	
Age	at	time	of	1st	skin	test	(years)	
<1.0	 477	 8	 9.56	 0.84	 0.42	–	1.67	 1	 	 0.004	1.0	–	1.9	 846	 17	 16.79	 1.01	 0.63	–	1.63	 1.2	 0.5	–	2.8	 *<0.001	test	for	trend	2.0	–	2.9	 835	 31	 16.25	 1.91	 1.34	–	2.71	 2.3	 1.1	–	5.0	3.0	–	3.9	 605	 23	 9.52	 2.42	 1.61	–	3.64	 2.8	 1.2	–	6.3	4.0	–	4.9	 303	 12	 3.69	 3.25	 1.85	–	5.73	 3.8	 1.6	–	9.5		 	 	 	 	 	 	 	 	 	Sex	 Female	 1521	 40	 27.74	 1.44	 0.97	–	1.97	 1	 	 0.26	Male	 1545	 51	 28.07	 1.82	 1.38	–	2.39	 1.3	 0.8	–	1.9	 		 	 	 	 	 	 	 	 	 	BCG	status	 Not	documented	 377	 20	 6.14	 3.26	 2.10	–	5.05	 1	 	 0.002	Documented	 2689	 71	 49.66	 1.43	 1.13	–	1.80	 0.5	 0.3	–	0.7	 		 	 	 	 	 	 	 	 	 	
Household-related	 	 	 	 	 	 	 	 	 	Dwelling	score	 1	(Worst)	 581	 10	 11.89	 0.84	 0.45	–	1.56	 1	 	 0.02		 2	 994	 41	 17.81	 2.30	 1.70	–	3.13	 2.7	 1.4	–	5.5	 		 3	 643	 16	 12.24	 1.31	 0.80	–	2.13	 1.5	 0.7	–	3.4	 		 4	(Best)	 530	 15	 8.62	 1.74	 1.05	–	2.89	 2.0	 0.9	–	4.5	 		 Missing	 318	 9	 	 	 	 	 	 	Continued…	
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	 Table	1	(Continued).		Risk	factors	for	incident	M.tb	infection		
	
N	 TST-conversion	
(≥13mm)	
Exposure	time	(100	py)	 M.tb	infection	incidence	per	100py	(95%	CI)	 Crude	rate	ratio*	(95%	CI)	 P	value	Household	SES	score	 1	(Lowest)	 199	 7	 3.82	 1.83	 0.87	–	3.85	 1	 	 0.56		 2	 671	 17	 12.53	 1.35	 0.84	–	2.18	 0.7	 0.3	–	1.7	 		 3	 1520	 51	 27.46	 1.86	 1.41	–	2.44	 1.0	 0.4	–	2.2	 		 4	(Highest)	 601	 15	 10.94	 1.37	 0.82	–	2.28	 0.7	 0.3	–	1.8	 		 Missing	 75	 0	 	 	 	 	 	 	Food	insecurity	 No	 1227	 33	 22.59	 1.46	 1.04	–	2.06	 1	 	 0.41		 Yes	 1610	 52	 29.75	 1.75	 1.3	–	2.29	 1.2	 0.8	–	1.9	 		 Missing	 229	 6	 	 	 	 	 	 	No.	of	adult	household	members	 1	 62	 1	 0.90	 1.11	 0.16	–	7.86	 1	 	 0.62	2	–	3	 2241	 70	 40.48	 1.73	 1.37	–	2.19	 1.6	 0.2	–	11.4	 	≥	4	 763	 20	 14.42	 1.39	 0.90	–	2.15	 1.3	 0.2	–	9.4	 	
Distance	from	tarmac	road	(km)	
<	0.5	 920	 26	 13.89	 1.87	 1.28	–	2.75	 1	 	 0.17	0.5	–	2.4		 968	 26	 15.31	 1.70	 1.16	–	2.50	 0.9	 0.5	–	1.6	 	2.5	–	5.0	 503	 9	 11.04	 0.82	 0.42	–	1.57	 0.4	 0.2	–	1.0	 	>	5.0	 675	 30	 15.54	 1.93	 1.35	–	2.76	 1.0	 0.6	–	1.8	 	
Distance	to	nearest	clinic	(km)	
<	0.5	 117	 5	 1.90	 2.64	 1.10	–	6.34	 1	 	 0.13		0.5	–	2.4		 948	 34	 15.53	 2.19	 1.57	–	3.07	 0.9	 0.3	–	2.6	2.5	–	5.0	 1128	 30	 19.48	 1.54	 1.08	–	2.20	 0.6	 0.2	–	1.8	>	5.0	 873	 22	 18.90	 1.16	 0.77	–	1.77	 0.5	 0.2	–	1.4	Population	density	in	residential	area,	person/km2	
<	200	 765	 24	 14.62	 1.64	 1.10	–	2.45		 1	 	 0.86	200	–	399		 758	 23	 12.76	 1.80	 1.20	–	2.71	 1.2	 0.6	–	2.2	 	400	-	999	 826	 25	 17.06	 1.47	 0.99	–	2.17	 0.9	 0.5	–	1.7	 	≥1000	 717	 19	 11.37	 1.67	 1.07	–	2.62	 1.0	 0.5	–	2.0	 	Continued…	
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	 Table	1	(Continued).		Risk	factors	for	incident	M.tb	infection	
	
N	 TST-conversion	
(≥13mm)	
Exposure	time	(100	py)	 M.tb	infection	incidence	per	100py	(95%	CI)	 Crude	rate	ratio*	(95%	CI)	 P	value	
TB-related	 	 	 	 	 	 	 	 	 	Known	household	infectious	TB	contact	 No	 3055	 89	 55.63	 1.60	 1.30	–	1.97	 1	 	 0.04	Yes	 11	 2	 0.17	 11.70	 2.93	–	46.78	 6.9	 1.6	–	29.3	 	Distance	from	nearest	known	infectious	TB	case	during	the	study	period	(metres)	
>200	 2783	 81	 51.42	 1.58	 1.27	–	1.96	 1	 	 0.06	100	–	200	 146	 2	 2.33	 0.86	 0.21	–	3.43	 0.5	 0.1	–	2.2	 	<100	 128	 6	 1.88	 3.20	 1.44	–	7.11	 2.0	 0.8	–	4.7	 	Within	HH	 11	 2	 0.17	 11.70	 2.93	–	46.78	 7.1	 1.7	–	30.1	 	Community	M.	tuberculosis	exposure	measure:	 	 	 	 	 	 		Av.	smear-positive	TB	notification	rate	(per	100,000/area/yr)	 ≤30	 1783	 42	 35.53	 1.18	 0.87	–	1.60	 1	 	 0.002	>30	 1283	 49	 20.28	 2.42	 1.83	–	3.20	 2.1	 1.3	–	3.2	 	
	 	 	 	 	 	 	 	 	 	
HIV-related	 	 	 	 	 	 	 	 	 	
HIV	exposure	in	utero	 No	 2588	 77	 47.33	 1.63	 1.30	–	2.03	 1	 	 0.42	Yes	 306	 11	 5.06	 2.18	 1.21	–	3.93	 1.6	 0.7	–	2.4	 	Unknown	 172	 3	 3.41	 0.88	 0.28	–	2.72	 0.6	 0.2	–	1.8	 	
HIV-positive	mother	 No	 2609	 75	 47.35	 1.58	 1.26	–	1.99	 1	 	 0.16	Yes	 340	 14	 5.54	 2.53	 1.50	–	4.27	 1.5	 0.9	–	2.7	 	Unknown	 117	 2	 2.91	 0.69	 0.17	–	2.75	 0.5	 0.1	–	1.9	 	
HIV-positive	father	 No		 2043	 50	 37.54	 1.33	 1.01	–	1.76	 1	 	 0.04	Yes	 196	 10	 3.40	 2.95	 1.59	–	5.47	 2.2	 1.1	–	4.4	 	Unknown	 827	 31	 14.87	 2.09	 1.47	–	2.97	 1.6	 1.0	–	2.5	 	HIV	prevalence	in	residential	area	(%)	 <4.0	 680	 28	 14.84	 1.89	 1.30	–	2.73	 1	 	 0.15	4.0	–	7.9	 1837	 54	 37.93	 1.42	 1.09	–	1.86	 0.8	 0.5	–	1.2	 	≥8.0%	 549	 9	 3.04	 2.96	 1.54	–	5.69	 1.5	 0.7	–	3.5	 	
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*Adjusted	for	clustering	in	residential	area	
Table	2.	Attendance	at	gathering	places	as	risk	factors	for	incident	M.tb	infection	(n=2041)		 	
N	(%)	 No.	of	M.tb	infections	 Exposure	time	(100	py)	 M.tb	infection	incidence	(per	100py)	95%	CI	 Crude	rate	ratio*	
	
	
	
95%	CI	 P	value	Overall	study	population	incidence	rate		 2041	 66	 44.82	 1.50	 1.18	–	1.90	 -	 -	 -	
	 	 	 	 	 	 	 	 	 	
Attendance	at	gathering	place	
(no.	of	visits	per	year)	 	 	 	 	 	 	 	 	Church	 <4	 223	 3	 4.23	 0.71	 0.23	–	2.20	 1	 	 0.15		 ≥4	 1796	 63	 40.21	 2.36	 1.22	–	2.01	 2.4	 0.7	–	7.7	 	Health-care	facility	 None	 319	 8	 6.51	 1.23	 0.61	–	2.46	 1	 	 0.47		 At	least	one	visit	 1701	 58	 37.95	 1.53	 1.18	–	1.98	 1.3	 0.6	–	2.8	 	Travel	on	mini-bus	 None		 1008	 26	 22.24	 1.17	 0.80	–	1.72	 1	 	 0.07		 At	least	one	trip	 1012	 40	 22.20	 1.80	 1.32	–	2.46	 1.6	 1.0	–	2.6	 	Market	 None	 1133	 44	 24.22	 1.82	 1.35	–	2.44	 1	 	 0.13		 At	least	one	visit	 902	 22	 20.48	 1.08	 0.71	–	1.63	 0.7	 0.4	–	1.2	 	Funeral	 None		 1663	 54	 36.80	 1.47	 1.12	–	1.92	 1	 	 0.92		 At	least	one	attendance	 372	 12	 7.89	 1.52	 0.86	–	2.68	 1.0	 0.5	–	1.9	 	School	attendance	 No	 1281	 36	 28.00	 1.29	 0.93	–	1.78	 1	 	 0.09		 	Yes	 755	 30	 16.71	 1.80	 1.26	–	2.57	 1.6	 0.9	–	2.7	 	*Adjusted	for	clustering	in	residential	area		py	person-year	CI	confidence	interval
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Table	3.		Multivariable	analysis	of	risk	factors	for	incident	M.tb	infection		
	
M.tb	infection	defined	as	TST		
conversion	≥13mm	
Sensitivity	analyses	
M.tb	infection	defined	as	
TST	conversion	≥10mm	
M.tb	infection	defined	as	
TST	conversion	≥15mm	
TST	conversion	≥13mm	
excluding	children	with	
conversions	9-12mm	
	 Multivariable	model	1*	(n=1826)	 PAF	(95%	CI)	 Multivariable	model	2*	(n=1826)	 Multivariable	model	3*	(n=1826)	 Multivariable	model	4*	(n=1778)		 	 RR	 95%	CI	 p	value	 	 RR	 95%	CI	 p	value	 RR	 95%	CI	 p	value	 RR	 95%	CI	 p	value	
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Age	at	time	of	1st	skin	test	(years)	 1.4	 1.1	–	3.0	 0.01	 -	 1.3	 1.1	–	1.5	 0.02	 1.4	 1.1	-1.8	 0.01	 1.4	 1.1	–	3.1	 0.01	
HIV-positive	father	 No		 1	 	 0.04	 	 1	 	 0.12	 1	 	 0.04	 1	 	 0.04	Yes	 2.5	 1.1	–	5.8	 	 6.9%	(1.1	–	9.5)	 1.8	 0.8	–	3.7	 	 3.0	 1.2	–	7.6	 	 2.6	 1.1	–	5.9	 	Unknown	 1.7	 1.0	–	3.0	 	 	 1.5	 1.0	–	2.4	 	 1.7	 0.9	–	3.5	 	 1.8	 1.0	–	3.1	 	
Known	community	M.tb	exposure:	 	 	 	 	 	 	 	 	 	 	 		Av.	smear-positive	TB	notification	rate	(per	100,000/	area/yr)	 ≤30	 1	 	 0.001	 	 1	 	 0.002	 1	 	 0.02	 1	 	 0.001	>30	 2.0	 1.3	–	3.1	 	 28.7%	(13.2	–	38.9)	 1.7	 1.2	–	2.4	 	 2.0	 1.2	–	3.4	 	 2.1	 1.3	–	3.1	 	Attendance	at	church		(visits	per	year)		 <4		 1	 	 0.04	 	 1	 	 0.04	 1	 	 0.15	 1	 	 0.04	≥4		 3.4	 0.8	–	14.0	 	 67.8%	(-24.1	–	90.0)	 2.6	 0.9	–	7.1	 	 2.5	 0.6	–	10.4	 	 3.5	 0.8	–	14.3	 	Travel	on	mini-bus	 None		 1	 	 0.03	 	 1	 	 0.05	 1	 	 0.05	 1	 	 0.02	Any	trip	 1.8	 1.1	–	3.1	 	 27.7%	(5.7	–	42.2)	 1.5	 1.0	–	2.3	 	 1.8	 1.0	–	3.4	 	 1.8	 1.1	–	1.7	 	*Adjusted	for	clustering	in	residential	and	all	risk	factors	in	the	model	in	addition	to	sex,	household	SES	and	dwelling	structure			TST	tuberculin	skin	test	RR	rate	ratio	CI	confidence	interval	PAF	population	attributable	fraction	SES	socioeconomic	status
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Figures	
	
Figure	 1.	 Flow	 diagram	 illustrating	 study	 participant	 flow	 at	 each	 stage	
from	eligibility	through	to	analysis.	TST=tuberculin	skin	test			 	
Children eligible for entry into cohort 
n=3357
Consented and had 2nd TST placed 
n=3070 (91.5%)
N=287 (8.5%) 
Refused  n=20 
Missed    n=238  
Left area  n=26 
Died         n=3
TST read within 48-72 hours 
n=3066 (91.3%)
N=4 
Missed TST reading
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Figure	2.	(a)	Histogram	of	increase	in	induration	size	between	1st	and	2nd	
TST	[n=350]	(b)	2-component	mixture	model	based	on	implementation	of	
Expectation	Maximization	 (EM)	 algorithm	 to	 derive	 the	 cut-off	 value	 for	
TST	conversion	(KEY:	grey	bars=histogram	bars;	blue	solid	line=kernel	density	estimation	of	the	distribution;	blue	dashed	line=finite-mixture	model;	red	solid	line=cut-off	value;	red	dashed	lines=95%	CI	around	cut-off	value)	
	
	 	
p<0.05	false	positive	using	a	cut-
off	of	TST	conversion	≥13mm	
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Online	supplement	
Table	S1.	Characteristics	of	 study	participants	missing	data	on	gathering	
places	compared	with	study	participants	who	had	data	collected		 Data	available	on	gathering	places		(n=2041)	 Missing	data	on	gathering	places	(n=1025)	Age	in	years	(mean	(sd))	 2.1	(1.0)	 2.7	(1.3)	
Male	(%)	 50.2	 50.8	
Proportion	in	the	lowest	SES	category	 7.2%	(95%	CI	6.1	–	8.4)	 5.7%	(95%	CI	4.4	–	7.4)	
Median	no.	of	adults	in	HH	(IQR)	 2	(2	-	3)	 2	(2	-	2)	
Father	HIV	positive	(%)	 5.8%	(95%	CI	4.9	–	6.9)	 7.5%		(95%	CI	6.0	–	9.3)	
Mother	HIV	positive	(%)	 9.3%	(95%	CI	8.1	-10.7)	 14.6%	(95%	CI	12.5	–	17.0)	
Community	M.tb	exposure:	av	notification	rate	>30	per	100,000	population	per	year	 39.4%	(95%	CI	37.3	–	41.6)	 46.8%		(95%	CI	43.7	–	49.9)	Resident	in	an	area	where	HIV	prevalence	>8.0%	 9.5%	 0%	
Household	TB	contact	 0.3%		(95%	CI	0.1	–	0.6)	 0.5%		(95%	CI	0.2	–	1.1)	
M.tb	incidence	rate	 1.5	per	100py	(95%	CI	1.2	–	1.9)	 2.2	per	100py	(95%	CI	1.5	–	3.3)	sd	 standard	 deviation;	 HH	 household;	 IQR	 interquartile	 range;	 CI	 confidence	 interval	 SES	socioeconomic	status;	py	person-years				
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Abstract	
Background:	Understanding	of	 the	effects	of	HIV	and	anti-retroviral	 treatment	(ART)	 on	Mycobacterium	 tuberculosis	 (M.tb)	 transmission	 dynamics	 remains	limited.		We	undertook	a	cross-sectional	study	of	household	contacts	of	smear-positive	pulmonary	tuberculosis	cases	to	assess	the	effect	of	established	ART	on	the	infectiousness	of	TB	
Method:	 Prevalence	 of	 tuberculin	 skin	 test	 (TST)	 positivity	 was	 compared	between	contacts	aged	2-10	years	of	index	cases	who	were:	HIV-negative;	HIV-positive	not	on	ART;	on	ART	<1	year	and	on	ART	for	≥1	year.	Random	effects	logistic	regression	was	used	to	take	account	of	clustering	within	households.			
Results:	M.tb	 infection	prevalence	 in	 contacts	of	HIV-negative,	HIV-positive	on	ART	≥1	year	and	HIV-positive	not	on	ART/	on	ART	<1	year	index	cases	was	44%,	21%	and	22%	respectively.	Compared	to	contacts	of	HIV-positive	index	cases	not	on	ART	or	 recently	 started	 on	ART,	 the	 odds	 of	 TST	positivity	was	 similar	 in	contacts	of	HIV-positive	index	cases	on	ART	≥1	year	(aOR	1.0;	95%	CI	0.3	–	3.7).		The	odds	were	2.9	 times	higher	 in	 child	 contacts	 of	HIV-negative	 index	 cases	(aOR	2.9;	95%	CI	1.0	–	8.2).		
Conclusions:	 We	 found	 no	 evidence	 that	 established	 ART	 increased	 the	infectiousness	of	smear	positive	HIV-positive	index	cases.		 Word	count:	196		
Key	Words:	 M.tb	 infection;	 infectiousness;	 tuberculosis;	 antiretroviral	treatment;	HIV	 	
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Introduction	The	 human	 immunodeficiency	 virus	 (HIV)	 pandemic	 continues	 to	 challenge	global	 tuberculosis	(TB)	control,1,2	yet	our	understanding	of	 the	effects	of	HIV	and	 anti-retroviral	 treatment	 (ART)	 on	 Mycobacterium	 tuberculosis	 (M.tb)	transmission	dynamics	remains	limited.3-7			In	HIV-positive	individuals,	ART	reduces	TB	incidence	across	all	CD4	cell	counts,8	yet	despite	 long-term	ART,	TB	 incidence	 remains	higher	 than	 in	HIV-negative	people	in	both	high	and	low	TB-burden	settings.9,10	As	life	expectancy	is	greatly	extended	 by	 ART,	 the	 cumulative	 lifetime	 risk	 of	 TB	 for	 HIV-positive	 people	remains	 very	 high.9	 While	 HIV-positive	 TB	 patients	 with	 advanced	immunosuppression	are	less	likely	to	transmit	to	household	contacts	than	their	HIV-negative	counterparts,11-17	partly	mediated	through	a	lower	bacillary	load	in	sputum,11,16,17	ART	may	increase	the	infectiousness	of	TB	by	shifting	the	clinical	manifestation	to	be	more	similar	to	HIV-negative	patients.18,19	
	Concerns	 have	 been	 raised	 that	 the	 increased	 life-expectancy	 and	 possible	increased	infectiousness	due	to	ART	might	increase	TB	incidence	at	a	population-level.20	This	might	be	negated	by	reduced	HIV	transmission,21,22			but	a	rebound	in	TB	incidence,	exceeding	levels	present	before	ART	roll-out,	is	possible	if	good	adherence	 to	 ART	 is	 not	 sustained.23	 Programmatic	 data	 from	 South	 Africa,	Malawi	and	Zimbabwe	have	shown	a	reduction	in	TB	incidence,	as	inferred	from	trends	in	TB	case	notification,	 in	association	with	ART	scale-up.24,25	 	However,	short-term	 reductions	 in	 TB	 incidence	 may	 be	 due	 to	 protection	 from	progression	to	disease	rather	than	a	reduction	in	M.tb	transmission	per	se.		
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We	examine	the	effect	of	HIV	and	ART	on	intra-household	M.tb	transmission	by	measuring	the	prevalence	of	M.tb	infection	among	child	contacts	of	adult	smear-positive	tuberculosis	cases.						
Methods	
Study	setting	Karonga	District,	 northern	Malawi,	 is	 predominantly	 rural,	with	 an	 adult	 HIV	prevalence	of	9%	and	new	smear-positive	TB	incidence	of	87	per	100,000	adults	per	year.26	60%	of	TB	cases	are	HIV-positive.26	The	 first	ART	clinic	opened	 in	2005	and	by	2012,	16	clinics	in	the	district	were	certified	to	initiate	and	provide	ART.27			
Study	design	A	cross-sectional	household	study	of	all	diagnosed	smear-positive	TB	cases	in	the	district	 was	 conducted	 from	 January	 2013	 to	 April	 2015.	 Households	 were	eligible	if	a	smear-positive	case	had	lived	there	for	at	least	2	weeks	after	the	onset	of	symptoms	and	prior	to	initiation	of	treatment.		Bacteriological,	demographic	and	clinical	 (including	HIV	and	ART	status)	data	 from	all	patients	 starting	TB	treatment	in	the	district	have	been	collected	in	a	TB	case	cohort	study	since	1988	to	date,	which	has	been	previously	described.26,28		Households	were	visited	approximately	6	weeks	after	TB	diagnosis	of	index	case	(date	of	first	smear-positive	sputum).		All	children	aged	2	to	10	years-old	resident	within	 the	 household	 were	 included.	 A	 tuberculin	 skin	 test	 (TST)	 was	administered	and	read	according	to	standard	international	guidelines29	using	2	
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international	units	of	RT23	(Statens	Serum	Institute,	Copenhagen,	Denmark)	and	induration	 was	 measured	 48-72	 hours	 later.	 	 A	 positive	 TST	 was	 defined	 as	induration	≥	10mm.		Children	under	the	age	of	2	years	were	excluded	to	minimize	misclassification	of	infection	status	due	to	false-positive	TST	as	a	result	of	recent	BCG	vaccination.30				A	 questionnaire	 was	 completed	 which	 included	 data	 on	 demographics,	 BCG	vaccination	 status,	 exposure	 to	 index	 case	 (whether	 index	 case	 was	 mother,	duration	of	sleeping	 in	same	room	and	of	 living	 in	 the	same	household	whilst	index	 case	 was	 symptomatic),	 and	 household	 characteristics	 (number	 of	residents,	 socio-economic	 indicators	 including	 quality	 of	 dwelling	 place).	 	 A	composite	score	for	household	socioeconomic	status	was	created	using	head	of	household	employment,	number	of	assets,	food	security	and	availability	of	soap,	and	 a	 composite	 score	 for	 quality	 of	 dwelling	 place	 was	 based	 on	 building	materials,	 type	 of	 roof,	 number	 of	 rooms,	 water	 source,	 presence	 of	 glass	windows,	electricity	and	latrine	type.	
	Any	child	with	symptoms	suggestive	of	TB	(fever,	weight	loss,	failure	to	thrive,	night	sweats	or	cough)	was	reviewed	by	a	clinician	and	referred	to	the	district	hospital	 where	 appropriate.	 	 All	 children	 aged	 <5	 years	 without	 evidence	 of	active	 disease	 were	 commenced	 on	 6-month	 isoniazid	 preventive	 treatment	(5mg/kg	once	daily)	irrespective	of	TST	induration	size	(as	per	Malawi	National	TB	programme	guidelines).31			
	
	
	127		
Ethics	approval	The	 study	 was	 approved	 by	 the	 Malawi	 National	 Health	 Sciences	 Research	Committee	 (#1049)	 and	 the	 London	 School	 of	 Hygiene	 &	 Tropical	 Medicine	Ethics	 committee	 (#6285).	 	 At	 the	 time	 of	 study	 recruitment,	 smear	 positive	pulmonary	TB	patients	were	asked	for	written	consent	to	visit	their	household(s)	to	 screen	 household	 members	 for	 infection	 and	 disease.	 	 Written	 informed	consent	was	then	obtained	from	a	parent	or	guardian	of	each	participating	child	at	the	time	of	household	visit.		
Statistical	analysis	Prevalence	 of	 tuberculin	 skin	 test	 (TST)	 positivity,	 was	 compared	 between	household	contacts	by	HIV	and	ART	status	of	the	index	case,	distinguishing	those	not	 on	 ART	 or	 on	 ART	 for	 <1	 year	 and	 on	 ART	 for	 ≥1	 year	 at	 tuberculosis	diagnosis.	 	We	performed	univariate	analyses	 for	 covariates	known	 to	be	risk	factors	for	M.tb	infection.	They	were	assessed	as	confounders	of	the	association	between	 HIV/ART	 status	 and	 TST	 positivity,	 first	 individually	 and	 then	 in	 a	multivariable	 model,	 using	 random	 effects	 logistic	 regression	 to	 account	 for	clustering	within	household.				Sputum	smear	grade	and	duration	of	symptoms	were	not	included	in	the	initial	multivariable	 model	 as	 they	 were	 considered	 to	 be	 on	 the	 causal	 pathway	between	HIV/ART	status	and	prevalence	of	TST	positivity	in	the	child	contact.		However,	they	were	examined	as	mediators	of	the	association	in	the	subsequent	models.			
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Sensitivity	analyses:		The	analysis	was	repeated	(i)	grouping	all	patients	on	ART	irrespective	of	time	on	ART,	(ii)	separating	patients	on	ART	for	≥2	years,	and	(iii)	using	a	TST	cut-off	≥	15mm.	
	
Results	388	child	contacts	of	187	index	cases	were	eligible	for	inclusion	(Figure	1).		309	child	contacts	had	a	TST	placed	and	read	within	48-72	hours	(80%;	153	index	cases).	HIV/ART	status	was	missing	for	3	index	cases	(7	contacts).		Therefore	302	child	 contacts	 of	 150	 index	 cases	 were	 included	 in	 the	 final	 analysis.	 	 One	hundred	and	seventy-seven	children	(58.4%)	had	no	induration;	the	frequency	distribution	of	those	children	with	non-zero	TST	induration	(n=125)	is	shown	in	Figure	2.		
Index	case	characteristics		Of	the	150	index	cases,	63%	were	male.		Median	age	was	33.6	years	(interquartile	range	[IQR]	28.2	–	39.3)	for	female	index	cases	and	37.6	years	(IQR	30.6	–	44.9)	for	 male.	 	 22%	 of	 index	 cases	 were	 on	 ART	 at	 TB	 diagnosis,	 with	 a	 median	duration	on	ART	of	2.8	years	 (IQR	1.2	–	4.5;	n=33).	Table	1	shows	 index	case	characteristics	by	HIV/ART	status.	The	median	duration	of	symptoms	prior	to	TB	diagnosis	 (by	 self-report)	 was	 shortest	 in	 HIV-positive	 on	 ART	 ≥1	 year	 (8.3	weeks	IQR:	7.0	–	16.3).				
TST	positivity	in	child	contacts		The	 prevalence	 of	 TST	 positivity	 among	 all	 child	 contacts	 was	 34.4%.	 	 TST	positivity	in	the	child	contacts	of	HIV-positive	index	cases	not	on	ART	was	23.1%	
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(15/65);	as	there	were	only	11	child	contacts	of	8	HIV-positive	index	cases	on	ART	for	<1	year	(TST	positivity	18.2%)	this	category	was	combined	with	the	HIV-positive	 not	 on	 ART	 index	 cases.	 TST	 positivity	 was	 44.1%	 (75/170),	 21.4%	(12/56)	and	22.4	%	(17/76)	in	contacts	of	index	cases	who	were	HIV-negative,	HIV-positive	on	ART	≥1	year,	and	HIV-positive	not	on	ART/on	ART	for	<1	year,	respectively	(Table	2).			Factors	associated	with	TST	positivity	in	child	contacts	included:	HIV/ART	status	of	index	case;	sex	of	index	case;	whether	index	case	was	the	mother;	index	case	sputum	smear	grade;	and	degree	of	exposure	of	contact	(Table	2).		Compared	to	contacts	of	HIV-positive	index	cases	not	on	ART	or	on	ART	for	<1	year,	the	odds	of	a	positive	TST	were	higher	in	the	contacts	of	HIV-negative	index	cases	(crude	OR	4.3:	95%	CI	1.4-13.1,	reducing	to	OR	2.9:	95%CI	1.0–8.2	after	adjustment	 for	 socio-demographic	 factors)	but	not	 in	 contacts	of	HIV-positive	index	cases	who	had	been	on	ART	for	≥	1	year	(crude	OR	1.1:	95%CI	0.3–4.6,	adjusted	OR	1.0;	95%	CI	0.3–3.7,	Table	2).		Further	adjustment	assessed	the	effect	of	 factors	 that	 may	 be	 on	 the	 causal	 pathway.	 Adjustment	 for	 duration	 of	symptoms	(model	2a,	Table	3)	made	little	difference	to	the	odds	of	TST	positivity	in	contacts	of	HIV-negative	index	cases	but	adjustment	for	smear	grade	(model	2b)	reduced	the	association	(aOR	2.2:	95%	CI	0.8–6.3).	Among	contacts	of	HIV-positive	index	cases	there	was	no	association	of	TST	positivity	with	ART	duration	in	any	model	(Table	3).				
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The	results	of	the	sensitivity	analyses	are	also	shown	in	Table	3.		Using	a	cut-off	TST	≥15mm,	regrouping	those	on	ART	ignoring	duration,	or	separating	those	on	ART	>2	years	made	little	difference	to	the	results.	
	
Discussion	We	 found	no	evidence	 that	 child	 contacts	of	HIV-positive	TB	patients	on	ART	were	 more	 likely	 to	 have	 a	 positive	 TST	 compared	 to	 child	 contacts	 of	 HIV-positive	 TB	 patients	 not	 on	 ART.	 	 However,	 child	 contacts	 of	 HIV-negative	individuals	had	nearly	three	times	the	odds	of	having	a	positive	TST	compared	to	 child	 contacts	 of	 HIV-positive	 TB	 patients	 not	 on	 ART;	 this	 was	 partly	explained	by	differences	in	the	degree	of	smear	positivity.			Some	TB	household	contact	studies	have	found	no	difference	in	infectiousness	between	HIV-positive	TB	patients	compared	to	HIV-negative	TB	patients	if	HIV-positive	index	cases	were	less	immunosuppressed	(CD4>250)16	or	were	smear-positive	 and/or	 had	 cavitatory	 disease.17	 	 Heterogeneity	 observed	 in	 the	estimates	 of	 infectiousness	 of	 HIV-positive	 TB	 patients	 compared	 to	 HIV-negative	TB	patients	has	been	well-described,16,17,32	although	no	studies	to	date	have	examined	the	effect	of	ART	status	of	the	HIV-positive	index	case.	Possible	reasons	for	heterogeneity	seen	include	differences	in	patient	eligibility	(smear-positive	 only	 vs	 all	 TB	 patients),	 study	 settings	 (high	 vs	 low	 HIV	 and	 TB	background	prevalence),	household	contacts	screened	for	M.tb	infection	(adults	and	 children	 vs	 children	 only)	 and	 study-related	 biases,	 such	 as	 exposure	assessment	bias	and	recall	bias.33	Study	calendar	period	may	also	influence	the	
	131		
estimates	of	infectiousness	as	the	degree	of	immunosuppression	of	HIV-positive	TB	 cases	 on	 a	 population-level	 will	 be	 a	 function	 of	 the	 maturity	 of	 the	 HIV	epidemic	and	the	time	since	roll-out	of	ART.		The	lack	of	evidence	for	increased	infectiousness	in	TB	patients	established	on	ART,	compared	to	those	not	on	ART	in	our	study	may	be	due	to	earlier	diagnosis	resulting	in	a	shorter	duration	of	infectiousness.		However,	adjusting	for	duration	of	symptoms	in	model	2a	did	not	alter	the	odds	of	a	positive	TST	in	contacts	of	index	cases	who	had	been	on	ART	≥	1	years.	This	might	be	due	to	the	fact	that	duration	of	 symptoms	at	 time	of	TB	diagnosis	 is	notoriously	difficult	 to	 recall	accurately.	 Interestingly,	 a	 contemporaneous	 study	 of	 attendance	 at	 the	HIV/ART	 clinic	 undertaken	 at	 the	 Karonga	 District	 Hospital	 found	 that	 HIV-positive	individuals	on	ART	attended	clinic	much	more	regularly	than	those	not	on	ART;	median	number	of	visits	per	year	were	5	(IQR	4	–	6)	for	ART	patients	and	1	(IQR	1-2)	for	HIV	patients	not	on	ART	(unpublished	data).		This	gives	much	greater	opportunity	for	early	diagnosis	of	TB.	Another	reason	for	the	absence	of	evidence	for	increased	infectiousness	in	TB	patients	established	on	ART	may	be	that	 in	our	population	 in	northern	Malawi,	 the	effect	of	ART	 is	masked	by	the	degree	 of	 immunodeficiency	 of	 the	 index	 case	 because	 ART	 is	 started	 in	individuals	with	more	advanced	HIV	infection.				CD4	 cell	 count	 testing	 is	 not	 done	 routinely	 in	 Karonga,	 northern	 Malawi	resulting	 in	 the	 absence	 of	 a	 biological	 marker	 for	 the	 level	 of	immunosuppression	 of	 HIV-positive	 TB	 patients	 and	 degree	 of	 immune	reconstitution	in	those	established	on	ART	in	this	study.	Limitations	of	our	study	
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also	include	the	absence	of	radiological	data	to	assess	extent	of	lung	cavitation	by	HIV/ART	status.	These	data	would	have	helped	to	interpret	the	apparent	lack	of	effect	of	ART	on	infectiousness.	Knowing	the	HIV	status	of	the	child	contacts	would	have	also	strengthened	this	study,	as	an	HIV-positive	child	with	advanced	immunosuppression	may	be	more	 likely	 to	have	 a	 false-negative	TST	 than	an	HIV-negative	child,	and	an	HIV-positive	child	is	more	likely	to	be	resident	in	the	household	of	an	HIV-positive	index	case.		This	is	one	potential	explanation	for	the	lower	prevalence	of	M.tb	infection	in	the	child	contacts	of	index	cases	with	HIV	infection	 irrespective	 of	 ART	 status	 found	 in	 this	 study.	 However,	 ART	 for	prevention	of	mother	to	child	transmission	is	widely	used	and	the	proportion	of	infected	children	will	be	very	low.		
	
Conclusion	We	 found	 a	 higher	 prevalence	 of	M.tb	 infection	 among	 child	 contacts	 of	 HIV-negative	tuberculosis	patients	compared	to	contacts	of	HIV-positive	index	cases,	irrespective	of	ART	status.		We	found	no	evidence	that	HIV-positive	index	cases	on	ART	for	≥	1	year	at	tuberculosis	diagnosis	were	more	likely	to	transmit	than	other	HIV-positive	index	cases.	Frequent	health	service	contacts	of	HIV-positive	individuals	on	ART	leading	to	prompt	diagnosis	of	TB	may	mitigate	the	effects	of	any	 increase	 in	 infectiousness.	 	 Further	 studies	 are	 required	 to	 definitively	establish	 whether	 ART	 has	 a	 biological	 effect	 on	 the	 infectiousness	 of	 HIV-positive	TB	patients.	
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Tables	and	figures	
Table	1.	Index	case	characteristics	by	HIV/ART	status	of	index	case	(n=150)	
sd	standard	deviation;	IQR	interquartile	range		
Table	2.	Demographic	 and	 clinical	 characteristics	of	 index	 case	and	 contact:	
risk	factors	for	TST	positivity	(n=302)	
Continued…	
	 	 HIV/ART	status	of	index	case	
Case	
characteristics	
HIV-	 HIV+	ART	≥1	yr	 HIV+	ART	<	1yr	 HIV+	no	ART	(N=82)	 (N=25)	 (N=8)	 (N=35)	Male	 (%)	 50	 (61.7)	 14	 (56.0)	 5	 (62.5)	 25	 (71.4)	Age	in	years	(mean	(sd))	 36.1	 (14.7)	 39.9	 (6.1)	 36.1	 (4.8)	 36.7	 (8.7)	Index	case	mother	(%)	 15	 (18.3)	 7	 (28.0)	 2	 (25.0)	 5	 (14.3)	Smear	grade	 Scanty	 2	 (2.5)	 3	 (12.0)	 1	 (12.5)	 4	 (11.4)	+1	 11	 (13.4)	 4	 (16.0)	 2	 (25.0)	 9	 (25.7)	+2	 27	 (32.9)	 9	 (36.0)	 3	 (37.5)	 4	 (11.4)	+3	 42	 (51.2)	 9	 (36.0)	 2	 (25.0)	 18	 (51.5)	Duration	of	symptoms	in	weeks		(median	(IQR))	 13.2	 (7.6	–	20.6)	 8.3	 (7.0	–	16.3)	 18.6	 (8.2	–	28.6)	 12.4	 (8.0	–	19.7)	
Characteristics	 TST≥10mm	 Crude	OR	(95%	CI)	 P	value	(N=302)	n/N	(%)	
Index	Case	 HIV/ART	status	 HIV+	no	ART/	ART<1y	 17/76	 (22.4)	 1	 0.009		 	 HIV+	on	ART	≥	1y	 12/56	 (21.4)	 1.1	(0.3	–	4.6)	 		 	 HIV-	 75/170	 (44.1)	 4.3	(1.4	–	13.1)	 		 Sex	 Female	 52/116	 (44.8)	 1	 0.01		 	 Male	 52/186	 (28.0)	 0.3	(0.1	–	0.8)	 		 Age	(years)	 <30	 35/86	 (41.9)	 1	 0.3		 	 30	-	44	 53/156	 (34.0)	 0.6	(0.2	–	1.7)	 		 	 ≥45	 15/60	 (25.0)	 0.3	(0.1	–	1.3)	 		 Index	case	relationship	 Not	mother	 70/243	 (28.8)	 1	 0.002		 Mother	 34/59	 (57.6)	 4.7	(1.7	–	13.0)	 		 Smoker	 No	 72/207	 (34.8)	 1	 0.8		 	 Yes	 32/95	 (33.7)	 0.9	(0.3	–	2.5)	 	
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OR	odds	ratio;	CI	confidence	interval;	*missing	BCG	scar	status	on	13	child	contacts			
Table	2	(Continued).	Demographic	and	clinical	characteristics	of	index	case	and	contact:	risk	factors	for	TST	positivity	(n=302)	
Characteristics	
TST≥10mm	
(N=302)	
n/N	(%)	
Crude	OR	(95%	
CI)	 P	value		 Sputum	smear	grade	 Scanty	 1/19	 (5.3)	 0.02	(0.001	–	0.5)	 0.005		 	 +1	 12/57	 (21.1)	 0.2	(0.06	–	0.8)	 		 	 +2	 35/92	 (38.0)	 0.7	(0.2	–	1.9)	 		 	 +3	 56/134	 (41.8)	 1	 		 Duration	of	symptoms	(weeks)	 <	8	 34/118	 (28.8)	 1	 0.1		 ≥	8	 70/184	 (38.0)	 2.1	(0.8	–	5.6)	 	
Contact	 Sex	 Female	 52/148	 (35.1)	 1	 0.6		 	 Male	 52/154	 (33.8)	 0.8	(0.4	–	1.7)	 		 BCG	scar*	 No		 17/41	 (41.5)	 1	 0.3		 	 Yes	 82/248	 (33.1)	 0.6	(0.2	–	1.7)	 		 Age	(years)	 2	-	3	 30/75	 (40.0)	 1	 0.7		 	 4	-	5	 24/62	 (38.7)	 1.2	(0.4	–	3.3)	 		 	 6	-	7	 22/77	 (28.6)	 0.7	(0.3	–	1.7)	 		 	 ≥	8	 28/88	 (31.8)	 0.8	(0.3	–	1.9)	 		 Degree	of	exposure	to	index	case	whilst	symptomatic	
Resident	 44/175	 (25.1)	 1	 0.008		 Sleep	same	room	≤	30days	 16/46	 (34.8)	 1.5	(0.5	–	4.3)	 		 Sleep	same	room	>	30days	 42/81	 (51.9)	 4.0	(1.7	–	10.4)	 	
Household	 No.	of	adults	 1	-	2	 42/101	 (41.6)	 1	 0.3		 	 3	-	4	 47/139	 (33.8)	 0.6	(0.2	–	1.7)		 		 	 ≥	5	 15/62	 (24.2)	 0.3	(0.1	–	1.3)	 		 Socio-economic		 Lowest	score	 54/148	 (36.5)	 1	 0.08		 	 Middle	 33/80	 (41.3)	 1.3	(0.4	–	3.9	 		 	 Highest	score	 17/74	 (23.0)	 0.3	(0.09	–	1.1)	 		 Quality	of	dwelling	score	 lowest	 28/64	 (43.8)	 1	 0.1		 	 middle	 45/118	 (38.1)	 0.6	(0.2	–	2.1)	 		 	 highest	 31/117	 (26.5)	 0.3	(0.08	–	1.0)	 		 Crowding	(persons/room)	 1	-	2	 45/131	 (34.4)	 1	 0.6		 	 3	-	4	 45/138	 (32.6)	 1.0	(0.4	–	2.7)	 		 	 ≥	5	 14/33	 (42.2)	 2.3	(0.5	–	11.7)	 	
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Table	3.	Multivariable	analysis	of	association	of	HIV/ART	status	of	index	case	with	TST	positivity	in	child	contacts	
		 	 	 TST	positive	(n=302)	 Crude	OR	 Multivariable	model	1a	(n=302)	 Multivariable	model	2ab	(n=302)	 Multivariable	model	2bc	(n=302)		 n/N	 (%)	 OR	(95%	CI)	 P	value	 OR	(95%	CI)	 P	value	 OR	(95%	CI)	 P	value	 OR	(95%	CI)	 P	value	Index	case	HIV/ART	status	 HIV+	no	ART/	ART<1y	 17/76	 (22.4)	 1	 0.009	 1	 0.05	 1	 0.06	 1	 0.2	HIV+	on	ART≥1y	 12/56	 (21.4)	 1.1	(0.3	–	4.6)	 	 1.0	(0.3	–	3.7)	 	 1.1	(0.3	–	4.4)	 	 0.9	(0.2	–	3.4)	 	HIV-	 75/170	 (44.1)	 4.3	(1.4	–	13.1)	 	 2.9	(1.0	–	8.2)	 	 3.0	(1.0	–	8.7)	 	 2.2	(0.8	–	6.3)	 	
	 	 	 	 	 	 	 	 	 	 	
Sensitivity	analyses	 	 	 	 	 	 	 	 	 	 		 HIV+	no	ART	 15/65	 (23.1)	 1	 0.009	 1	 0.05	 1	 0.06	 1	 0.2		 HIV+	on	ART	 14/67	 (20.9)	 0.9	(0.2	–	3.5)	 	 0.9	(0.3	–	3.3)	 	 1.0	(0.3	–	3.7)	 	 0.9	(0.2	–	3.3)	 		 HIV-	 75/170	 (44.1)	 3.8	(1.2	–	12.2)	 	 2.8	(1.0	–	8.1)	 	 2.9	(1.0	–	8.5)	 	 2.2	(0.7	–	6.4)	 		 	 	 	 	 	 	 	 	 	 	 		 HIV+	no	ART	 15/65	 (23.1)	 1	 0.03	 1	 0.1	 1	 0.1	 1	 0.3		 HIV+	on	ART<2y	 8/41	 (19.5)	 0.9	(0.1	–	5.5)	 	 0.8	(0.1	–	4.2)	 	 0.8	(0.1	–	4.3)	 	 0.6	(0.1	–3.5)	 		 HIV+	on	ART	≥2y	 6/26	 (23.1)	 0.9	(0.2	–	4.3)	 	 1.0	(0.2	–	4.8)	 	 1.2	(0.3	–	5.9)	 	 1.2	(0.2	–	5.6)	 		 HIV-	 75/170	 (44.1)	 3.8	(1.2	–	12.2)	 	 2.8	(1.0	–	8.1)	 	 2.9	(1.0	–	8.5)	 	 2.2	(0.7	–	6.5)	 		 	 	 	 	 	 	 	 	 	 	 	
TST≥15mm	 	 	 	 	 	 	 	 	 	 		 HIV+	no	ART/	ART<1y	 12/76	 (15.8)	 1	 0.008	 1	 0.08	 1	 0.1	 1	 0.2		 HIV+	on	ART	≥	1y	 7/56	 (12.5)	 0.6	(0.1	–	3.5)	 	 0.6	(0.1	–	2.8)	 	 0.7	(0.1	–	3.4)	 	 0.5	(0.1	–	2.4)	 		 HIV-	 58/170	 (34.1)	 4.2	(1.2	–	15.0)	 	 2.3	(0.7	–	7.5)	 	 2.4	(0.7	–	8.1)	 	 1.7	(0.5	–	5.5)	 	
	a	Adjusted	for	household	clustering;	age	and	sex	of	index	case;	age	and	sex	of	contact;	degree	of	exposure	of	contact	to	case;	household	SES;	quality	of	dwelling	structure;	whether	index	case	was	the	mother;	and	number	of	adults	in	the	household	
b	Adjusted	for	household	clustering	and	for	all	risk	factors	in	the	model	1	plus	duration	of	symptoms	
c	Adjusted	for	household	clustering	and	for	all	risk	factors	in	the	model	1	plus	duration	of	symptoms	and	smear	grade	
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Figure	 1.	 	 Study	 flowchart:	 TB	 case	 through	 to	 child	 contact	 TST	 data	
included	in	analysis		 	
388 child contacts
187 (78%) index cases with 
household contacts aged 2 to 10 years
Eligible smear-positive TB index cases  
n=318
HIV-                            164 (52%)  
HIV+ on ART                74 (23%)  
HIV+ not on ART          60 (19%) 
HIV unknown                20 (6%)
HIV-                           122 (51%)  
HIV+ on ART               60 (25%)  
HIV+ not on ART         48 (20%) 
HIV unknown                 9 (4%)
244 TB index case household consented 
of 239 (75%) index cases
HIV-                              92 (52%)  
HIV+ on ART                38 (23%)  
HIV+ not on ART          40 (23%) 
HIV unknown                  3 (2%)
HIV/ART status of index case
309 (80%) child contacts had TST placed 
and read within 48-72hrs
HIV-                            207 (53%) 
HIV+ on ART                85 (22%) 
HIV+ not on ART          88 (23%)  
HIV unknown                 8  (2%)
82 HIV-                       170 (55%)  
33 HIV+ on ART          67  (22%)  
35 HIV+ not on ART    65  (21%)  
3 HIV unknown             7   (2%)
170         82 HIV- index cases 
56           25 HIV+ on ART ≥ 1yr 
76           43 HIV+ on ART < 1 yr / no ART
No. of child contacts included in the 
analysis (n=302)
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Figure	 2.	 Histogram	 illustrating	 the	 frequency	 distribution	 of	 non-zero	
induration	in	child	contacts	(n=125)		
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7	 Discussion				
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7.1	 Introduction	
Tuberculosis	 (TB)	 is	 estimated	 to	 have	 caused	 more	 deaths	 than	 any	 other	infectious	disease	in	history.1	Since	1993,	when	TB	was	declared	a	global	health	emergency,	we	 have	 seen	 the	 successful	 roll	 out	 of	 the	DOTS	 strategy	which,	despite	being	one	of	the	most	cost-effective	public	health	interventions	to	date,2,3	was	unable	to	mitigate	the	impact	of	the	human	immunodeficiency	virus	(HIV)	epidemic	on	TB	control.4		The	ensuing	Stop	TB	strategy,	in	conjunction	with	the	concurrent	roll-out	of	anti-retroviral	treatment	(ART)	across	sub-Saharan	Africa	did,	however,	result	in	achieving	the	Millennium	Development	Goal	target	“to	halt	and	begin	to	reverse	the	incidence	of	tuberculosis	by	2015”.5	Despite	a	concerted	global	effort	which	has	undoubtedly	saved	millions	of	lives,6	80	years	after	Wade	Hampton	Frost	predicted	the	eventual	eradication	of	TB,	we	are	far	off	target	for	eliminationii	by	2050	and	nowhere	near	eradicationiii.	The	aim	of	this	research	was	to	address	some	of	the	knowledge	gaps	and	gain	a	better	understanding	of	
M.tb	 transmission	dynamics,	 especially	 in	high	HIV	burden	 settings,	 to	 inform	how	 best	 to	 interrupt	 transmission	 thereby	 accelerating	 the	 decline	 in	 TB	incidence	required	to	achieve	the	goal	of	TB	elimination	and	a	“world	free	of	TB”.5		
7.2	 Key	research	findings	
Key	research	findings	are	summarised	in	Table	1	below.		
																																																								ii	Elimination	is	defined	as	achieving	an	incidence	of	less	than	1	case	of	all	forms	of	TB	per	million	population	iii	 Eradication	 defined	 as	 the	 permanent	 reduction	 to	 zero	 of	 the	worldwide	 incidence	 of	 the	infection	and	interventions	measures	are	no	longer	required7	
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Table	1.	Summary	of	key	research	findings		
Area	of	research	 Key	Findings	 Comments	
Measuring	M.tb	
transmission	at	a	
population-level	
M.tb	infection	prevalence	estimates:		Rust	and	Thomas	was	the	only	method	which	adjusted	for	BCG-attributable	induration	in	the	very	young,	most	recently	vaccinated	children		
For	the	Rust	and	Thomas	method,	data	need	to	be	collected	at	scale	and	in	household	TB	contacts	within	the	same	population	as	non-contacts	(Chapter	3)	Logistically	more	complicated	to	execute	than	a	simple	tuberculin	survey		
Estimates	of	risk	of	M.tb	infection:		Marked	differences	in	estimates	of	the	risk	of	infection	when	using	cross-sectional	data	versus	longitudinal	data	(0.3%	vs	1.6%	per	annum	respectively)	
Underestimates	of	M.tb	infection	risk	using	cross-sectional	data	are	discussed	in	Chapter	5.			A	cross-sectional	analysis	of	the	2nd	round	of	TST	data	using	TST≥15mm	cut-off	method	gives	an	M.tb	prevalence	estimate	of	3.5%	compared	to	1.1%	found	at	the	baseline	survey	[See	Appendix	III].		
Age:		Risk	of	M.tb	infection	is	dependent	on	age,	even	in	the	under-5s;	approximately	1.5-fold	increase	in	the	risk	of	incident	M.tb	infection	for	each	one	year	increase	in	age		 This	finding	is	remarkably	consistent	when	using	increasingly	more	specific	cut-offs	to	define	TST	conversion.	[See	Appendix	IV:	Table	A2]	
Drivers	and	
locations	of	
community	M.tb	
transmission	
Household	smear-positive	TB	contact:		- Associated	with	a	5-fold	increase	in	the	odds	of	prevalent	M.tb	infection;	PAF	2%	- Associated	with	a	7-fold	increase	in	the	risk	of	incident	
M.tb	infection;	PAF	2%	
PAF	of	household	TB	contact	for	prevalent	M.tb	infection:	15%	if	based	on	data	from	TB	household	study	[See	Appendix	V].		This	estimate	is	similar	to	the	PAF	estimates	from	other	studies	conducted	in	Karonga	and	much	higher	than	the	2%	estimated	from	the	baseline	TST	survey	and	the	TST	cohort	study.		
	 Neighbourhood	smear-positive	TB	contact:	(defined	as	resident	within	200m	of	an	infectious	TB	case	excluding	household	TB	contact):		- Associated	with	a	2-fold	increase	in	odds	of	prevalent	
M.tb	infection;	PAF	17%	
No	evidence	of	an	association	of	neighbourhood	TB	contact	(excluding	household	TB	contact)	with	risk	of	incident	M.tb	infection	
Continued…			
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	 	 		Table	1	(Continued).	Summary	of	key	research	findings	
Area	of	research	 Key	Findings	 Comments	
Drivers	and	
locations	of	
community	M.tb	
transmission	
Community	M.tb	exposure:	(defined	as	the	av.	smear-positive	TB	notification	rate	of	>30	per	100,000	pop	per	year):		- Associated	with	2-fold	increase	in	the	odds	of	prevalent	
M.tb	infection;	PAF	39%	- Associated	with	a	2-fold	increase	in	risk	of	incident	M.tb	infection;	PAF	29%	
PAFs	for	community	M.tb	exposure	are	relatively	similar	for	prevalent	and	incident	M.tb	infection.	In	the	multivariable	model	for	both	prevalent	M.tb	infection	and	incident	M.tb	infection,	household	and	neighbourhood	infectious	TB	contact	were	not	included	in	the	model	due	to	collinearity.	However,	including	household	and	neighbourhood	TB	contact	in	the	model	did	not	alter	the	effect	estimate	of	community	M.tb	exposure.		[See	main	text	below	(Section	7.3)]	
	 HIV	infection	in	the	family:		- HIV	exposure	in	utero	associated	with	nearly	4-fold	increase	in	odds	of	prevalent	M.tb	infection;	PAF	6%		- HIV-positive	father	associated	with	a	2.5-fold	increase	in	risk	of	incident	M.tb	infection;	PAF	7%	
	[See	main	text	below	(Section	7.3)]		
	 Church	attendance:		- Associated	with	a	nearly	4-fold	increase	in	risk	of	incident	M.tb	infection;	PAF	68%	 Highlight	that	poorly-ventilated	crowded	indoor	spaces	pose	substantial	risk	of	onward	M.tb	transmission,	even	in	settings	with	a	low-to-moderate	TB	burden.	Although	inference	is	limited	due	to	the	wide	confidence	interval	around	the	PAF	for	church	attendance	which	includes	0.		 Travel	on	mini-buses:			- Associated	with	a	nearly	2-fold	increase	in	risk	of	incident	infection;	PAF	27%	
Effect	of	HIV	and	
ART	on	M.tb	
transmission	
dynamics	
Difference	in	infectiousness:		HIV-positive	smear-positive	TB	cases	are	less	infectious	than	HIV-negative	smear-positive	TB	cases;	no	evidence	that	HIV-positive	on	long-term	ART	are	more	likely	to	transmit	M.tb	infection	than	HIV-positive	TB	cases	not	on	ART	
Likely	to	be	dependent	on	biological	factors,	such	as	degree	of	immunosuppression	of	HIV+	index	TB	cases	at	a	population-level	(which	is	in	turn	dependent	on	the	maturity	of	HIV	epidemic),	contextual	factors,	such	as	the	stage	at	which	HIV	is	being	diagnosed	(early	vs	late)	and	quality	and	amount	of	TB	screening	of	HIV+	individuals	at	a	health	systems-level	and	behavioural,	such	as	health-seeking	behaviour	and	how	good	ART	adherence	is)		Need	further	studies	to	definitively	establish	whether	ART	has	a	biological	effect	on	the	infectiousness	of	HIV+	TB	patients	BCG	bacille	Calmette-Guerin;	TST	 tuberculin	skin	 test;	ARTI	average	annual	risk	of	M.tb	 infection;	CI	confidence	 interval;	PAF	population	attributable	 fraction;	ART	antiretroviral	treatment	
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7.3	 Interpretation	of	key	findings	
Measures	of	population-level	M.tb	transmission	using	tuberculin	data	The	 challenges	 of	 using	 tuberculin	 data	 to	 measure	 population-level	 M.tb	transmission	have	been	discussed	 in	Chapter	3	with	regards	to	estimating	the	average	 annual	 risk	 of	 M.tb	 infection	 (ARTI)	 derived	 from	 M.tb	 prevalence	estimates,	 and	 in	 Chapter	 5	 with	 regards	 to	 estimating	 the	 incidence	 of	M.tb	infection	using	serial	TSTs.					An	 additional	 analysis	 (Appendix	 III)	 was	 undertaken	 as	 an	 internal	 validity	check	of	the	data	to	estimate	the	prevalence	of	M.tb	infection	at	the	2nd	round	of	skin	testing.		The	eligibility	criteria	for	this	analysis	was	as	per	the	baseline	TST	survey	presented	in	Chapter	3	(i.e.	restricted	to	children	aged	between	2.0	to	4.9	years	at	the	time	of	the	2nd	TST)	but	these	children	had	undergone	two	TSTs	as	opposed	to	one.			ARTI	derived	from	the	2nd	round	was	significantly	higher	(ARTI	1.0%:	95%	CI	0.8	 –	1.2%)	 than	 the	 estimate	derived	 from	 the	baseline	 round	(Chapter	4:	0.3%;	95%	CI	0.2	–	0.4%),	and	closer	to	the	estimate	of	the	annual	incidence	risk	estimated	from	the	longitudinal	analysis	(1.6%;	95%	CI	1.3	–	2.0:	Chapter	5).	 	Thus	leading	one	to	postulate	whether	 ‘boosting’	from	the	1st	TST	‘unmasked’	 the	 waned	 immunity	 from	 remote	 M.tb	 infection	 that	 was	 not	apparent	at	the	1st	round	in	some	children,	which	then	contributed	to	the	ARTI	estimate	derived	from	the	2nd	round.	However,	it	is	not	possible	to	make	any	such	conclusions	based	on	the	data	available.	
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Even	if	tuberculin	surveys	at	a	single	point	in	time	do	underestimate	the	ARTI	within	a	population,	repeat	TST	surveys	in	the	same	age	group	of	children	over	time,	will	probably	still	allow	estimates	of	 the	trend	in	 force	of	 infection	to	be	gauged.8,9		That	is	as	long	as	the	method	used	to	estimate	the	prevalence	of	M.tb	infection	is	able	to	appropriately	account	for	cross-reactions	due	to	BCG	and/or	NTM	infections,	even	as	the	prevalence	of	M.tb	infection	decreases	over	time.10	With	regards	to	longitudinal	studies,	which	involve	serial	skin	testing	to	estimate	the	incidence	of	M.tb	infection,	the	difficulty	remains	in	disentangling	what	is	a	true	conversion	(new	incident	M.tb	infection),	boosting	of	remote	M.tb	infection	(which	 occurred	 prior	 to	 the	 start	 of	 the	 study	 and	 therefore	 should	 not	contribute	to	the	estimate	of	incidence)	and	boosting	of	previous	BCG	vaccination	and/or	sensitisation	to	NTM.		
Community	vs	household	transmission	in	an	HIV	prevalent	setting	The	 proportion	 of	 prevalent	 and	 incident	 M.tb	 infections	 attributable	 to	household	 infectious	 TB	 contact	 in	 this	 study	 population	 was	 similar,	 at	approximately	 2%	using	 data	 from	 the	DSS	 area	 alone.	 	 However,	 the	 PAF	 of	household	TB	contact	for	prevalent	M.tb	infection,	which	was	based	on	the	ratio	of	 the	prevalence	of	M.tb	 infection	 in	household	contacts	of	smear-positive	TB	cases	 in	the	TB	case-contact	household	study	(Chapter	3	Table	2:	 ‘Higher	risk’	group	aged	≥	2	years)	to	the	prevalence	of	M.tb	infection	in	those	not	known	to	have	had	any	household	 contact	with	 an	 infectious	TB	 case	 from	 the	baseline	survey	(Chapter	4	Table	1)	was	more	than	7-fold	higher	than	the	PAF	presented	in	 Chapter	 4	 (15%	 vs	 2%	 respectively:	 see	 Appendix	 V).	 	 A	 PAF	 of	 15%	 for	
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household/close	 contact	 is	 nearer	 to	 the	 estimates	 found	 in	 other	 studies	conducted	in	Karonga	district.			A	molecular	 study	of	 epidemiologically	 linked	cases	 found	 that	only	9-13%	of	tuberculosis	cases	were	estimated	to	be	attributable	to	recent	transmission	from	identifiable	 close	 contacts,11	 and	 a	 more	 recently	 published	 molecular	 study	using	 whole	 genome	 sequencing	 (WGS)	 found	 that	 the	 proportion	 of	 TB	attributable	 to	 known	 contacts	 was	 estimated	 to	 be	 9.4%	 overall.12	 	 Similar	results	were	demonstrated	 in	another	study	using	a	case-control	study	design	which	 estimated	 that	 identifiable	 recent	 contact	 with	 known	 smear-positive	cases	 accounted	 for	 12.5%	of	 the	 burden	 of	 disease	 in	 the	 district.13	 A	 cross-sectional	household	case-contact	study	conducted	in	the	district	also	found	that	an	estimated	20%	of	M.tb	infection	in	children	under	10	years	was	attributable	to	smear-positive	household	contact.14				The	higher	PAF	observed	is	primarily	driven	by	the	higher	absolute	risk	in	the	household	 contacts	of	 an	 infectious	TB	 case	 in	 the	TB	 case-contact	household	study,	compared	to	the	absolute	risk	derived	from	the	baseline	TST	survey.		One	reason	for	this	difference	in	risk	may	be	because	the	TB	household	study,	and	the	other	 studies	 mentioned	 above,	 were	 all	 conducted	 district-wide	 and	 not	confined	to	the	DSS.		TB	screening	of	all	adults	is	undertaken	as	part	of	the	annual	re-census	 in	 the	 DSS,	 which	 consists	 of	 a	 simple	 symptom	 screen	 and	 if	symptomatic,	 individuals	 are	 asked	 to	 submit	 a	 sputum	 sample	 for	 smear	microscopy.	More	generally,	research	has	been	conducted	in	the	DSS	for	the	last	12	 years,	which	may	 have	 impacted	 on	 the	 behaviour	 of	 the	 population	with	
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regards	to	health-seeking	behaviour-	a	form	of	‘Hawthorne	effect’.15	This	may	be	leading	 to	 earlier	 case	 detection	 of	 smear-positive	 TB	 cases	 in	 the	DSS	 and	 a	shorter	duration	of	 infectiousness,	resulting	 in	a	 lower	risk	of	 intra-household	transmission	 to	 children	 compared	 to	 smear-positive	 TB	 cases	 in	 the	 district	outside	of	the	DSS,	where	the	majority	of	TB	cases	are	diagnosed	through	passive	case-finding.				Although	household/neighbourhood	contacts	of	a	known	infectious	TB	case	are	at	 high	 risk	 for	M.tb	 infection,	 the	 majority	 of	M.tb	 transmission	 to	 children	appears	to	be	occurring	through	casual	contact	in	the	community	or	from	contact	with	 undiagnosed	 TB	 cases	 within	 the	 family	 (including	 extended	 family	members	and	close	non-familial	contacts),	even	in	this	low-to-moderate	burden	setting.	 	 The	PAF	of	 neighbourhood	 contact	 (defined	 as	 being	 resident	within	200m	 of	 a	 diagnosed	 smear-positive	 TB	 case	 excluding	 known	 household	contact)	was	only	17%	for	prevalent	M.tb	infection,	and	there	was	no	evidence	for	an	association	of	neighbourhood	contact	with	incident	M.tb	 infection.	 	This	may	have	been	due	to	the	fact	that	all	diagnosed	smear-positive	TB	cases	during	the	lifetime	of	the	child	were	included	for	the	analysis	of	prevalent	M.tb	infection	whereas	only	those	individuals	diagnosed	with	smear-positive	TB	from	2013	to	2015	 were	 included	 in	 the	 M.tb	 infection	 incidence	 analysis,	 to	 assess	 the	association	of	M.tb	infection	incidence	with	concurrent	(rather	than	historical)	TB	in	neighbourhood,	thereby	reducing	the	power	to	identify	an	association	with	neighbourhood	contact.				
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Approximately	 40%	 of	 prevalent	 M.tb	 infections	 and	 30%	 of	 incident	 M.tb	infections	in	young	children	were	attributable	to	living	in	an	area	with	a	higher	community	M.tb	exposure	(defined	as	the	average	smear-positive	TB	notification	rate	per	100,000	population	per	year	per	residential	area).	Areas	with	a	higher	TB	notification	rate	in	the	DSS	may	be	a	marker	of	communities	where	there	is	a	higher	 burden	 of	 undiagnosed	 TB.	 	 If	 the	 higher	 average	 notification	 rates	 of	smear-positive	TB	were	due	to	better	case	detection	in	these	residential	areas	then	 one	 would	 expect	 that	 duration	 of	 infectiousness	 of	 TB	 cases	 would	 be	shorter	and	therefore	there	would	be	a	decreased,	rather	than	an	increased	risk	of	M.tb	infection	to	children.			Together	these	findings	suggest	that	the	majority	of	M.tb	 transmission	 to	 young	 children	 is	 occurring	 from	 close	 contacts	 with	undiagnosed	infectious	TB	and/or	unidentifiable	casual	contacts	with	(known	or	unknown	 infectious	 TB)	 in	 the	 community.	 	 The	 fact	 that	 age	 is	 so	 strongly	associated	with	 an	 increasing	 risk	 of	 incident	M.tb	 (as	 children	 become	more	mobile),	and	that	68%	of	incident	M.tb	infections	may	be	attributable	to	church	attendance	(bearing	in	mind	the	large	confidence	interval	around	the	PAF)	and	approximately	 28%	 are	 attributable	 to	 travel	 on	 mini-buses,	 all	 point	 to	 the	interpretation	 that	 unidentifiable	 casual	 contacts	 with	 (known	 or	 unknown	infectious	TB)	is	playing	a	role	in	driving	community	M.tb	transmission	to	pre-school	children.			
HIV	infection	in	the	family	HIV	 infection	 in	 the	 family,	 although	 not	 accounting	 for	 the	 majority	 of	M.tb	infections	in	children	in	this	setting,	was	associated	with	a	significantly	increased	risk	of	M.tb	infection	through	a	number	of	mechanisms.		As	discussed	in	Chapter	
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5,	 maternal	 HIV	 infection	 was	 not	 associated	 with	 incident	 M.tb	 infection,	although	it	was	strongly	associated	with	prevalent	M.tb	infection.	This	was	most	likely	 because	 children	 who	 had	 a	 TST≥10mm	 at	 baseline	 (prevalent	 M.tb	infection)	were	not	eligible	for	a	repeat	skin	test	and	were	thus	excluded	from	the	cohort	analysis.				An	 exploratory	 analysis	 of	 population-level	 M.tb	 infection	 prevalence	 was	undertaken,	stratified	by	in	utero	HIV-exposure	status	in	the	DSS	[see	Appendix	VI].	 	Using	cut-off	methods	and	mixture	analysis,	the	prevalence	was	similar	in	the	HIV-exposed	and	un-exposed	children,	whereas	using	the	Rust	and	Thomas	method,	the	prevalence	of	M.tb	infection	was	over	4-fold	higher	in	HIV-exposed	children	 (2.5%)	 compared	 to	 HIV-unexposed	 children	 (0.6%).	 	 However,	 this	observed	difference	 in	prevalence	 estimates	 is	primarily	driven	by	very	 small	numbers	 in	 the	nth	category	 (TST≥20mm):	 	1/264	 in	 the	HIV-exposed	versus	6/4461	 in	 the	 unexposed	 children.	 Hence	 this	 exploratory	 analysis	 was	 not	included	 in	 the	 paper	 on	 estimating	 the	M.tb	 prevalence	 using	 the	 Rust	 and	Thomas	 method	 which	 was	 published	 in	 American	 Journal	 of	 Epidemiology	(Chapter	3).		Notwithstanding	this	limitation,	it	does	triangulate	with	the	finding	that	 HIV-exposed	 children	 in	 the	 DSS	 had	 a	 4-fold	 increase	 in	 the	 odds	 of	prevalent	M.tb	infection	compared	to	HIV-unexposed	children	in	the	risk	factor	analysis	of	baseline	survey	(Chapter	4).				An	increased	risk	of	M.tb	infection	among	HIV-exposed	children	has	been	shown	in	 a	 number	 of	 other	 studies	 across	 sub-Saharan	 Africa.16-21	 Increased	 M.tb	exposure	 in	 the	 home	may	 underlie	 this	 association,	 as	HIV-exposed	 children	
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even	if	not	infected	with	HIV	may	have	a	higher	risk	of	acquiring	M.tb	infection	from	undiagnosed	TB	in	their	mothers	(or	fathers)	than	children	whose	parents	are	HIV-negative.	They	may	be	at	a	greater	risk	of	nosocomial	M.tb	exposure	from	accompanying	HIV-positive	mothers	to	clinic	and	they	may	also	be	more	likely	to	acquire	M.tb	infection	following	M.tb	exposure	due	to	alterations	in	innate	and	adaptive	immunity	that	affect	susceptibility	to	infection.16,22	
	HIV	infection	in	the	father	was	associated	with	a	2.5-fold	increase	in	risk	of	M.tb	infection	in	the	longitudinal	analysis	(Chapter	5).		This	increased	risk	of	incident	infection	 observed	 in	 young	 children	may	 be	 due	 to	 undiagnosed	 TB	 in	 their	fathers.	 This	 potentially	 sheds	 some	 light	 as	 to	why	 the	more	 holistic	 TB-HIV	intervention	at	the	household	level	of	newly	diagnosed	TB	patients,	compared	to	enhanced	 case-finding	 in	 the	 community	 in	 the	 ZAMSTAR	 study	 (a	 cluster-randomised	 trial	 of	 interventions	 to	 reduce	 M.tb	 transmission	 in	 high	 HIV	prevalence	 settings)	 had	 an	 effect	 on	M.tb	 transmission	 at	 community	 level.23	This	was	a	somewhat	surprising	finding	at	the	time,	as	contact	investigation	of	known	TB	cases	has	always	been	deemed	low	priority	in	low-income	settings	due	to	it	being	resource-intensive	to	conduct,	and	had	been	thought	to	have	limited	impact	as	a	control	strategy	to	reduce	community	Mtb	transmission,24	as	most	secondary	 cases	 arise	 outside	 identified	 contacts	 in	 high-incidence	 areas.		However,	 it	 is	 possible	 that	 through	 the	household	 intervention	 in	 ZAMSTAR,	more	men	with	undiagnosed	TB	(with	and	without	HIV	infection)	were	screened	for	TB,	than	would	have	been	accessed	through	the	enhanced	case	finding	which	required	men	 to	 actively	 seek	 a	 community	 sputum	 collection	 point,	 thereby	
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reducing	the	duration	of	 infectiousness	 in	 the	communities	randomised	to	 the	household	intervention	arm.  		
Differences	in	infectiousness	by	HIV/ART	status		Although	index	TB	cases	with	HIV	infection	(irrespective	of	ART	status)	have	a	lower	risk	of	transmission	within	the	household,	as	inferred	from	TST	positivity	in	child	contacts	in	this	setting	(Chapter	6),	on	a	population-level,	HIV	positive	TB	cases	may	still	play	a	substantial	role	in	onward	M.tb	transmission.				A	large-scale	WGS	study	of	72%	of	all	culture-positive	TB	episodes	in	Karonga	district	 from	 1995	 to	 2010	 found	 no	 association	 in	 transmissibility	 with	 HIV	infection.25	 One	 reason	 cited	 was	 that	 this	 may	 have	 been	 due	 to	 the	 social	clustering	 of	 HIV-positive	 individuals,	 which	 increases	 the	 opportunities	 for	transmission	to	susceptible	individuals	who	manifest	disease,	balancing	out	any	decreased	 transmissibility.25	 The	 relative	 risk	 (RR)	 of	 having	 transmissions	confirmed	 using	 WGS	 from	 HIV-positive	 compared	 to	 HIV-negative	 smear-positive	named	contacts	was	0.78	(95%	CI	0.54	–	1.1).26	Approximately	60%	of	smear-positive	TB	patients	are	HIV-positive,	so	if	transmission	were	reduced	by	22%,	HIV-associated	TB	would	still	account	for	47%	of	all	transmission	resulting	in	disease	in	Karonga.			Much	 quoted	 epidemiological	 studies	 undertaken	 in	 the	 mid-2000s	 in	 South	Africa	 and	 Zimbabwe,	 found	 that	 despite	 a	 huge	 difference	 in	 the	 TB	 disease	incidence	 between	 HIV-negative	 and	 HIV-positive	 individuals,	 the	 point	
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prevalence	of	active	TB	disease	(the	main	driver	of	onward	M.tb	transmission)	differed	little	by	HIV	status.27,28	Thus	it	was	surmised	that	the	rapid	progression	and	 lower	per-case	 infectivity	of	HIV-associated	TB,	 resulted	 in	maintaining	 a	static	 M.tb	 transmission	 rate,	 despite	 the	 large	 increase	 in	 TB	 incidence	observed.27-29	However,	 some	 of	 these	 findings	may	 have	 been	 specific	 to	 the	context	in	which	they	were	conducted	and	not	generalisable,	as	contrary	results	have	 been	 documented	 in	 other	 studies.	 	 For	 example,	 stable	 age-specific	incidence	rates	were	observed	in	HIV-negative	gold	miners	in	a	single	workforce	in	the	Free	State	Province,	South	Africa,29	whereas	a	retrospective	cohort	among	men	working	in	four	mines	in	the	Gauteng	Province,	South	Africa	conducted	over	the	same	time	period	found	that	incidence	of	new	pulmonary	TB	in	HIV-negative	men	doubled,	reflecting	increased	M.tb	transmission,	which	had	occurred	despite	regular	TB	screening	and	readily	available	treatment	administered	under	direct	supervision.30	 	 Other	 conflicting	 results	 include	 estimates	 around	 duration	 of	infectiousness	 stratified	 by	 HIV	 status.	 A	 TB	 prevalence	 survey	 conducted	 by	Wood	et	al.	in	Cape	Town	in	2005,	estimated	that	the	duration	of	infectiousness	was	similar	 in	HIV-positive	and	HIV-negative	 individuals,	and	 that	87%	of	 the	total	 person-years	 of	 undiagnosed	 smear-positive	 TB	 in	 the	 community	were	among	HIV-positive	individuals,31	which	differs	from	the	conclusions	drawn	from	the	studies	referred	to	above,27,28	and	from	a	TB	prevalence	survey	conducted	in	Harare,	 Zimbabwe	 in	 2005-2006,	 which	 estimated	 that	 duration	 of	infectiousness	was	much	shorter	in	HIV-positive	individuals.27,28,32	 
 Conflicting	results	from	studies	assessing	the	impact	of	HIV	on	M.tb	transmission	at	a	population-level	done	nearly	10-20	years	ago	have	also	not	been	resolved.33-
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37	 	Trends	 in	 the	observed	ARTI,	as	measured	by	 tuberculin	surveys	 in	school	children,	differed	by	country.		In	Kenya,	a	downward	trend	in	ARTI	in	the	pre-HIV	era	was	reversed	in	areas	where	there	was	a	higher	HIV	prevalence,33		whereas	in	Tanzania	the	ARTI	continued	to	fall	as	the	HIV	epidemic	took	off.34,35	However,	this	 sustained	 downward	 trend	 in	 ARTI	 observed	 in	 Tanzania	 coincided	with	significant	strengthening	of	the	TB	control	programme	in	the	country.35	In	Cape	Town,	South	Africa,	the	ARTI,	although	extremely	high	at	~4%,	was	found	to	be	consistent	across	age	groups	between	the	ages	of	5	to	17	years,	 leading	to	the	conclusion	that	HIV-associated	TB	was	not	having	a	major	impact	on	the	ARTI.36	The	validity	of	this	conclusion	was	questioned,	because	ARTI	as	an	indicator	of	the	risk	of	infection	from	a	single	survey,	ignores	the	effects	of	cohort	and	age.		Thus,	despite	what	may	be	a	true	increase	in	the	risk	of	infection	over	time,	the	increase	in	the	risk	of	infection	in	the	younger	children	may	be	masked	due	to	the	levelling	effect	of	the	lower	risk	in	older	children	from	times	gone	by.37			Interestingly,	 the	 results	 of	 an	 exploratory	 ecological	 spatial	 analysis	 in	 the	Karonga	DSS,	using	a	distance-based	mapping	approach	in	R,38	undertaken	by	the	candidate	identified	a	‘hot	spot’	of	incident	M.tb	infection	in	children	in	the	same	localised	geographical	area	as	a	 larger	 ‘hot	spot’	of	higher	than	expected	adult	HIV	prevalence	for	the	population	(unpublished	data:	Appendix	VII).	However,	it	is	 not	 clear	whether	 clustering	 of	M.tb	 infection,	 which	 is	manifest	 as	 spatial	heterogeneity	 as	 seen	 with	 TB	 disease	 incidence	 in	 other	 settings,11,39-41	 is	occurring	 as	 result	 of	 localised	 ‘hot	 spots’	 of	 M.tb	 transmission	 due	 to	undiagnosed	infectious	cases	or	reflects	a	concentration	of	people	with	shared	risk	factors	for	susceptibility	to	infection	and/or	progression	to	disease.9			
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7.4	 Limitations	
The	 limitations	 of	 each	of	 the	 studies	 have	been	discussed	 in	 the	 appropriate	discussion	sections	in	each	paper.	However,	one	limitation	which	has	not	been	addressed	is	that	this	research	has	not	examined	the	role	of	re-infection	in	M.tb	transmission	dynamics,	which	 is	 likely	 to	 have	 important	 implications	 for	 the	development	 of	 TB	 control	 strategies	 depending	 on	 the	 epidemiological	context.42,43	Also	there	is	minimal	multidrug-resistant	TB	in	this	area	(<1%,	even	in	 retreatment	 cases),44	 most	 likely	 as	 a	 result	 of	 the	 well-implemented	 TB	control	 programme,	 and	 therefore	 findings	 from	 this	 research	 may	 not	 be	generalisable	 to	 settings	 where	 there	 are	 poorly	 functioning	 TB	 control	programmes	and	a	higher	burden	of	drug-resistant	TB.			
7.5	 Recommendations	
Improve	surveillance	to	enable	context-specific	targeting	of	control	strategies	The	availability	of	socio-demographic	and	geo-positional	data	of	diagnosed	TB	cases	in	this	setting	enabled	elucidation	of	risk	factors	driving	M.tb	transmission	at	a	community-level.	Collecting	more	detailed	programmatic	data	would	allow	the	identification	of	factors	driving	the	epidemic	at	a	more	local	level,45	although	this	 will	 require	 building	 up	 surveillance	 infrastructure	 which	 is	 currently	lacking	in	most	high	burden	settings.		‘Know	your	epidemic’,	which	was	originally	coined	 by	 the	 Joint	 United	 Nations	 Programme	 on	 HIV/AIDS	 (UNAIDS)	 as	 its	mantra	 for	HIV	prevention,46	 needs	 to	 be	urgently	 adopted	by	 the	TB	 control	community.		Targeted	TB	control	strategies	specific	to	the	local	epidemiological	context	are	much	more	likely	to	be	effective	than	a	 ‘one	size	fits	all’	approach.	
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Active	case-finding	in	the	household	as	a	component	of	integrated	HIV/TB	care	in	high	HIV	prevalence	settings,	may	be	more	effective	in	interrupting	the	M.tb	transmission	 cycle,47	 whereas	 in	 other	 settings,	 for	 example,	 where	 the	prevalence	of	HIV	is	not	so	high	such	as	Peru	or	Brazil,	targeting	certain	‘hotspots’	of	disease	incidence	may	be	more	successful.38,48			It	 may	 be	 that	 in	 Karonga	 district,	 a	 targeted	 approach	 focussing	 on	 the	households	of	newly	diagnosed	TB	patients,	irrespective	of	HIV	status,	and	HIV-positive	patients	starting	ART	may	be	most	effective.		A	proposed	strategy	would	involve	a	similar	intervention	to	that	used	in	ZAMSTAR,	which	would	include	HIV	testing	and	TB	screening	for	all	members	of	the	household.		Isoniazid	preventive	therapy	(IPT)	would	not	be	restricted	to	young	children	but	would	include	older	children	 and	 adolescents	 irrespective	 of	 HIV	 status,49	 and	 all	 HIV-positive	individuals	would	be	started	on	ART	and	IPT.50,51		
Children	with	M.tb	infection	as	targets	of	control	strategies	Children	 are	 the	 seedbeds	 of	 future	 epidemics,	 and	 as	M.tb	 infection	 can	 be	lifelong,52	cases	will	continue	to	emerge	over	time.		Although	in	our	setting	only	4%	of	children	were	born	to	an	HIV-positive	mother;	each	year	worldwide	over	a	million	infants	are	born	to	HIV-positive	mothers20,	and	HIV-exposed	uninfected	children	 now	 account	 for	 as	 many	 as	 30%	 of	 all	 births	 in	 parts	 of	 southern	Africa.21		This	growing	population,	although	not	infected	with	HIV,	may	be	more	vulnerable	 to	 infection	 following	M.tb	exposure,19,22	 and	TB	compared	 to	HIV-unexposed	children.53	This	is	especially	worrying	in	some	high	HIV	prevalence	settings,	 such	 as	 South	 Africa	 where	 there	 is	 ongoing	 transmission	 of	 drug-
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resistant	M.tb,	as	there	may	be	a	rapidly	growing	reservoir	of	drug-resistant	M.tb	infection	waiting	to	reactivate	in	the	coming	years.		
Better	infection	control	practices	in	congregate	settings	There	 is	 no	 doubt	 that	 better	 infection	 control	 practices	 are	 required	 in	congregate	 settings,	 such	 as	 churches	 and	 public	 transport.	 	 Simple	 infection	control	 practices,	 such	 as	 opening	windows	 or	 even	 holding	 congregations	 in	outdoor	 spaces	may	 go	 some	way	 to	mitigating	 the	 risk	 of	M.tb	 transmission.	These	have	been	highlighted	in	Chapter	2	and	Chapter	5.		
7.6	 Future	work	
As	stated	by	Rieder	in	the	Epidemiological	Basis	of	Tuberculosis	Control:52		 	“…tuberculous	infection	takes	center	stage	for	providing	an	understanding	of	the	dynamics	of	the	tuberculosis	epidemic	in	the	community.”		
M.tb	infection	incidence	and	prevalence	are	the	primary	determinants	of	current	and	 future	 TB	 disease	 incidence,54	 so	 accurately	 quantifying	 these	 metrics	 is	essential	 for	 future	 planning	 and	 to	 assess	 the	 effectiveness	 of	 control	interventions	to	reduce	M.tb	transmission.		But,	as	highlighted	by	this	research,	accurate	 measurements	 of	 these	 parameters	 at	 a	 population-level	 remain	problematic.			Conducting	 robust	 TB	 epidemiological	 studies	 is	 resource-intensive	 and	expensive	and	collecting	epidemiological	data	at	scale	will	be	even	less	possible	
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in	budget-constrained	times.	 	Thus,	we	are	somewhat	dependent	on	models	to	predict	the	future	burden	and	effectiveness	of	control	interventions	in	different	geographical	areas,	over	time	and	at	scale.	These	models	are	entirely	dependent	on	a	number	of	priority	parameters;	M.tb	 infection	risk	being	one	of	 the	most	integral	 to	 improving	the	predictive	ability	of	virtually	all	TB	models.55	Further	research	is	required	to	attain	a	robust	proxy	measure	for	M.tb	transmission	at	a	population-level.			Despite	the	improved	specificity	of	interferon	gamma	release	assays	(IGRA)	over	TST,56	skin	testing	remains	the	only	practical	method	of	measuring	infection	in	populations,	 especially	 in	 low-income	 settings	 with	 limited	 laboratory	infrastructure.57	Through	a	combination	of	newer	statistical	techniques	such	as	latent	variable	modelling,	systematic	calibration	studies	of	TST,	IGRAs,58-60	and	the	newer	skin	tests,	such	as	C-Tb	skin	test	(a	novel	skin	test	containing	M.tb-specific	antigens,	ESAT-6	and	CFP-10),61	in	a	variety	of	populations	(infant,	child,	adolescent,	adult)	and	geographical	settings	with	high	and	low	HIV/TB	burden,	it	may	be	possible	to	derive	a	method	to	quantify	a	robust	proxy	measure	of	M.tb	transmission.				We	 also	 need	 a	 better	 understanding	 of	 what	 is	 actually	 being	 measured	 by	TST/IGRAs.	 	 A	 recent	 study	 by	 Andrews	 et	 al.	 found	 that	 interferon-gamma	values	 showed	 a	 bimodal	 distribution	 in	 infants,	 which	 was	 not	 seen	 in	adolescents	 in	 the	 same	 area	 in	Western	 Province.62	 	 Such	 findings	 raise	 the	questions	of	whether	we	are	actually	measuring	M.tb	exposure,	or	susceptibility	to	infection	following	M.tb	exposure,	and	how	to	distinguish	the	two?	Improved	
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diagnostics	of	M.tb	infection	status	would	go	a	long	way	in	helping	to	understand	the	natural	history	of	M.tb	exposure	through	to	established	M.tb	infection.		Studies	which	were	undertaken	in	the	pre-ART	era	need	to	be	repeated	in	the	post	ART	roll-out	era	as	it	likely	that	the	epidemiology	of	HIV-associated	TB	has	changed.	 In	HIV-positive	 individuals,	ART	reduces	TB	incidence	across	all	CD4	cell	 counts,63	 yet	despite	 long-term	ART,	TB	 incidence	 remains	higher	 than	 in	HIV-negative	 people	 in	 both	 high	 and	 low	 TB-burden	 settings.50,64	 As	 life	expectancy	is	greatly	extended	by	ART,	the	cumulative	lifetime	risk	of	TB	for	HIV-positive	 people	 remains	 very	 high,64	 and	 ART	 may	 even	 increase	 the	infectiousness	of	TB	by	shifting	the	clinical	manifestations	to	be	more	similar	to	that	 in	 HIV-negative	 patients.65,66	 We	 need	 to	 re-assess	 the	 population-level	impact	of	HIV	on	M.tb	transmission,	and	gain	a	better	understanding	of	the	effect	of	ART	on	M.tb	transmission	dynamics.	More	data	are	required	to	address	 the	issue	of	conflicting	evidence	on	TB	disease	duration	ratio	between	HIV-positive	and	HIV-negative	individuals,67	and	this	is	likely	to	have	changed	in	the	ART	era.	There	has	been	also	accumulating	evidence	from	prevalence	surveys	that	in	some	settings	 there	may	 be	 a	 large	 hidden	 burden	 of	 asymptomatic	 subclinical	 TB	cases,68,69	even	in	people	with	HIV	infection,28,31,70,71	thus	raising	the	question	as	to	 whether	 passive	 diagnosis	 is	 indeed	 enough	 in	 some	 settings	 to	 prevent	onward	M.tb	 transmission.72	However,	 the	evidence	 in	support	of	community-wide	active-case	finding	as	a	means	to	reduce	M.tb	transmission	at	a	population-level	 is	scarce,73,74	therefore	reiterating	the	point	that	greater	insights	into	the	
M.tb	 transmission	 dynamics	 in	 populations	 with	 moderate-to-high	 HIV	
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prevalence	 are	 required	before	 advocating	 the	widespread	 implementation	of	resource-expensive	control	strategies.			
7.7	 Concluding	remarks	
A	hallmark	of	TB	epidemiology	is	its	variability	among	populations.75	M.tb	and	its	host	population	undergo	continuous	change	over	time	which	mutually	affect	each	other.54	Factors	driving	M.tb	transmission	in	one	setting	may	not	be	relevant	in	another;	 and	 what	 was	 seen	 historically	 may	 no	 longer	 be	 relevant.		Understanding	 the	TB	epidemic	at	a	 local	 level	 through	continual	 surveillance	allows	 the	 implementation	 of	 the	 most	 effective	 context-specific	 control	interventions.	Only	then	will	we	accelerate	the	decline	in	TB	incidence	towards	the	goal	of	TB	elimination.				 	
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Cross-sectional	analysis	of	2nd	round	of	TST	data		
The	incidence	of	M.tb	infection	estimated	from	the	TST	cohort	study	(Chapter	5)	was	much	higher	than	the	average	annual	risk	of	M.tb	infection	(ARTI)	estimated	from	the	cross-sectional	survey	(Chapter	4).		As	an	internal	validity	check	of	the	data,	the	second	round	of	TST	data	was	analysed	as	cross-sectional	data,	using	the	TST≥15mm	cut-off	to	estimate	M.tb	prevalence,	with	the	premise	that	ARTI	should	not	have	changed	significantly	between	rounds.			Only	those	children	aged	between	2.0	to	4.9	years	of	age	at	the	time	of	the	2nd	TST	were	eligible	to	be	included	in	this	analysis	of	the	2nd	round	of	TST,	as	per	eligibility	 of	 the	 1st	 round	 (baseline).	 	 14	 of	 the	 prevalent	 M.tb	 infections	identified	in	the	first	round	were	included	in	the	numerator	and	denominator,	as	these	children	would	have	been	eligible	to	have	been	tested	(i.e.	aged	between	2.0	–	4.9	years	when	skin	testing	was	taking	place	in	their	residential	area	as	part	of	the	2nd	round).	Of	the	60	children	who	had	a	TST≥15mm	at	the	2nd	round	of	skin	testing,	36/60	(60%)	had	zero	induration	at	baseline.		Table	A1	shows	the	difference	in	ARTI	between	the	1st	and	2nd	round.				Table	A1.	illustrating	the	ARTI	estimated	from	M.tb	prevalence	at	the	2	rounds		
TST	cohort	study	
M.tb	prevalence	(TST≥15mm)	 Mean	age	 ARTI	n/N	 %	 95	%	CI	 (years)	 %	 95	%	CI	1st	Round	 35/3170	 1.1	 0.8	–	1.5	 3.5	 0.3	 0.2	–	0.4	2nd	Round		 74/2105	 3.5	 2.8	–	4.4	 3.7	 1.0	 0.8	–	1.2			
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Interpretation	The	ARTI	estimated	from	the	2nd	round	of	skin	testing	is	significantly	higher	than	the	 ARTI	 estimated	 from	 the	 1st	 round	 suggesting	 that	 this	 increase	 in	M.tb	prevalence	observed	in	the	2nd	round		is	a	result	of	‘boosting’	of	the	host	response	from	the	TST	given	in	the	1st	round.			 	
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Sensitivity	analysis	of	the	association	of	incident	M.tb	infection	and	age	
Table	A2.	Sensitivity	analysis	using	different	criteria	to	define	incident	M.tb	infection	and	the	association	with	age	
	 	 Increment	between	1st	and	2nd	TST	(1st	TST	<10mm)		 	 10mm		 13mm		 15mm	 17mm	 19mm	
	 	 Incidence	per	100py	 IRR	(95%	CI)	 Incidence	per	100py	 IRR	(95%	CI)	 Incidence	per	100py	 IRR	(95%	CI)	 Incidence	per	100py	 IRR	(95%	CI)	 Incidence	per	100py	 IRR	(95%	CI)	
	 Overall	 2.5		(2.1	–	2.9)	 -	 1.6		(1.3	–	2.0)	 -	 1.1		(0.8	–	1.4)	 -	 0.6		(0.4	–	0.8)	 -	 0.2		(0.1	–	0.4)	 -	
Age	at	
1st	TST	
(years)	
<1.0	 1.4		(0.8	–	2.3)	 1	 0.8		(0.4	–	1.7)	 1	 0.3		(0.1	–	1.0)	 1	 0.1		(0.01	–	0.7)	 1	 0.1		(0.02	–	0.7)	 1	
1.0	-	1.9	 1.9		(1.3	–	2.7)	 1.4		(0.7	–	2.7)	 1.0		(0.6	–	1.6)	 1.2		(0.5	–	2.8)	 0.8		(0.5	–	1.3)	 2.5		(0.7	–	8.8)	 0.5		(0.2	–	1.0)	 4.6		(0.6	–	36.7)	 0.06		(0.008	–	0.4)	 0.6		(0.04	–	9.1)	
2.0	-	2.9	 2.6		(1.9	–	3.5)	 1.9		(1.0	–	3.6)	 1.9		(1.3	–	2.7)	 2.3		(1.1	–	5.0)	 1.4		(0.9	–	2.1)	 4.4		(1.3	–	14.6)	 0.6		(0.3	–	1.1)	 5.9		(0.8	–	46.1)	 0.3		(0.09	–	0.7)	 2.4		(0.3	–	21.1)	
3.0	-	3.9	 3.5		(2.5	–	4.9)	 2.5		(1.3	–	4.7)	 2.4		(1.6	–	3.6)	 2.8		(1.2	–	6.3)	 1.6		(1.0	–	2.6)	 5.0		(1.4	–	17.3)	 0.8		(0.4	–	1.7)	 8.1		(1.0	–	64.5)	 0.4		(0.2	–	1.1)	 4.0		(0.5	–	36.0)	
4.0	-	4.9	 4.6		(2.9	–	7.4)	 3.3		(1.6	–	6.9)	 3.3		(1.9	–	5.7)	 3.8		(1.6	–	9.5)	 1.9		(0.9	–	4.0)	 6.2		(1.6	–	24.4)	 1.1		(0.4	–	2.9)	 10.5		(1.2	–	94.2)	 0.8		(0.3	–	2.5)	 7.8		(0.8	–	74.7)	
Age	as	a	linear	variable	 1.3		(1.2	–	1.6)	 	 1.4		(1.2	–	1.7)	 	 1.5		(1.2	–	1.8)	 	 1.5		(1.1	–	2.0)	 	 2.0	(1.2	–	3.2)		 TST	tuberculin	skin	test;	py	person-years;	IRR	incidence	rate	ratio;	CI	confidence	interval				
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Population	attributable	fraction	of	known	household	contact		
It	was	possible	to	estimate	the	population	attributable	fraction	(PAF)	of	known	household	contact	with	an	infectious	TB	case	for	prevalent	M.tb	infection	using	two	different	methods	in	this	thesis.		The	two	methods	used	were	as	follows:	
1. PAF	 = 	p’ (()*(( 	where	p’	=	proportion	of	cases	exposed	to	household	contact	with	infectious	TB	case;	RR	=	relative	risk	of	the	association	of	prevalent	M.tb	infection	in	children	and	household	contact	with	infectious	TB	case		 2. PAF	 = +((()*)+ (()* .*	where	p	=	proportion	of	the	population	exposed	to	household	contact	with	infectious	TB	case;	RR	=	as	above			To	ensure	consistency	of	PAF	estimates	using	the	2	methods,	 the	definition	of	prevalent	 M.tb	 infection	 is	 based	 on	 the	 TST≥15mm	 cut-off	 method	 and	restricted	to	the	children	aged	between	2.0	to	4.9	years.		
Estimates	of	PAF	Method	1	estimates	the	PAF	of	household	TB	contact	to	be	2.1%	as	calculated	in	Chapter	 4,	 where	 p’=1/35	 and	 RR=3.6	 (see	 Chapter	 4	 page	 347	 of	 published	paper	with	erratum	noted	at	end	of	chapter).		Even	when	the	unadjusted	RR	is	used	(RR=4.6),	the	PAF	is	2.2%.		
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Method	2	uses	data	from	the	TB	case-contact	household	study	where	prevalence	of	M.tb	infection	in	children	resident	with	a	smear-positive	TB	index	case	is	0.319	(Chapter	3	Table	2:	estimate	of	M.tb	prevalence	in	‘Higher	Risk’	group	aged	≥2	years).	The	comparator	(prevalence	of	M.tb	infection	in	children	from	DSS	with	no	known	household	contact	with	an	infectious	TB	case)	is	the	same	as	Method	1,	(0.011;	Chapter	3	Table	2,	which	is	the	same	as	Chapter	4	Table	1	excluding	household	 contact:	 34/3150);	 yields	 a	 relative	 risk	 of	 29	 (0.319/0.011).	 	 The	proportion	of	the	population	exposed	to	an	infectious	TB	case	in	the	household	is	 0.0063	 (20/3170),	 thus	 giving	 a	 PAF	 of	 15%.	 	 	 Repeating	 the	 above	 PAF	calculation	using	data	from	the	baseline	TST	survey	alone	gives	a	PAF	of	2.3%,	which	is	similar	to	the	PAF	estimated	from	method	1.				The	key	difference	driving	 this	discrepancy	between	 the	PAF	estimates	 is	 the	much	higher	absolute	risk	in	the	child	household	contacts	of	an	infectious	TB	case	derived	from	the	TB	case-contact	household	study.					 	
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M.tb	infection	prevalence	stratified	by	HIV	exposure	status	
Background		Several	 studies	 have	 found	 a	 high	 prevalence	 of	M.tb	 infection	 among	 HIV-exposed	uninfected	 infants	 in	 sub-Saharan	Africa,1-6	which	may	be	 one	 of	 the	contributing	factors	for	the	increased	risk	of	morbidity	and	mortality	observed	in	this	population	despite	the	successful	roll-out	Prevention	of	Mother-to-Child	Transmission	 (PMTCT)	 programmes.7-9	 As	 data	 on	 HIV-exposure	 status	 was	available	 for	 children	 in	 this	 study,	 it	 thought	 that	 an	 exploratory	 analysis	stratifying	by	HIV-exposure	status	would	be	of	interest	as	these	data	are	unlikely	to	be	available	on	a	population-level	in	other	settings.	However,	this	analysis	was	not	included	in	the	published	paper	due	to	the	very	limited	sample	size.		The	idea	for	stratifying	by	HIV-exposure	status	had	come	from	the	original	paper	by	 Rust	 and	 Thomas	 which	 had	 also	 included	 a	 stratified	 analysis	 based	 on	calendar	period	and	region.		The	findings	had	demonstrated	substantial	regional	variation	 in	M.tb	 infection	prevalence	consistent	with	TB	epidemiology	at	that	time	 in	 the	US,	which	were	not	as	apparent	when	using	the	traditional	cut-off	method	of	TST≥10mm.	 	The	authors	 also	 found	 that	 infection	prevalence	had	declined	by	8.5%	per	annum	between	1961	to	1968	in	the	US	Navy	recruits	using	their	method,	rather	than	a	decline	of	4.5%	per	annum	using	the	traditional	cut-off	method,	postulating	that	reactions	to	atypical		mycobacteria	had	obscured	the	extent	of	decline	in	M.tb	infection	prevalence	over	time.10				
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Study	 hypothesis:	M.tb	 infection	 prevalence	 is	 higher	 in	 HIV-exposed	 children	than	in	HIV-unexposed	children	at	a	population-level	in	the	DSS.			
Definition	 of	 HIV-exposure	 status:	Children	whose	mothers	were	 known	 to	 be	HIV-positive	at	the	time	of	delivery	were	defined	as	HIV-exposed,	while	children	whose	mothers	were	HIV-negative	after	or	up	to	1	year	before	their	birth	were	defined	as	HIV-unexposed.			
Result	of	exploratory	data	analysis	Data	 on	 HIV-exposure	 status	 of	 the	 children	 was	 available	 on	 4840/5119	(94.5%).	 Web	 figure	 4	 in	 the	 paper	 (chapter	 3)	 illustrates	 the	 percentage	distribution	of	induration	category	stratified	by	HIV-exposure	and	contact	status	of	the	child	and	Table	A3	presents	the	frequency	distribution	of	induration.	Table	A4	(below)	shows	the	different	estimates	of	M.tb	infection	prevalence	stratified	by	 risk	 group	 and	 HIV-exposure	 status.	 The	 population	 of	 interest	 for	 this	analysis	was	the	‘lower	risk	group’	which	are	the	children	resident	in	the	DSS.				All	the	methods	of	deriving	infection	prevalence	demonstrate	similar	estimates	for	HIV-exposed	and	HIV-unexposed	children	apart	from	the	Rust	and	Thomas	model.		The	point	estimate	for	M.tb	infection	prevalence	is	4.3	times	higher	in	the	HIV-exposed	population	than	HIV-unexposed	children	(2.5%	vs	0.6%),	although	the	95%	confidence	interval	for	the	HIV-exposed	group	includes	zero	due	to	the	very	small	sample	size	of	HIV-exposed	children	in	the	DSS.	 	The	ARTI	for	HIV-exposed	children	in	the	DSS	was	0.9%	(95%	CI:	0	–	7.2%)	and	0.2%	(95%	CI:	0.04	–	0.6%)	for	HIV-unexposed	children.	
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Table	A3.	Frequency	Distribution	 of	 Tuberculin	Data	 in	 Children	 Aged	Under	 5	years	Stratified	by	Risk	Group	and	HIV-exposure	status	
	 FREQUENCY	DISTRIBUTION	OF	TUBERCULIN	DATA	
INDURATION	
SIZE	
(MM)	
LOWER	RISK	GROUP	(N=4725)	 HIGHER	RISK	GROUP	(N=115)	HIV-EXPOSED	 HIV-UNEXPOSED		 HIV-EXPOSED	 HIV-UNEXPOSED			 n	 %	 n	 %	 n	 %	 n	 %	0	 225	 85.2	 3770	 84.5	 91	 52.9	 54	 55.1	2	–	3	 2	 0.8	 24	 0.5	 1	 5.9	 1	 1.0	4	–	5	 2	 0.8	 67	 1.5	 1	 5.9	 1	 1.0	6	–	7	 7	 2.7	 150	 3.4	 0	 0	 3	 3.1	8	–	9	 14	 5.3	 171	 3.8	 0	 0	 1	 1.0	10	–	11	 3	 1.1	 90	 2.0	 0	 0	 2	 2.0	12	–	13	 3	 1.1	 79	 1.8	 1	 5.9	 5	 5.1	14	–	15	 5	 1.9	 58	 1.3	 0	 0	 6	 6.1	16	–	17	 1	 0.4	 29	 0.7	 2	 11.8	 8	 8.2	18	–	19	 1	 0.4	 17	 0.4	 2	 11.8	 9	 9.2	20	–	21	 1	 0.4	 2	 0.1	 1	 5.9	 6	 6.1	22+	 0	 0	 4	 0.1	 0	 0	 2	 2.0		
Table	 A4.	 M.tb	 infection	 prevalence	 estimates	 and	 95%	 confidence	 intervals	stratified	by	HIV	exposure	and	contact	status	using	different	methods		
	
Method	to	
estimate	M.tb	
infection	
prevalence		
LOWER	RISK	GROUP	(DSS)	(N=4725)	 HIGHER	RISK	GROUP	(TB	HOUSEHOLD)	(N=115)	HIV-UNEXPOSED	N=4461	 HIV-EXPOSED	N=264	 HIV-UNEXPOSED	N=98	 HIV-EXPOSED	N=17	%	 (95	%	CI)	 %	 (95	%	CI)	 %	 (95	%	CI)	 %	 (95	%	CI)	TST	cut-off	 10	mm	 6.3	 (5.6	–	7.0)	 5.2	 (2.8	–	8.5)	 38.8	 (29.1	–	49.2)	 35.3	 (14.2	–	61.7)		 15mm	 1.9	 (1.5	–	2.3)	 1.8	 (0.6	–	4.2)	 29.6	 (20.8	–	39.7)	 29.4	 (10.3	–	56.0)	
Fixed	mirror		 1.3	 (1.0	–	1.6)	 1.5	 (0.4	–	3.7)	 40.8	 (31.0	–	51.2)	 41.2	 (18.4	–	67.1)	
Mixture	model	 7.0	 (3.7	–	10.6)	 7.5	 (0.07	–	15.2)	 32.7		 (11.8	–	55.5)	 37.2	 (19.7	–	52.3)	
Rust	&	Thomas	
model	
0.6	 (0.1	–	1.5)	 2.5	 (0.0	–	19.1)	 35.2	 (23.8	–	46.4)	 39.7	 (0.0	–	79.3)	
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Interpretation	of	findings	Using	the	Rust	and	Thomas	method,	prevalence	of	M.tb	infection	was	higher	in	children	 born	 to	 HIV-positive	 mothers	 compared	 to	 children	 born	 to	 HIV-negative	 mothers	 in	 the	 Karonga	 DSS	 as	 hypothesised.	 	 But	 findings	 of	 this	exploratory	analysis	should	be	interpreted	with	caution	and	not	over-stated	due	to	the	limited	sample	size.			Interestingly,	the	magnitude	of	the	effect	estimate	of	HIV-exposure	status	on	M.tb	prevalence	using	the	Rust	and	Thomas	method	to	analyse	tuberculin	data	in	this	study	is	similar	to	that	seen	in	a	cross-sectional	study	in	Uganda	where	children	born	 to	 HIV-infected	 mothers	 had	 a	 4-fold	 higher	 prevalence	 of	 Quantiferon	Gold-in-Tube	assay	(QFT-GIT)	positivity	compared	to	those	children	born	to	HIV-negative	 mothers	 (6.4%	 vs.	 1.5%;	 prevalence	 ratio	 4.3).4	 The	 corresponding	ARTI	 for	 HIV-exposed	 children	 and	 HIV-unexposed	 children	 in	 the	 Ugandan	study	was	approximately	2.5%	and	0.5%	respectively.		This	is	much	higher	than	the	ARTI	seen	in	both	HIV-exposed	and	HIV-unexposed	children	in	the	Karonga	DSS	 and	 is	 in	 keeping	with	 local	 epidemiology.	 	 The	 annual	 TB	 incidence	 (all	cases)	is	400	per	100,000	population	in	the	rural	district	in	which	the	study	in	Uganda	was	conducted,	whereas	in	Karonga	it	is	approximately	120	per	100,000	population.		However,	the	studies	are	not	entirely	comparable	because	the	prevalence	of	M.tb	infection	in	the	HIV-exposed	group	in	our	setting,	reflects	the	prevalence	of	M.tb	infection	in	HIV-exposed	uninfected	and	HIV-positive	children	as	the	child’s	HIV	status	was	 unknown,	whereas	 the	 Ugandan	 study	 only	 included	HIV-exposed	
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uninfected	 children.	 	 It	 maybe	 that	M.tb	 infection	 prevalence	 in	 HIV-exposed	uninfected	children	in	our	study	may	be	even	higher	if	HIV-positive	children	with	advanced	 immunosuppression	 have	 been	 included,	 as	 these	 children	 are	 less	likely	to	mount	a	response	to	tuberculin	even	if	infected	with	M.tb,11	leading	to	an	 underestimate	 of	 M.tb	 infection	 prevalence.	 	 Alternatively,	 HIV-positive	children	may	be	more	susceptible	to	M.tb	infection	following	exposure	than	HIV-exposed	uninfected	children	resulting	in	an	over-estimate	of	the	prevalence	of	
M.tb	infection	in	HIV-exposed	uninfected	children	in	our	population.		Either	way,	ART	for	prevention	of	mother	to	child	transmission	is	widely	used	in	the	DSS,12	and	the	proportion	of	infected	children	is	likely	to	be	very	low.		
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Exploratory	geo-spatial	analyses	in	the	Karonga	DSS	
Geo-positional	data	were	available	for:	(i)	all	children	in	the	baseline	TST	survey	and	cohort	study;	(ii)	diagnosed	smear-positive	TB	patients	from	2007	to	2012	(during	the	lifetime	of	the	children	included	in	the	baseline	survey);	and	all	adults	aged	≥15	years	in	the	DSS	with	HIV	and	antiretroviral	(ART)	use	status.		Exploratory	analyses	were	undertaken	to	examine	if	there	was	any	evidence	for	‘hotspots’	in	the	DSS	of:		i. smear-positive	TB	cases		ii. adults	with	diagnosed	HIV	infection		iii. adult	ART	use		iv. children	with	prevalent	M.tb	infection	from	the	baseline	TST	survey		v. children	with	incident	M.tb	infection	from	TST	cohort			
Brief	statistical	methods	Maps	were	generated	which	highlighted	areas	in	continuous	space	with	greater-than-expected	risk	of	each	outcome.	A	non-parametric	distance-based	mapping	approach	 was	 used,	 as	 this	 approach	 is	 less	 sensitive	 to	 asymmetric	 spatial	patterns	of	cases	and	controls	than	Kernel-density	estimation.1			These	‘hot	spot’	maps,	present	a	visual	representation	of	the	relative	risk	of	being	a	‘case’	or	a	‘control’	at	each	spatial	location.	Cases	were	defined	as	follows:	for	analysis	(i)	all	adults	aged	≥15	years	resident	in	the	DSS	from	2007	to	2012	with	diagnosed	smear-positive	TB	were	designated	as	cases,	and	all	adults	aged	≥15	years	without	smear-positive	TB	were	designated	as	controls;	for	analysis	(ii)	all	
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adults	aged	≥15	years	resident	in	the	DSS	in	2014	diagnosed	with	HIV	infection	were	defined	as	cases	and	all	those	with	known	HIV-negative	status	as	controls.		The	same	principle	was	repeated	for	(iii)	adult	ART	use,	and	(iv)	prevalent	and	(v)	incident	M.tb	infection	in	children.		A	colour	scheme	to	visually	highlight	‘hot	spots’	 was	 generated	 by	 creating	 100	 simulated	 datasets	 with	 randomly	permutated	case	labels,	with	each	simulated	dataset	representing	a	scenario	in	which	 the	overall	 ratio	of	cases	 to	controls	remains	constant	 (and	 identical	 to	observed	data)	but	in	which	the	case/control	status	is	independent	of	household	location.	 	 The	 distance-based	 algorithm	 is	 applied	 to	 each	 of	 the	 randomised	simulated	datasets	and	minimum	and	maximum	score	values	are	obtained	using	the	same	100	x	100	grid.		These	values	were	then	used	to	create	a	colour	scale	for	the	map.		Different	definitions	of	prevalent	 and	 incident	M.tb	 infections	were	examined,	including	TST≥10mm	cut-off	and	TST≥15mm	cut-off	for	prevalent	M.tb	infection	and	 TST	 conversion≥10mm	 and	 TST	 conversion≥13mm	 for	 incident	 M.tb	infection.	 Datasets	 were	 created	 using	 Stata	 version	 13.1	 for	 Mac	 (Stata	Corporation,	 College	 Station,	 TX)	 and	 ArcGIS	 10®	 software	 (Environmental	Systems	Research	Institute,	Redlands,	CA,	USA).	All	the	geospatial	analyses	were	undertaken	 in	 R	 (R	 Foundation	 for	 Statistical	 Computing,	 Vienna)	 using	 the	
hotspotr	package.3		
Results	Figure	 A1	 summarises	 the	 results	 of	 the	 geospatial	 analyses.	 	 Due	 to	confidentiality	issues,	hot	spot	maps	were	displayed	as	x	y	co-ordinates	on	a	grid	
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rather	 than	on	geographical	maps	as	areas	of	higher	HIV	prevalence/ART	use	were	easily	identifiable	from	the	map	of	the	DSS.		The	grids	generated	for	adult	HIV	prevalence	and	adult	ART	use	were	identical	so	the	only	the	grid	depicting	ART	use	in	the	DSS	is	displayed	in	the	figure.		There	was	no	evidence	of	a	hot	spot	of	 incident	M.tb	 infection	 in	 the	DSS	 using	 the	 definition	 of	 TST	 conversion	 ≥	13mm.	 	Map	 (d)	 shown	 below	 is	 generated	 using	 TST	 conversion	 ≥10mm	 to	define	incident	M.tb	infection	and	in	map	(c)	definition	of	prevalent	infection	was	TST≥15mm	 in	 those	 aged	 2-4	 years.	 There	was	 no	 evidence	 of	 a	 hot	 spot	 of	prevalent	 M.tb	 infection	 in	 children	 using	 the	 more	 sensitive	 cut-off	 of	TST≥10mm.		
	
Figure	A1.	 ‘Hotspot’	maps	in	the	Karonga	demographic	surveillance	area.		KEY:	Red	areas	highlight	score	values	greater	than	the	95th	percentile	of	the	maximum	value	from	the	randomly	permuted	maps;	blues	area	highlight	score	values	 less	 than	5th	percentile	of	 the	minimum	value	from	the	randomly	permuted	maps.		
(c) Child prevalent M.tb infection
(a) Adult Sm+ TB prevalence (b) Adult HIV/ART prevalence
(d) Child incident M.tb infection
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Interpretation	of	findings	There	was	no	evidence	of	a	hot	spot	of	either	prevalent	smear-positive	TB	cases	in	the	DSS	between	2007-2012	and	no	evidence	of	a	hot	spot	of	prevalent	M.tb	infection	in	children	aged	2-4	years	in	the	DSS.		There	was	also	no	evidence	of	hotspot	 of	 incident	M.tb	 infection	 using	 the	 definition	 used	 in	 the	 risk	 factor	analysis	 in	Chapter	5	(TST	conversion	≥13mm).	However,	when	using	the	less	stringent	 cut-off	 of	 TST	 conversion	 ≥	 10mm	 to	 define	 incident	M.tb	 infection,	there	was	evidence	of	a	hotspot	of	incident	M.tb	infection	in	the	same	area	of	the	DSS	as	the	hotspot	of	adult	HIV	prevalence/ART	use	in	the	DSS.		This	 is	 an	 exploratory	 ecological	 analysis	 and	 findings	 should	 not	 to	 be	 over-interpreted.	Especially	in	view	of	the	fact	that	there	was	no	evidence	of	a	hot	spot	using	the	TST	conversion	≥13mm	as	the	definition	of	incident	M.tb	infection.		This	may	 have	 been	 because	 of	 reduced	 power	 due	 to	 a	 smaller	 sample	 of	 ‘cases’,	compared	 to	 using	 TST	 conversion≥10mm	 as	 the	 definition	 of	M.tb	 infection.	However,	the	finding	of	the	hot	spot	of	incident	M.tb	infection	albeit	using	the	less	stringent	definition	in	the	same	location	as	the	hotspot	of	adult	HIV/ART	use	does	lend	itself	to	generating	a	study	hypothesis	that	should	be	further	investigated.	Namely,	is	HIV/ART	use	driving	community	M.tb	transmission,	as	inferred	from	TST	conversion	in	pre-school	children	in	some	areas	in	the	DSS?			
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